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ABSTRACT
The nucleotide sequence of sacbrood virus (SBV) which causes a fatal infection of 
honey bee larvae has been determined. The genomic RNA of SBV is longer than that 
of typical mammalian picomaviruses (8854 nucleotides) and contains a single, large 
open reading frame (201-8774) encoding a polyprotein of 2858 amino acids. 
Sequence comparison with other virus polyproteins revealed regions of similarity to 
characterized helicase, protease and RNA-dependent RNA polymerase domains; 
structural genes were located at the 5' terminus with non-structural genes at the 3' end. 
Picomavirus-like agents of insects have two distinct genomic organizations; some 
resemble mammalian picomaviruses with stmctural genes at the 5' end and non- 
stmctural genes at the 3' end, and others resemble calicivimses in which this order is 
reversed; SBV thus belongs to the former type. Sequence comparison with 
mammalian, insect and plant picorna-like vimses suggested that SBV is most closely 
related to infectious flacherie virus (IFV) of the silk worm, which possesses an RNA 
of similar size and gene order, although this relationship is distant. A reverse 
transcription-polymerase chain reaction (RT-PCR) has been developed using SBV 
specific primers which was able to amplify part of the polymerase gene from all the 
strains in SBV tested and to distinguish between SBV and black queen cell vims 
(BQCV). Partial sequence information was also obtained from BQCV and acute bee 
paralysis vims (ABPV).
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CHAPTER 1 
INTRODUCTION
Introduction
1.1 Honey bees
Honey bees are members of the order Hymenoptera. Apis mellifera (Latin 
meaning 'honey bearing bee') is the only British species of its genus and almost 
entirely farmed. Honey bees are social animals which live in organised permanent 
communities and the colony stores enough food during the summer to keep it alive 
through the winter. The colony consists of variable numbers of drones (males) whose 
sole purpose is to fertilise the queen. These die after doing so or are killed by the 
worker bees and do not overwinter. There may be more than 50,000 workers (sterile 
females) and a queen who lays eggs (Burton, 1974). Worker bees do all the work of 
the hive; feeding the queen, drones and larvae, cleaning the hive, keeping off 
intruders, building up the cells and collecting nectar and pollen. When foraging bees 
return to the hive after a successful sortie they do a remarkable dance (waggle-dance) 
to indicate to other foragers the location of the food supplies (Davies, 1967).
Eggs to produce queens are laid in large rounded cells and larvae are fed on a 
richer diet (royal jelly) than the worker bees which grow in typical hexagonal comb 
cells. The queen lays eggs in each cell continuously for 3-4 years, when she is killed 
by the workers. When the hive gets overcrowded, the old queen will fly out of the 
hive, taking half the colony (app. 30,000 bees) with her and set up a new hive, a 
process called swarming. The old queen leaves behind several developing queen 
larvae, and the first to emerge kills all the other queens whilst still in their cells; after 
a mating flight the new queen begins egg laying (Burton, 1974). The four major 
stages in honey bee development are shown in Figure 1.1.
Larva
Pupa
Adult
Figure 1.1 The four major stages in honey bee development.
Adapted from Winston (1987)
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1.2 History of sacbrood
Sacbrood, a disease of the larvae of honey bee Apis mellifera, was first 
described by White (1913) who attributed the condition to a virus (White, 1917). The 
virus itself; sacbrood virus (SBV), was first obtained by Bailey et al. (1964). SBV 
appears to be the most widely distributed of all the honey bee viruses and infects 
colonies of A. mellifera in every continent of the globe. Although SBV causes a 
serious disease of bee larvae, it also infects adult worker bees. However infection in 
the adult fails to produce outward physical signs of the disease (Bailey, 1969; 
Anderson & Gibbs, 1989), although such adults may have a decreased life span 
(Bailey, 1969; Wang & Moller, 1970; Bailey & Fernando, 1972).
Honey bees are important to agriculture as they pollinate many crops and 
sacbrood reduces their efficiency in this role (Bailey & Fernando, 1972; Anderson & 
Giacon, 1992). This effect is most marked on those plants that flower during spring or 
early summer when sacbrood is at its height (Anderson & Giacon, 1992). The disease 
is of commercial importance because the effects of the virus on both larvae and adults 
weaken the colony leading to a drop in honey production. Consequently, honey bee 
viruses are increasingly of interest to both bee researchers and beekeepers. In the 
United Kingdom this has been stimulated by the association of these viruses with the 
parasitic mite Varroa jacobsoni recently discovered in this country (Allen & Ball, 
1996).
Diseases of bees can be separated into two groups - those which affect larvae 
and those which affect adult bees. Without exception all the known pathogens are 
specific for the one or the other insect stage (Bailey, 1968). There are now at least 
eighteen viruses known to be associated with the honey bee (Allen & Ball, 1996;
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Bailey & Ball, 1991). The majority of bee viruses are RNA viruses (Ball & Bailey, 
1991). Only SBV of these eighteen viruses appears to attack the larval stage of the 
bee rather than the adult.
1.3 Sacbrood virus
The Electron microscopical study shows that SBV particles are nonenveloped, 
round and featureless in appearance and 28 nm in diameter (Figure 1.2). A high 
proportions of particles appear to be 'empty' when negatively stained with neutral 
sodium phospho-tungstate (PTA) because the stain penetrates and fills the interior. 
These empty particles are fragile and are best seen when the virus preparations are 
fixed in 1% formaldehyde for 15 minutes before PTA staining (Bailey, 1976). The 
particles have a sedimentation coefficient of 160S (Break & Kralik, 1965; Lee & 
Furgala, 1965; Bailey, 1968) and a buoyant density in CsCl is 1.33-1.34 g/cm^ (pH 
7.0-9.0) (Newman et al., 1973). The nucleic acid of SBV is RNA shown by a positive 
orcinol test and negative diphenylamine reaction (Lee & Furgala, 1965). The 
A:C:G:U base composition of single stranded nucleic acid is 
32.1%: 17.9%: 19.1%:30.9% (Newman et al., 1973). The SBV RNA has G+C content 
of 37-39% which is significantly lower than that of any mammalian picomaviruses 
except human rhinoviruses (40%) (Newman gr al., 1973). SBV resembles rhinovims 
in acid stability being unstable below pH 5.0. The vims RNA has been estimated as 
2.6x10^ (Moore et al., 1985) which would give a genome size of 7.5 Kb. The 
molecular mass of SBV capsid proteins has been reported as 25, 28, and 31.5 kDa 
(Bailey et al., 1976).
:Figure 1.2: Electron micrograph of SBV particles from Apis mellifera.
X 200,000. Provided by Dr. B. V. Ball.
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1.4 Effects of sacbrood virus infection
1.4.1 In larvae
Healthy bee larvae pupate 4 days after they have been sealed in their cells by 
the worker bees. However larvae infected with SBV fail to pupate and remain as 
healthy prepupae, stretched on their backs with their heads towards the cell capping. 
Usually adult bees detect infected larvae one or two days after they have been sealed 
in their cells and eject them from the colony (Bailey et a l, 1964). If not removed, the 
final larval skin becomes detached from the pupal integument as usual but then 
instead of being shed, becomes a tough transparent sac accumulating much ecdysial 
fluid around the developing pupa. This fluid resembles the ecdysial fluid produced by 
a healthy individual but unlike these, larvae with sacbrood can not dissolve the thick 
endocuticle (Fernando, 1972), so they are unable to shed their final skin and fluid 
accumulates abnormally beneath it. It is possible that SBV prevents the formation of 
chitinase (needed to dissolve the endocuticle) because virus may continue to multiply 
in the epidermis or the dermal moulting glands, where the enzyme is normally 
secreted and pass from there into the ecdysial fluid. At this time of death a larva may 
contain in excess of 10^^ particles of SBV. At this stage the body colour of the larva 
changes from pearly white to a pale yellow. A few days after it has died, the dead 
larvae dry up to form flat brown gondola shaped scales (Bailey, 1975) (Figure 1.3). 
The LD50 of SBV for 2-day-old larvae is 10^ to 10^ particles in their food but the 
viability of SBV decreases rapidly in dead larvae and no infectious virus remains after 
3 weeks.
SBV infection particularly affects the brain and the corpora allata which 
control the moulting processes through hormones production (Break & Kralik, 1965).
Figure 1.3: Honey bee (Apis mellifera) larvae infected with sacbrood virus 
leading to formation of scales.
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Surgical removal of the corpora allata causes excessive production of moulting fluid 
within the tough cuticle and mimics this characteristic of the disease, suggesting that 
the virus attacks the glands affecting hormone secretion (Fyg, 1959).
1.4.2 In the adult bee
Adult honey bees (A. mellifera) appear normal 12 days after injection with
purified SBV. However 5 days after injection viral inclusions were observed in thin
sections of fat-body tissue from injected bees (Lee & Furgala, 1965). Following
natural infection SBV multiplies in the brains of infected bees, especially drones, and
in the hypopharyngeal glands of worker bees, without causing symptoms (Bailey &
2
Fernando, 1972). The extract of each infected head contained about 10 lethal doses
(LD50S) of SBV for larvae when given in their food. Young adult bees are readily
2
infected by ingesting the virus, the infective dose for them by mouth is about 10 
larval LD50 . The infective dose of SBV by injection for adults is about 10”^  of the 
LD50 in food for larvae (Bailey, 1969). SBV accumulates to the extent of 0.1 mg of 
virus in the head of an infected worker and most of it is in the brain (Bailey, 1976). A 
crude extract in 0.05 ml saline of the brain of one drone infected with SBV contains 
sufficient virus to be detected readily by immunodiffusion test (Bailey & Fernando, 
1972). Adult bees infected with SBV suffer a decreased metabolic rate and shortened 
life, they become more susceptible to chilling and fail to collect pollen. Infected bees 
then die of premature senility (Bailey & Fernando, 1972). The foraging behavioural 
changes observed in bees after SBV infection including a permanent loss of appetite 
for pollen, are identical to those which occur after bees have been briefly 
anaesthetised with carbon dioxide (Bailey, 1969).
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1.5 Spread of SB V
Transmission of sacbrood disease can occur in two ways. The virus may be 
transmitted from diseased brood to healthy brood within a colony and also from a 
diseased colony to a healthy one. The virus of sacbrood produces the disease when it 
is added directly to the food of young larvae or when it is mixed with syrup and fed to 
a colony and therefore sacbrood may result whenever the food or water used by the 
bees contains the viable virus (White, 1917).
Although larvae are easily infected by feeding them SBV at any time of the 
year, sacbrood usually disappears spontaneously in late summer under natural 
circumstances and fails to spread much even when combs containing many diseased 
larvae are then placed in bee colonies (Hitchcock, 1966). Probably this is because 
adult bees quickly detect larvae with sacbrood and remove them from the bee colony 
(Bailey et al., 1964).
In spite of virtual disappearance of SBV in summer, the failure of the virus to 
remain infective for long and the absence of larvae in winter, the disease is perennial 
and very common (Bailey, 1976). This gap is bridged by an inapparent infection of 
adult bees with SBV. Many adult bees are infected because the youngest workers, 
which are most susceptible, remove larvae killed by sacbrood. During this process 
they are contaminated and may ingest liquid constituents of the larvae, especially 
ecdysial fluid. Subsequently the SBV begins to collect in the hypopharyngeal glands 
of infected adult bees and transmits sacbrood when they feed larvae with secretions 
from these glands (Bailey, 1975).
However bees are usually prevented from transmitting the virus by 
behavioural changes (Bailey & Fernando, 1972). They fly and forage, do so much
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earlier in life than is usual and they almost all fail to collect pollen (Bailey, 1975). 
Because of this the young bees soon cease to feed and tend larvae. Those few bees 
which do collect pollen, bring SBV back in their pollen loads, each load containing 
about 10^ virus particles, secreted by the bees from their glands into the liquid they 
add to the pollen when they collect it. As only a few infected bees collect pollen, few 
susceptible larvae which rapidly consume pollen become infected (Bailey, 1976). The 
possibility of transmission of SBV through contamination of flowers visited by bees 
is probably quite remote, it is however, theoretically possible.
1.6 Occurrence of SBV
SBV is widespread but cases of severe disease are few (Bailey, 1968). It has 
been estimated in surveys in England and Wales that over 80% of all diseased honey 
bee larvae that were free of bacterial pathogens were infected with SBV and up to 
30% of apparently healthy colonies contained a few larvae killed by the virus (Bailey, 
1967).
SBV has been reported from the USA, Trinidad and Tobago, Brazil, 
Denmark, Lativa, Spain, U.K, former USSR, Egypt, Iran, Philippines, Thailand, 
Western Australia and Hawaii (Matheson, 1995). In most of the cases it produces 
overt disease in brood. In Germany, SBV has been detected in adult bee samples from 
two bee colonies (Ball & Allen, 1988). It has been reported to be the most common 
honey bee virus and occasionally causes serious losses of brood in Australia (Dali, 
1985). SBV was detected as an inapparent infection in more than 40% of healthy 
worker pupae (Anderson & Gibbs, 1988), as an overt infection in more than 90% of 
colonies (Anderson, 1983) and in 10% of samples of dead queen larvae (Anderson,
Introduction
1993) in Australia. Many other countries have been found to have SBV present in 
their bees (Allen & Ball, 1996).
1.7 Inactivation of SBV
White (1917) has reported a number of ways by which SBV can be destroyed; 
such as heating in water for 10 minutes at 59°C, in glycerine for 10 minutes at 70^C 
or in honey for 10 minutes at 70®C. He also showed that larvae dead from sacbrood 
ceased to be infectious in less than one month after death if left in the brood comb. 
SBV is also destroyed in 6-7 hours by exposure to the direct sunlight when the virus 
is dry, and even faster, 4-6 hours when suspended in honey. Putrefactive processes 
inactivate SBV in 7-10 days depending upon the temperature.
1.8 Picornavirus-like agents infecting the honey hee
A number of other small RNA viruses affecting honey bees, have physico­
chemical properties similar to members of the Picomaviridae. The position of all 
these viruses within the family Picomaviridae is under review (Murphy et ah, 1995). 
The biophysical properties of picorna-like honey bee viruses have been presented in 
Table 1.1. They are discussed briefly as follows.
1.8.1 Thai sachrood virus (TSBV)
Bailey et al. (1982) obtained a strain of SBV from larvae of the Eastern honey 
bee. Apis cerena, sent from Thailand and North East India. This strain of virus was 
called Thai sacbrood virus (TSBV). Unlike SBV, TSBV frequently causes severe 
brood mortality in its host and is reported to have destroyed more than 95% of
w
O Û
Ï S5 CO
4-1 s
o
o
A
T3
o ”co
&
O
4-1 VO
o >
.a
>r>
CO
I
I
§
P3
w
UC/3
u
>
(N
d
in
00<N
in
i n c qCO O n
CO CO CN
i n
CO
c s CO
v d
in
Tf
in
in
cn
CO
CO
i n CO i > t > VO
c q c q c q c q c q c q c q c q
00 00 O  O  
(N  (N  CO CO
:S
in
in
?
d
CO
O O O in
CO CO CO CO
T301
CO
CO
C/3
8c3
s
c3C4
P l 4
8
o (D
g (D
. ac r r O
1 I 1
X
'§ 3  * _ _
o o H P Q < U X c n < p q
1 
a.
8  S I  111
i.
*0
!!lî 
§ • «  
a i
it
Introduction
colonies in the Hindukush-Himalyan region in the early 1980s (Verma et ah, 1990). 
In 1990s TSBV caused the loss of up to 10,000 colonies in the state of Kerala in 
India. One of the significant features of TSBV is that only about 5% of the colonies in 
affected areas survive infection (Verma et al., 1990). TSBV has also been reported 
from Nepal (Allen & Ball, 1996) and China (Feng, 1990). In China sacbrood in A. 
cerena is termed 'Chinese sacbrood' but the virus is serologically indistinguishable 
from TSBV (Feng, 1990). TSBV infects A. mellifera in the laboratory (Bailey et al., 
1982). However it does not cause overt disease in this species in regions where both 
A. cerena and A. mellifera co-exist (Allen, 1995). Verma et al. (1990) reported that 
Apis cerena colonies surviving from TSBV disease, showed disease symptoms 
(failure to cover brood by nurse bees, tendency to abscond, increased aggressiveness 
and reduced ability to clean out dead brood) with more severity in parent colonies 
compared to subsequent generations where there was gradual improvement and 
colonies showed normal behaviour. Therefore, they suggested that some mechanism 
of resistance to TSBV disease exists in Apis cerena.
This isolate is found to be serologically related to SBV of Apis mellifera but it 
has its own physico-chemical properties which distinguish it from SBV (Bailey et al., 
1982). TSBV contains a single stranded RNA of molecular weight 2.8x10^ and it 
produces three close but well defined bands of protein on 5% SDS-acrylamide gels 
with apparent molecular weights of 30.2, 34 and 38.7 kDa (Bailey et al., 1982).
1.8.2 Black queen cell virus (BQCV)
BQCV was first isolated from dead queen larvae and prepupae (Bailey & 
Woods, 1977a). The queen pupae darken as they decompose and the walls of the cell
10
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often become almost black in patches (Bailey, 1982). BQCV multiplies abundantly in 
adults when these are also infected with Nosema apis (a common microsporidian 
parasite of adult bees) causing shortened life (Bailey et al., 1983). Bailey et al. (1981) 
reported presence of BQCV in about 15% of over 300 samples of adult bees from 
Britain during 1979 and these samples were also infected with N. apis. In Australia 
the most common cause of death of queen larvae was found to be BQCV which was 
detected serologically in 19% of diseased samples and at low levels in all apparently 
healthy adult queens examined by infectivity tests (Anderson, 1993). In Greece, 
BQCV was detected in 28% of diseased worker larvae from colonies infested with the 
mite V. jacobsoni (Allen & Ball, 1996).
The BQCV particle, like SBV is also a round and featureless particle, 30 nm 
in diameter which contains RNA. They have a sedimentation constant of 153S, a
3
buoyant density in CsCl of -1.34 g/cm and one major capsid protein of 30 kDa. The 
virus is serologically unrelated to any other known bee virus (Bailey & Woods, 
1977a; Bailey & Woods, 1977b).
1.8.3 Acute bee paralysis virus (ABPV)
ABPV has been detected in A. mellifera from most regions of the world 
including Britain (Bailey et a l, 1981), France, Italy, Canada (Bailey, 1965), New 
Zealand (Anderson, 1988) and Australia (Reinganum, 1969). It commonly persists as 
an inapparent infection in adult bees but large amounts of ABPV have been detected 
in dead adult bees and diseased brood from colonies in Europe and the USA infested 
with V. jacobsoni. Thus ABPV is a major cause of mortality in mite infested colonies 
(Ball & Allen, 1988; Batuev, 1979; Kulinsevic et al.,1990). The virus does not
11
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multiply in bee larvae. ABPV has also been detected in five bumble bees {Bombus 
species) in Britain (Bailey & Gibbs., 1964) and is the only honey bee virus that is 
known to have an alternative host in nature (Allen & Ball, 1996). In mixed infection 
experiments in the laboratory ABPV always predominates because of its more rapid 
replication rate (Ball & Allen, 1988) (see section 1.9).
ABPV particles are non-enveloped, featureless, and 30 nm in diameter with a 
single stranded RNA. Some appearing empty when negatively stained in PTA. They 
sediment in two fractions, corresponding to the full and empty particles, at 160S and
3
80S. The virus particles have a buoyant density in CsCl of 1.34 g/cm at pH 7.0 and 
are insensitive to ether. Virion proteins yield three bands on 15% SDS- 
polyacrylamide gels with molecular mass of 35, 33 and 24 kDa (Allen & Ball, 1995). 
The nucleic acid has a base ratio (A:C:G:U) of 30.3:20.5:18.8:30.4 (Newman et al., 
1973). In all these aspects ABPV and SBV are very similar. However they are 
serologically unrelated.
1.8.4 Chronic bee-paralysis virus (CBPV)
CBPV was one of the first viruses of honey bees to be identified and induces 
symptoms of trembling and flightless clusters of bees are seen crawling at the hive 
entrance (Bailey et al., 1963). The virus is endemic in apparently healthy colonies in 
Britain (Allen & Ball, 1996). CBPV kills bees in about 8 days when injected into the 
hemolymph whereas ABPV causes mortality in about 4 days (Bailey et al., 1963). 
CBPV has naked ellipsoid particles, and can be resolved into three or four 
components in the analytical ultracentrifuge or in sucrose density gradients, with 
sedimentation constants of about 82, 97-106, 110-124, and 125-136S (Bailey et ah.
12
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1963). All these components taken from sucrose gradients have modal lengths of 
about 30, 40, 55 and 65 nm. However, all have a modal width of about 22 nm. These 
particles are serologically indistinguishable and all have the same buoyant density of
3
1.33 gm/cm in CsCl (Bailey, 1976). All of them contain a single major type of 
protein of 23.5 kDa (Bailey & Woods, 1977a). The base ratio (A:C:G:U) of the 
nucleic acid is 24:28:20:28 (Bailey, 1968).
Both CBPV and APBV may persist as inapparent, sublethal infections in adult 
bees and they may be readily detected in live individuals from apparently normal 
colonies by sensitive infectivity tests.
1.8.5 Kasmir bee virus (KBV)
KBV was first isolated from Eastern honey bee Apis cerena, from Kashmir 
(Bailey & Woods, 1977b). Several serologically related strains of KBV have been 
found in Apis mellifera in Australia (Bailey et al., 1979; Anderson, 1985), Fiji 
(Anderson, 1990), Canada (Allen & Ball, 1995; Anderson, 1985; Stoltz et ah, 1995), 
Spain (Allen & Ball., 1995) and the U.S.A (Bruce et a l, 1995; Hung et a l,  1995, 
1996). Hung et al. (1996) reported the first occurrence of both ABPV and KBV in the 
same honey bee colony. In laboratory conditions KBV is the most virulent of all 
known honey bee viruses and injection of only a few particles into the hemolymph of 
adult bees or brood causes their death within three days (Bailey et al., 1979). 
However, like other bee viruses KBV has also been found as inapparent natural 
infection in honey bees (Bruce et al., 1995). Stoltz et al. (1995) have demonstrated 
that the polypeptide profile of this virus is similar to a typical picornavirus i.e. three 
major polypeptides in the range of 2 0 ^ 0  kDa and a much smaller one (5.6 kDa).
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KBV particles are round and featureless in appearance, about 30 nm in 
diameter with an RNA genome (Bailey et a l, 1981). KBV has a sedimentation
3
constant of 172S and buoyant density in CsCl of 1.37 g/cm (Bailey & Woods, 
1977b). The virus contains a single stranded RNA with estimated size of 9.5 kb 
(Allen & Ball, 1996). Several strains of KBV are serologically related to ABPV 
(Allen & Ball, 1995).
1.8.6 Chronic bee-paralysis virus associate (CPVA)
CPVA is a satellite virus which depends upon CBPV for its replication. The 
virus is 17 nm across, contain RNA and have a sedimentation constant of 46S. They 
are serologically unrelated to any known bee virus (Bailey et a l, 1980). As CPVA is 
specifically associated with CBPV, it is probably present in all countries where 
CBPV has been detected (Allen & Ball, 1996).
1.8.7 Slow bee-paralysis virus
Slow bee-paralysis virus was originally detected as an inapparent infection of 
adult honey bees in Britain and has been shown to shorten their lives in laboratory 
infections (Bailey & Woods, 1974). The virus has naked, featureless, isometric 
particles and 30 nm in diameter. The virus contains RNA and has a sedimentation
3
constant of 173-178S, with a buoyant density in CsCl of 1.37 gm/cm . The particles 
contain three major proteins of 27, 29 and 46 kDa (Bailey & Woods, 1977b).
14
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1.8.8 Arkansas bee virus
Arkansas bee virus was first detected as an inapparent infection of adult honey 
bees in Arkansas. The virus substantially reduces the lives of honey bees in laboratory 
infections (Bailey & Woods, 1974). The virus has naked isometric particles, 30 nm 
across with a sedimentation constant of 128S and a buoyant density in CsCl of 1.37
3
gm/cm . These contain RNA and a major protein of 41 kDa. They are not 
serologically related to any known honey bee viruses (Bailey & Woods, 1977b).
1.8.9 Bee virus X
Bee virus X multiplies in the gut of adult bees and significantly shortens the 
lives of infected bees (Allen & Ball, 1976). The virus has been detected in colonies in 
every continent except in Asia. The virus has naked, featureless, isometric particles, 
35 nm in diameter and contain RNA. They have a sedimentation constant of 187S, a
3
buoyant density in CsCl of 1.37 gm/cm and contain one major protein of 54.5 kDa 
(Bailey & Woods, 1977b).
1.9 Honey bees, virus and Varroa jacobsoni
V. jacobsoni was first noticed as an ectoparasite of A. cerena (Oudemans, 
1904). This mite now parasitizes A. mellifera from all the continents of the world 
except Oceania (Matheson, 1995). The impact of Varroa mite on colonies of 
European honey bees seemed to be more attributable to the transmission of viruses 
than the feeding activities of the mite (Ball, 1985). Furthermore, Ball (1989) and 
Bailey & Ball (1991) suggested that Varroa acts primarily as an activator of ABPV 
replication and secondly as an ABPV vector. Therefore, ABPV is a primary cause of
15
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adult bee and brood mortality in honey bee colonies severely infested with V. 
jacobsoni (Ball & Allen, 1988). In laboratory experiments, Batuev (1979) and 
Wiegers (1988) showed that Varroa could transmit ABPV because the virus was 
detected in the control pupae after Varroa mites were transferred from ABPV- 
positive pupae to healthy pupae. However, Hung et al. (1996) demonstrated that 
transmission of ABPV and KBV did not require Varroa as they found inapparent 
ABPV or KBV infection in pupae in colonies without Varroa. Therefore, they 
indicated that the impact of the Varroa mite is mainly the activation and not the 
transmission of the virus. ABPV has never been found to be responsible for mortality 
in nature (Ball & Allen, 1988). However, ABPV has been identified in large amounts 
in field-collected bees from Belize (Bailey et al., 1980) and also in Russia (Batuev, 
1979) where infection with this virus was associated with infestation of the colonies 
by V. jacobsoni.
SBV has been detected in large amounts in dead adult bees from colonies 
infested with V. jacobsoni in Poland (Topolska et al., 1995) and Germany (Ball & 
Allen, 1988). V. jacobsoni has been found to transmit SBV from severely infected to 
healthy pupae (Ball, 1989) however the possible role of the mite in the infection and 
mortality of adult bees with SBV is not understood. V. jacobsoni was first discovered 
in 1992 in Devon in Southern England (Paxton, 1992). In all about 298 apiaries were 
known to be infested in 1992. BQCV has been reported in German bee colonies with 
medium and high mite populations (Ball & Allen, 1988).
16
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1.10 General characteristics and gene organization of small positive strand RNA 
viruses of mammals and insects
Positive strand RNA viruses represent the largest and most diverse group of 
viruses (Francki et ah, 1991). Viruses of this type infect bacteria, plants and animals 
(Dolja & Carrington, 1992). Based on the sequence alignment of RNA-dependent 
RNA polymerase, positive strand RNA viruses are divided into three supergroups as 
in Figure 1.4 (Koonin, 1991; Dolja & Carrington, 1992). Picoma-like viruses belong 
to one of the subgroups of supergroup 1 (Strauss et al., 1996). The viruses in the 
families Picomaviridae, Caliciviridae, Comoviridae, Nepoviridae and Sequiviridae 
are called picorna-like viruses (Strauss et al., 1996; Shen et al., 1993; Turnbull-Ross 
et al., 1993). A single superfamily may embrace a wide variety of genome 
organizations. SBV is one of many insect viruses generally referred to as 
picornavirus-like, largely on the basis of biophysical properties and possession of an 
RNA genome (Moore et al., 1985). But the classification of SBV has been hampered 
because of insufficient information about the genome structure. The two most 
common types of genome organizations in picorna-like superfamily are picornavirus- 
like and calicivirus-like. The picornavirus genome has a single large open reading 
frame (ORF) and the capsid proteins are encoded in the 5' terminus of the genome. In 
contrast, the calicivirus genome may contain separate ORFs, and the capsid proteins 
are always encoded in the 3' terminus of the genome. The common organization of 
the picornavirus genome and calicivirus genome are illustrated in Figure 1.5 and 1.6 
respectively.
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1.10.1 Picornavirus
Picornaviruses are small icosahedral particles with no envelope and have a 
particle size of 24-30 nm in diameter. Some of the picornaviruses (enteroviruses, 
cardioviruses, Theiler's murine encephalomyelitis virus and hepatitis A virus (HAV) 
are acid stable, surviving pH 3.0 or even lower where as others (rhinoviruses and
I
apjthoviruses) are labile below pH 6.0. Picornaviruses differ widely in buoyant density 
depending on the genus. The enteroviruses and cardioviruses have a buoyant density 
in CsCl of 1.34 g/ml whereas equine rhinoviruses and some of the apjthoviruses band 
at 1.45 g/ml (reviewed in Rueckert, 1996). Picornaviruses typically contain four 
polypeptides with approximate molecular weights of 33.5 (VPl), 30 (VP2), 26.4 
(VP3) and 7.4 (VP4) kDa (Kitamura et a l, 1981). The capsid is composed of 60 
protein subunits each consisting of these four proteins. They contain a single 
molecule of infectious, positive sense, ssRNA of 7-8.5 kb in size with a 5' 
untranslated sequence of variable length followed by a single long open reading
3
frame (ORF) encoding the polyprotein precursor (Mr 240-250x10 ) to both structural 
proteins (PI) and non-structural proteins (P2, P3). This is followed by a short 
noncoding sequence and a poly (A) tract of variable length (Murphy et al., 1995). The 
small protein VPg (or 3B) is attached covalently to the 5'-terminal nucleotides of the 
genomic RNA. This is present on all picornaviruses and its removal does not affect 
translation (Wimmer, 1982). The length of this protein varies from 20 amino acids in 
cardioviruses to 23/24 amino acids in foot-and-mouth disease virus (FMDV). FMDV 
however, encodes three VPg genes in tandem, all three being attached to the RNA but 
all other picornaviruses encode only one (King et a/.,1980).
18
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The 5' UTR of picornavirus RNA is unusually long compared to the 
homologous region of cellular messages and ranges in size from 624 nucleotides to 
1200 nucleotides (reviewed by Rueckert, 1996). Picornavirus RNAs lack the 5'- 
terminal cap structure (m^GpppN) found on all cellular mRNAs and their 5' UTR 
contain extensive secondary structure and often multiple AUG codons. These features 
are unfavourable for cap dependent initiation of protein synthesis. Studies have 
shown that picornavirus polyprotein synthesis follows internal binding of ribosomes 
to sequences within the 5' UTR, termed internal ribosome entry site (1RES) (Pelletier 
& Sonenberg, 1988; Bienkowska et ah, 1988; Jang et al., 1988, 1989). This region 
consists of around 450 nucleotides upstream of the authentic initiation codon and 
contains extensive secondary structure which is believed to be essential to its 
functions as 1RES (Jackson et al., 1990). The secondary (and presumably also 
tertiary) structure of the 1RES has been considered more important than its primary 
sequence possibly because these structures act to present several quite short primary 
sequence motifs, most of them in unpaired loops and bulges, in the correct three- 
dimensional spatial array (reviewed by Jackson & KamiiTski, 1995). Although the 
ribosome makes contact with the sequences dispersed through out the 1RES, the 
actual ribosome entry site in all the picornavirus 1RES es is at the 3' end, some 25
r
nucleotides downstream from the start of the universal oligopyrimidine tract 
(reviewed by Jackson & Kaminiski, 1995). Three classes of 1RES elements have been 
identified in the picornavirus 5' UTR. The 1RES elements of poliovirus (PV) (and 
other enteroviruses) together with the rhinoviruses (classed as type I) are different 
from encephalomyocarditis virus (EMCV) and FMDV 1RES elements (classed as 
type II). The 1RES elements of HAV form type El which shares some similarity with
19
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the cardiovirus and a^hovirus 1RES elements (reviewed by Jackson & Kaminski, 
1995; Ehrenfeld, 1996). There is little sequence similarity between groups apart from 
the presence of polypyrimidine tract at the 3' end of the 1RES (Jackson et ah, 1994). 
There is limited sequence conservation within a group (less than 50% between 
different members). However, secondary structure conservation within type I and II of 
1RES elements is good.
In PV 3' end of the 1RES lies at around 600 nucleotides and 5' end of the 1RES 
lies around 130 nucleotides (Pellitier & Sonenberg, 1988; Pilipenko et al., 1992). In 
EMCV 3' end of the 1RES is found to be close to the initiation codon at 834 
nucleotides, whereas no translation was found on deletion of 421 nucleotides from 
the 5' end of the 1RES (Jang & Wimmer, 1990). The 1RES element in FMDV lies 
within 369 to 805 nucleotides (Belsham & Brangwyn, 1990).
All the picornavirus 1RES elements contain a polypyrimidine tract of around
12-15 nucleotides in length preceding the polyprotein reading frame (Kuhn et al.,
1990; reviewed by Jackson et a l, 1994; Jackson & Kaminiski, 1995). In cardiovirus
and arbovirus 5' UTRs this tract is situated close to the initiator codon. However in
enterovirus and rhinovirus 5' UTRs the oligopyrimidine sequence could be found in
nucleotide 560-570 region. These oligopyrimidine tracts are involved in initiation of
translation as its mutational alteration in this region result in inefficient protein
synthesis (Jang & Wimmer, 1990). A critical sequence of UUC(C) in the 5' of the
tract has been found to be important in PV 1RES. However mutations in the rest of
the tract had no effect on 1RES functions (lizuka et ah, 1989; Pestova et ah, 1991).
k5' UTR of some picornaviruses (cardiovirus and ap^hovirus) contain poly (C) 
tracts. In cardiovirus the tract lies about 150 nucleotides from the 5' end whereas in
20
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ap^hovirus it is present about 400 nucleotides from the 5’ end (Chumakov & Agol, 
1976; Perez-Bercoff & Gander, 1977; Harris & Brown, 1976; Rowlands et a l, 1978). 
Length of the poly (C) tract has been found to be important in determining virulence 
of some picornaviruses. Duke et al. (1990) reported that shortening of the long poly 
(C) region markedly reduced the virulence of mengovirus but not of apthovirus. 
Furthermore, natural isolates of cardioviruses containing longer length are more 
virulent but it has not been found apparently in arboviruses (reviewed by Rueckert, 
1996).
Picornaviruses shut off host cell translation by cleavage of the translation 
initiation factor eIF4G (formerly termed p220 or eIF47), a member of the cap binding 
complex, eIF-4F (the others are elF4A, elF4B and eIF4E), which collectively 
recognise the capped 5' terminus of mRNA, unwind mRNA secondary structure and 
permit the scanning by the 40S ribosomal subunit for the initiation codon (Merrick, 
1992; Rhoads, 1993). The cleavage of eIF4G is mediated by the enterovirus and 
rhinovirus 2A proteases (Krausslich.gr al, 1987) and FMDV leader (L) protease 
(Devaney et al. 1988).
The full length polyprotein is never detected within cells as it is 
cotranslationally processed to functional proteins by the virus coded proteinases 
(Figure 1.7). There are 3 different types of virus coded proteinases for the 
picornaviruses (L, 2A and 3C). Various genera of picornaviruses use distinct 
processing sites and catalytic mechanisms. In enteroviruses and rhinoviruses the 2A 
portion of the nascent polyprotein is able to cleave between the P1-P2 junction. In 
these 2 genera cleavage takes place at the (Y,T,H,A,V)-G dipeptide pair that marks 
the junction of the PI and P2 regions. Cardioviruses and apthoviruses achieve
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efficient primary cleavage of the polyprotein through the use of a unique self 
cleavage mechanism between the glycine and proline of the sequence NPGP 
spanning the 2A-2B junction (Ryan et ah, 1991). The cleavage between PI and 2A in 
these 2 groups appears to be mediated by 3C (Jackson, 1986; Parks et al. 1986; 
Vakharia, et al 1987; Clark & Sangar, 1988). The mechanism and site(s) used for 
initial cleavage in hepatitis A virus have not been determined as neither the 
distinguishing catalytic sequence for protease nor the reactive tetrapeptide sequence 
are present (Palmenberg, 1990). Both arboviruses and cardioviruses possess a leader 
or L protein. However, only L proteins of FMDV and equine rhino virus serotypes 1 
have been demonstrated to have proteolytic activity (Strebel & Beck, 1986; Wutz et 
al., 1998). The cleavage of the L/Pl bond is catalysed by FMDV L proteins where as 
the cleavage of the L/Pl junction in EMCV takes place by 3C (Parks et al., 1986). 
The 3C protease of mammalian picornaviruses is responsible for the majority of the 
polyprotein processing events. In PV, 3C mediated cleavages occur at Q/G sites. 
However, other picornaviruses can utilise other dipeptide sequences. The 3C 
proteinase of EMCV cleaves at Q/G, Q/S, E/S while in FMDV the 3C cleavage sites 
appear to be E/G, E/S, V/G, Q/T, Q/L and Q/1 amino acid pairs. It has been 
demonstrated that not all potential cleavage sites are recognised by the 3C 
proteinases. In PV, only 9 out of 13 predicted Q/G pairs in the polyprotein are 
cleaved (Toyada et al., 1984). Therefore, the proteolytic cleavage may also be 
influenced by amino acid sequences flanking these sites. The cleavage sites of 
enterovirus and rhinovirus polyproteins usually have an aliphatic residue (e.g. 
alanine) in the P4 position (P^ denotes the wth residue amino terminal to the cleaved 
peptide bond and P^' denotes the nth residue carboxy terminal to the cleaved bond)
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and cardioviruses seem to prefer proline at the ?2  or P2 ' location (Nicklin et al, 
1986; Palmenberg et al, 1984). The cleavage of VPO into VP4 and VP2 in 
mammalian picornaviruses occurs at the final step of virus morphogenesis (capsid 
assembly). The cleavage site is buried within the particle and is probably cleaved 
autolytically (reviewed by Rueckert, 1996).
This cleavage processes ultimately generate 11 or 12 end products (Figure 
1.7) (reviewed by Rueckert, 1996). The PI region is ultimately cleaved into four coat 
proteins called lA (VP4), IB (VP2), 1C (VP3) and ID (VPl). The P2 polyprotein 
encodes for three proteins, 2A, 2B and 2C. Protein 2A is a protease. The role of 2A 
peptides are variable among the different members of the Picomaviridae. In 
enteroviruses and rhinoviruses, 2A molecule is a protease and catalyse the cleavage 
that marks the junction [(Y, T, H, F, A, V)- G] of the PI and P2 region. This 2A 
protease also cleaves a cellular protein, elF4G leading to shut off of host cell-specific 
protein. The 2A-coding sequences are strongly conserved among all the enteroviruses 
and rhinoviruses and these two groups of viruses share a catalytic triad (H20 , Dgg 
and CiQq). Thus 2A proteases resemble small trypsin-like serine proteases in 
structure (Palmenberg, 1990). However, the 2A proteins of cardioviruses and 
apthoviruses do not bear any visible relationship to the required and conserved 
catalytic triad of the enterovirus and rhinovirus 2A protease. The picornaviruses 2B 
gene is a host range determinant. Mutants of HRV2 selected to grow in murine cell 
appear to have selectively altered in the sequences found in protein 2B (Yin & 
Lomax, 1983). Studies have also shown that this protein is involved in RNA 
synthesis (Bernstein et al, 1985).
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2C protein is involved in RNA synthesis (Li & Baltimore, 1988). It has been 
found that 2C regions of these viruses show a typical nucleotide triphosphate (NTP) 
binding domain made up of 3 conserved motifs (A, B, and C) identified by Koonin & 
Dolja (1993). All positive strand RNA viruses with over 6 Kb genome size encode a 
RNA helicase. An exception to this rule is that human astrovirus genome though 
about 7.2 Kb in length, does not encode a helicase (Jiang et ah, 1993). RNA helicases 
are believed to involved in duplex unwinding during viral RNA replication 
(Gorbalenya & Koonin, 1989). Positive strand RNA virus helicases have been 
classified into 3 distinct superfamilies, each of them also includes cellular and DNA 
viral helicases (Gorbalenya et a l, 1988a, b, 1989, 1990). Helicases of picoma-like 
vimses belong to superfamily III. Although, there is no direct evidence that 2C 
protein of picorna-like viruses have helicase activity, mutagenesis experiments and 
sequence similarity identified 2C as a potential NTP binding protein led to the idea 
that 2C may be a helicase (Dmitrieva et a l, 1991; Teterina et a l, 1992).
The P3 region encodes for four proteins 3A, 3B, 3C and 3D. 3B protein is 
usually referred to as VPg, which is derived from a precursor 3AB. The cleavage 
product 3B is covalently attached to the 5' terminal uridylic acid of picomavims 
RNAs and is the smallest known protein to be generated by these vimses. 3B is 
believed to be involved in initiating RNA synthesis (Pallansch et a l, 1980). The 
mutations in poliovims 3 A affected uridylylation of VPg and selectively inhibited the 
initiation of plus-strand viral RNAs (Giachetti & Semler, 1991).
The 3C or its precursors 3CD protease mediates most of the cleavages, except 
early cleavages of the nascent polyprotein carried out by the L or 2A proteases. There 
are 2 main classes of positive-strand RNA vims proteases: i. Chymotrypsin-like
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cysteine and serine proteases and ii. papain-like cysteine proteases. Chymotrypsin- 
like enzymes comprise the largest class of viral proteases (Koonin & Dolja, 1993). 
Sequence alignments suggest that 3Cs of mammalian picornaviruses and insect and 
plant picoma-like vimses are members of chymotrypsin-related cysteine proteases. 
The sequence conservation in the viral chymotrypsin-like cysteine proteases is largely 
confined to 4 conserved motifs. Three of these motifs form the catalytic triad (H40 , 
Dg5 and C 147 in PV and equivalent residues in other picomavimses and picoma- 
like insect and plant vimses) and the fourth distal motif is implicated in substrate 
binding (Koonin & Dolja, 1993).
3D is a polymerase and is involved in elongating nascent RNA chains from an 
RNA template (Flanegan et al., 1977). RNA-dependent RNA polymerase of all the 
positive-strand RNA vimses share a set of 8 conserved motifs (Koonin & Dolja, 
1993). This enzyme is capable of elongating nascent RNA chains from an RNA 
template (Flanegan et al 1977).
The 3' UTR is relatively short ranging from 47 nucleotides in HRV14 
to 126 nucleotides in EMCV. This region is believed to be important at some stage of 
replication as insertions in this region produce temperature sensitive phenotype 
(Sarnow et al., 1986). However, Todd et al. (1997) reported that complete deletion of 
the 3' UTR of PVl and HRV14 had no significant effect on initial rounds of 
replication in tissue culture. The length of poly (A) tract of picomavims varies, 
ranging from 35 nucleotides in EMCV to 100 nucleotides in FMDV. The function of 
poly (A) is unknown but short poly (A) tract appears to be associated with lower 
infectivity (Sarnow, 1989; Spector &Baltimore, 1974). Poly (A) tract was shown to 
be necessary for infectivity of EMCV (Goldstein et al., 1976).
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1.10.2 Calicivirus
Caliciviruses are small, nonenveloped, 34-38nm in diameter, covered by cup 
like depression and composed of a single major capsid protein 60-70 kDa in size. A 
smaller capsid protein component of approximately 15 kDa has also been reported 
(Bachrach & Hess, 1973; Burroughs & Brown, 1978). The genome of the virus is 
single strand of positive sense RNA of 7.5-8.3 kb in size (Carter & Madeley, 1987; 
Schaffer et al., 1980) and a small protein, VPg is attached covalently at its 5' end 
(Burroughs & Brown, 1978).
The caliciviruses were originally classified as members of the Picomaviridae 
(Fenner, 1976). However presence of only one major structural polypeptide as well as 
their replication strategy, argued for their removal to a separate family (Schaffer et 
al., 1980). The genome of calicivirus is variable but a typical virus, like the feline 
calicivirus has three ORFs. Non-structural proteins are encoded at the 5' end in a 
separate ORF (ORFl) and capsid protein is encoded toward the 3' end by a second 
region (0RF2) separated from ORFl by a termination codon and a change in frame 
(Neill, 1991, Carter et al., 1992; Cubitt et al., 1995). However in some caliciviruses 
e.g. rabbit haemorrhagic disease virus and European brown hare syndrome virus, 
these two genes are fused in frame (ORF 1/2) and translated to form a single large 
polyprotein. A small third ORF at the extreme 3' end (ORF3) is present in most of the 
caliciviruses, but the function of this protein has not yet been determined (Herbert et 
al., 1996). In hepatitis E virus a third gene is located internally spanning the junction 
of ORFl and 2 (reviewed by Carter, 1994). Production of subgenomic RNA of 2.4-
2.7 kb in size, derived from the 3' terminus of the virus RNA is the major source of 
capsid protein.
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1.11 Diagnosis of honey bee viruses
Bailey et al. (1963) first obtained two viruses (ABPV and CBPV) from adult 
honey bees Apis mellifera and since then more serologically unrelated viruses have 
been obtained from the honey bee than from any other insect species (Bailey, 1981). 
Bailey et al. (1980) reported a method for obtaining most viruses of honey bees. This 
method uses purification of virus from the diseased honey bees and then examination 
of the concentrated virus by electron microscopy or the presence of virus particles can 
be confirmed using gel diffusion tests (Mansi, 1958). However genetic purity of 
honey bee viruses is a constant problem because most bees are already infected with 
multiple viruses (Bailey et ah, 1981; Hornitzky, 1981; Anderson, 1983).
Since there is no in vitro system for the propagation of honey bee viruses, 
virus can only be grown in vivo using white eyed pupae. Moreover these are not 
necessarily free of endogenous viruses, many of which may actually be activated by 
the inoculation procedure itself. Control inoculations with buffer alone activate 
inapparent virus infections in the pupae and cause contamination (Hung et al., 1996). 
Consequently, there is always the chance that preparations of any particular virus may 
be contaminated with one or more additional viruses and it is difficult to produce 
truly mono-specific antisera. This is a continuing problem for all tests based on 
serology. Moreover the sensitivity of gel diffusion test is poor and use of electron 
microscopy for testing large numbers of extracts is laborious. Bailey et al. (1981) 
suggested for the use of enzyme-linked immunosorbent assays (ELISA) method for 
detecting viruses in honey bees during surveys or where large numbers of samples 
require testing. Anderson (1984) showed that Radioimmunoassay (RIA) and ELISA 
tests were approximately one thousand times more sensitive than immune serum
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electron microscopy (ISEM) in detecting the particles of BQCV, CBPV, KBY and 
SBV (Anderson, 1984), however non-specific reactions were detected using RIA 
possibly due to limitations in specificity as above. Surprisingly no such non-specific 
reactions occurred using the ELISA method (Anderson, 1984). Stoltz et al. (1995) has 
used a molecular approach to detect KBY in infected bees by reverse transcription 
polymerase chain reaction (RT-PCR) using primers based on the sequence from virus 
RNA polymerase. The primers amplified a 417 nucleotide amplicon from the infected 
pupae. However, the same primers generated an amplicon of identical size from both 
ABPY and BQCY infected bees. Thus led Stoltz and colleagues to suggest possible 
contamination of the samples with KBY. KBY was readily distinguished from 
APBY, a closely related isolate by using monospecific antisera raised against the 
putative picomavirus-like YP4 polypeptide (Stoltz et al., 1995). In view of the 
difficulties in obtaining truly monospecific sera, viruses could be best distinguished 
using monoclonal antibodies or molecular means. However, at present no monoclonal 
antibodies to SBY exist.
1.12 Interactions of SBV with other honey hee viruses
There are some reports of interactions between inapparent virus infections in 
insects. Inapparent virus infections are rather common in honey bees (Hung et ah, 
1996; Dall,1985., Anderson & Gibbs, 1988; Bailey & Gibbs, 1964). A bee pupa may 
be inapparently infected with several viruses simultaneously (Anderson & Gibbs, 
1988). However often virus levels are below the threshold for detection by either the 
immunodiffusion test or even more sensitive enzyme-linked immunoabsorbent assay. 
The inapparent infections of honey bee viruses could be activated and replicated to
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detectable concentrations by the injection of rabbit sera, extracts of healthy bees 
(Dali, 1985), potassium phosphate buffer or by the infestation of V. jacobsoni (Hung 
et a l, 1996). Anderson & Gibbs (1988) demonstrated that KBV suppressed the 
replication of activated of SBV and BQCV. The ability of KBV to suppress activated 
SBV replication may be because KBV replicates faster than SBV or there may be a 
more specific inhibitory phenomenon such as competition for replication sites.
1.13 Evolution of positive-strand RNA viruses
The origin of RNA viruses is a topic of great deal of discussion and 
controversy. However many people are of the view that viruses arose from cellular 
elements that acquired the ability to self replicate and self assemble. Once a primitive 
protovirus existed the various families of RNA viruses arose from this ancestral 
protovirus through evolutionary divergence, including recombinational events 
(reviewed by Strauss & Strauss, 1988).
RNA viruses evolve rapidly and their genome is quite plastic and diverge very 
rapidly. The rate of mutation in RNA virus genome is approximately 10"^ per 
nucleotide per round of replication (Smith & Inglis, 1987; reviewed by Roosnick, 
1997; Steinhauer & Holland, 1987) which could be in part due to the lack of proof­
reading activity in RNA replicases. As there is very high rate of mutation and large 
number of rounds of replication of an RNA virus per year, the potential rate of 
divergence in the nucleotide sequence is very rapid and the virus populations are 
likely to be extremely heterogeneous. To describe this situation, the term 
'quasispecies' has been used, especially an equilibrium of RNA molecules each 
differing from the consensus at one or more locations (reviewed by Domingo, et al..
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1985). However most replicase errors are either neutral (e.g., by inserting silent 
mutations without changing the coding potential) or deleterious in which case they 
fail to become established ( reviewed by Strauss, et al., 1996).
Recombination also plays an important role in the positive strand RNA virus 
evolution. The recombination often occurs in natural systems. The intertypic 
recombinants have been isolated from individuals vaccinated with the trivalent oral 
poliovirus vaccines (Kew & Nottay, 1984; Minor et al., 1986; Cammack et al., 1988). 
Rico-hesse et al. (1987) reported recombinations between vaccine and wild-type 
strains of poliovirus. The sequence of coxsackievirus A21 indicates that the virus is a 
recombinant in which 2000 nucleotides at 3' end have been donated by a poliovirus 
(Hughes, et al., 1989). The 5' UTR of enterovirus 70 is very similar to that of 
polioviruses but rest of the genome is very divergent (Ryan et ah, 1990). Thus 
recombinations between closely related viruses could play a role in the virus 
evolution.
Another mechanism, introduction of cellular genetic information into the 
virus genome, might also be involved. A togavirus with an inserted sequence 
encoding animal ubiquitin has been isolated (Meyers, et al., 1989). An influenza virus 
variant containing a 28S ribosomal RNA insert in the haemagglutinin gene has also 
been reported (Kdiatchikian et al., 1989). The structural and functional homology of 
the picomavirus capsid to concanavalin A and similarity of the eukaryotic trypsin-like 
proteases with that of 2A and 3C picomavirus proteins indicates that picomavimses 
may have acquired information from cellular nucleic acids (Rossmann & Johnson, 
198<%.
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As RNA viruses evolve rapidly only important functional motifs are likely to 
be conserved in the wide range of virus groups. The comparison of sequence data 
from plant, insect and mammalian RNA viruses has led to a greater understanding of 
the rate of divergence of RNA viruses in nature. Positive strand insect viruses of the 
family Nodaviridae have two genome segments packaged together in an isometric 
particle. Both RNAs are capped and polyadenylated and the capsid protein is 
translated from a subgenomic message like caliciviruses (Dasmahapatra et al., 1985). 
Thus identification of an insect virus family with characteristics of both plant and 
animal viruses has led to the idea that the prototype positive strand virus originated in 
insects (reviewed by Strauss & Strauss, 1988).
Analyses of the replication mechanisms and genome structures suggested 
evolutionary relationships among the picorna-like viruses from mammals and plants. 
All picorna-like plant viruses (como-, nepo-, and potyviruses) share with true 
picomavimses and these vimses are all somehow genetically linked as they encode a 
number of non-stmctural proteins which display similar functions and significant 
amino acid homology (reviewed by Goldbach, 1987).
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1.14 Project outline
In the light of the discussions about honey bee viruses presented in the 
previous session it is clear that no information is available about the genome 
organization and replication strategy of the SBV. Also there is a need for specific and 
sensitive diagnostic technology to ascertain the presence of SBV in a honey bee 
colony which may have inapparent virus infections. Therefore the aims of the project 
are as follows:
i. To synthesize cDNA from the SBV genomic RNA and determine its
nucleotide sequence.
ii. To analyse the genomic organization of SBV as a possible member of the
Picomaviridae by comparing the sequences of SBV with published sequences 
available for other viruses.
iii. To develop sensitive diagnostic methods for detection of SBV in honey bees.
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List of materials used and suppliers are given in appendix 1. Details of 
common solutions and buffers used are found in appendix 2.
2.1 Sterilization and removal of unwanted nuclease activities
All media and buffers were sterilised by autoclaving at 1210C for 15 minutes 
at a pressure of 15 Ib/in^. Milli-Q water was used in the preparation of all media and 
buffer solutions and referred to as 'water' throughout this thesis. To obtain good 
preparations of RNA it is necessary to minimise the activity of RNAases. DEPC 
treated water was used in all the reactions containing RNA, otherwise autoclaved 
deionised water was used. Gloves were worn at all time to stop contamination with 
RNases from hands. RNase ZAP (Invitrogen) was used to remove surface RNase 
contamination.
2.2 Virus source
All the infected larvae (scales)/pupae and semi-purified virus samples were 
provided by Dr. B. V. Ball of Rothamsted, U. K. Details of the samples are as 
follows:
i. SBV infected larvae (scales) {Apis mellifera) from a natural outbreak in Devon,
U. K. Scales were stored frozen at -70°C until required.
ii. Semi-purified virus samples of German strain of SBV from an infected German 
bee colony {Apis mellifera) and TSBV was obtained from an infected colony (Apis 
cerena) in India.
iii. Freeze-dried white eyed pupae {Apis mellifera) inoculated with BQCV and ABPV 
in Rothamsted, U.K.
SBV from the U. K. was used for cDNA cloning and nucleotide sequencing 
and referred as SBV-UK and SBV from Germany is referred as SBV-G throughout 
this thesis.
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2.3 Virus Purification
2.3.1 Purification of virus on caesium chloride
SBV-UK infected larvae were homogenised in 5 ml NT buffer and the 
macerate was clarified at 3000 g for 10 minutes. The supernatant was extracted with 
an equal volume of 1,1,2-trichlorotrifluro ethane before the aqueous phase was 
layered over a discontinuous CsCl gradient (1.5 g/cm^ and 1.2 g/cm^) and 
centrifuged at 270,000g for 1 hour in a Sw50 rotor. The caesium interface was 
harvested and adjusted to a volume of 5 ml (final density 1.38 g/cm^) with CsCl 
solution and centrifuged at 270,000 g overnight. Two light scattering bands were 
formed which were collected separately, diluted with NT buffer and virus was 
collected by sedimentation at 270,000 g for 1 hour. Pellets were resuspended in NT 
solution.
2.3.2 Semi-purified virus
Freeze-dried infected larvae/pupae were soaked with NT buffer for 10 minutes 
and then homogenised and clarified as before (section 2.3.1). The clarified 
supernatant was centrifuged at 270,000 g for 1 hour after extraction with equal 
volume of 1,1,2-trichlorotrifluro ethane. The pellet was resuspended in NT buffer.
2.4 Extraction of RNA
2.4.1 Extraction of RNA from Virus sample
RNA extraction from both pure virus and semi-purified virus was carried out 
using RNAzol B (Biotecx Laboratories, Inc.), according to the manufacturer’s 
instructions. The RNAzol B procedure is a modification of that used by Chomczynski 
& Sacchi (1987). RNAzol B contains guanidinium thiocyanate and phenol which 
promotes the formation of complexes of RNA with guanidinium and water 
molecules, thereby abolishing the hydrophilic interactions of DNA and proteins. As a
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result of this, DNA and proteins are efficiently removed from the aqueous phase, 
while RNA remains in the aqueous phase during sample extraction.
0.9 ml of RNAzol B was added to 0.1 ml of resuspended purified or semi­
purified virus and mixed by passing it through a 1 ml micropipette. 100 \il of 
chloroform was added and the solution was mixed vigorously for 15 seconds by hand 
prior to a 5 minutes incubation on ice. The suspensions were centrifuged at 12000 g 
for 15 minutes at 4®C to separate the phases. The upper aqueous phase was removed 
and an equal volume of isopropanol added to it, mixed and incubated for 15 minutes 
on ice. The sample was centrifuged at 12,000 g for 15 minutes at 4®C and the 
resulting pellet was washed in 75% (v/v) ethanol. The pellet was then dried and 
resuspended in DEPC treated water. The amount of RNA recovered was assessed 
spectrophotometrically. RNA not used immediately, was precipitated by the addition 
of 2.5 volumes of ethanol and sodium acetate (pH 5.0) to a final concentration of 0.1 
M and stored at -70°C until required.
2.4.2 Extraction of RNA from sf21 cells
Healthy sf21 cells (gift from Dr. Margaret Carter) were lysed directly by the 
addition of RNAzol B solution to the monolayer. A total of 5 ml was used to 
solubilise the monolayers of 25 cm^ tissue culture flasks. 100 \il of chloroform was 
added per ml of the homogenate and then RNA extraction was carried out as in 
section 2.4.1.
2.5 Agarose gel electrophoresis of DNA
Electrophoresis grade agarose was dissolved in IX TBE to either 1.2 or 2% by 
boiling and poured into a flat-bed electrophoresis apparatus. Once set, IX TBE was 
added to the gel tank, and the gel comb was removed. Samples were mixed in equal 
volume with 2X TBE plus 20% glycerol and marker dyes (bromophenol blue and 
xylene cyanol FF) and loaded. The gel was electrophoresed at 100 to 150 volts for
36
Materials and Methods
various length of time (30 minutes to 1.5 hours) depending on requirements for a 
small (50 x 75 mm) gel. Ethidium bromide was added in both dissolved agar and 
running buffer at a concentration of 0.5 pg/ml. DNA bands were visualised using a 
UV transilluminator and an image taken using the Gel documentation system (GDS) 
(UVP Imagestore 5000).
When agarose gel electrophoresis was used for purification of DNA fragments 
for subsequent ligation into a plasmid vector, UV exposure was minimised as UV 
light causes nicking of the DNA (Sambrook et al., 1989).
2.6 Restriction enzyme digestion of DNA
Restriction enzymes were supplied by Boehringer Mannheim and New 
England Biolabs and digests were performed according to the manufacturer's 
instructions. The total reaction volume was altered according to the amount of DNA 
to be digested. For analytical digests, 0.2 pg of DNA was added to 1 |xl restriction 
enzyme buffer and 1 pi (10 Units) of restriction enzyme and the reaction made up to 
10 pi with water. The reaction was then incubated for 1-2 hours at 37^C and analysed 
with EcoR I/Hind m  digested lambda markers on 1.2% or 2% TBE agarose gel. 
Larger scale digests for preparation of vectors and fragments were performed using 
10 pg of DNA in a 50 pi volume.
2.7 Preparation of DNA size markers
DNA size markers (21.7, 5.15, 5.0, 4.27, 3.28, 1.98, 1.90, 1.59, 1.37, 0.96, 
0.84 and 0.56 kbp) were produced by digestion of the bacteriophage Lambda DNA 
with the restriction enzymes EcoR I and Hind m.
2.8 Extraction of DNA with phenol/chloroform
An equal volume of Phenol/chloroform was added to the DNA solution and 
mixed by gently inverting the tube. The aqueous and organic phases were separated
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by centrifugation at 12,000 g for 2 minutes and the aqueous phase containing the 
DNA was transferred to a fresh tube.
2.9 Preparation of vector for ligation
To reduce the level of vector self ligation, 5'-phosphate groups were removed 
from the linear vector DNAs using calf intestinal alkaline phosphatase (GIF) as per 
the method of Sambrook et a/.(1989). 10 pg of circular plasmid DNA 
(pcDNAn/pMAL-c) was digested with appropriate restriction enzyme (EcoR I/Sac I) 
for 2 hours. 0.2pg of this digested DNA was analysed by electrophoresis on 1.2% 
agarose gel using undigested plasmid DNA as marker for completion of digestion. 
Linear plasmid DNA was then purified using Wizard DNA clean-up system 
(Promega) (section 2.13.3). To dephosphorylate the 5' ends of the DNAs, 5 pi of lOX 
CIP buffer and 1 pi of CIP (1 Unit/pl) (Boerhinger) were added to 45 pi of purified 
linear DNA eluted in water. The reaction mix was incubated at 37®C for 30 minutes. 
A second aliquot of CIP was added to the reaction mix and the incubation was 
continued for further 30 minutes. At the end of the incubation 1.25 pi of 0.2 M EDTA 
was added and heated to 70°C for 10 minutes and chilled on ice. The DNA was 
further extracted twice with phenol/chloroform, electrophoresed on an agarose gel 
and purified using QIAquick gel extraction kit (Promega) (section 2.13.2). The 
purified DNA was diluted to 20 ng/pl in EB buffer.
2.10 Preparation of competent E, coli
Competent cells were prepared using the method described by Inoue et ah 
(1990). About 10 large (2-3 mm in diameter) colonies were used to inoculate to 250 
ml of SOB medium in a 2-liter flask, and grown at 18°C, with vigorous shaking 
(200-250) to an OD^qo 0.6. The culture was cooled on ice for 10 minutes and spun 
at 2500g for 10 minutes at 4®C. The pellet was resuspended in 80 ml of ice-cold 
transformation buffer (TB) incubated in an ice bath for 10 minutes and the bacteria
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were pelleted by centrifugation as before. The cell pellet was gently resuspended in 
20 ml of TB, and DMSO was added with gentle swirling to a final concentration of 
7%. After incubating in an ice bath for 10 minutes, the cell suspension was aliquoted 
in 0.5 ml amounts in a prechilled cryotubes and immediately chilled by immersion in 
liquid nitrogen.
2.11 Transformation and colony Growth
50 pi of E. coli strain DH5a competent cells were transformed with 5-10 ng 
DNA of the ligation mix as per the method of Hanahan (1983). 50 pi of competent 
cells were defrosted on ice. 5-10 ng of DNA was added and gently mixed. The cells 
were allowed to stand on ice for 30 minutes, followed by a 45 seconds heat shock at 
42°C. They were then placed on ice for 5 minutes before 0.2 ml of 2YT medium was 
added and cells were shaken (225 rpm) at 37°C for 1 hour to allow expression of the 
antibiotic resistance gene on the plasmids to allow the detection of recombinants by 
blue/white screening as inserted DNA will disrupt a-complementation of the S- 
galactosidase gene. They were spread onto 1.2% bacto-agar plates containing 
ampicillin, X-gal and IPTG (appendix 2). Alternatively, the transformation mix was 
spread onto 1.2% bacto-agar plates containing only ampicillin. The plates were 
allowed to dry and then inverted before incubating at 37°C overnight.
2.12 Storage of bacterial colonies
For short term, bacterial colonies remained viable at 4°C. Colonies which 
needed to be kept for any length of time were prepared as follows:
850 pi of fresh overnight culture of a colony was taken into 1.5 ml eppendorf 
tube, 150 pi sterile glycerol was added and the mixture vortexed for 5 seconds and 
stored at -70^C.
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2.13 Purification of DNA
2.13.1 Purification of plasmid DNA
Purification of plasmid DNA was carried out routinely by the alkaline lysis- 
diatomaceous earth method (Carter & Milton, 1993). 1.5 ml of an appropriate 
overnight culture was put into a microcentrifuge tube and the cells were pelleted 
using a microcentrifuge for 30 seconds. The supernatant was discarded and the pellet 
was resuspended in 200pl resuspension buffer by whirlmixing. 200 pi of lysis buffer 
was added, mixed for 2 minutes by inverting the tube until the suspension became 
clear. 200 pi of neutralization buffer was then added and mixed by inverting. A 
precipitate was found and immediately centrifuged for 5 minutes at 12,000 g. The 
supernatant was removed to a fresh tube and 1 ml of diatom suspension was added, 
mixed by inverting and left for 5 minutes to the plasmid DNA to bind - keeping the 
diatoms in suspension by occasional inverting. The diatoms were pelleted by 
centrifuging at 12,000 g for 30 seconds, and the supernatant was removed. The pellet 
was washed twice using 1 ml of pellet wash solution each time and pelleting the 
diatoms as before. Finally, the diatoms were washed with 1 ml of acetone and dried 
for 5 minutes at 65®C. To elute the plasmid DNA the dried pellet was resuspended in 
100 pi water and heated at 65®C for 2 minutes while keeping the diatoms in 
suspension. The diatoms were removed by centrifuging for 2 minutes at 12,000 g and 
the supernatant containing plasmid DNA was transferred to a fresh tube and 2 pi of 
this preparation was analysed by electrophoresis on an agarose gel.
Alternatively, plasmids to be sequenced were purified by a modified 
minialkaline-lysis/PFG precipitation procedure as stated in PRISM Ready Reaction 
Dye Deoxy ™ Terminator cycle sequencing kit protocol. Rev. B (Perkin Flmer). The 
key feature of this method of plasmid extraction is the PFG precipitation step which 
yields high-quality supercoiled plasmid DNA that is relatively free of contaminating 
chromosomal DNA and RNA.
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2.13.2 Purification of DNA fragments from an agarose gel
After size fractionation in agarose gel, it was often necessary to recover DNA 
fragments for use as a probe in hybridisation techniques or cloning into a vector. The 
DNA bands of interest were excised from the ethidium bromide stained agarose gel 
and purified with QIAquick gel extraction kit (Quiagen), according to the 
manufacturer's instructions. 3 volumes of buffer QG was added to the weighed piece 
of the gel in a microcentrifuge tube and heated to 50°C for 10 minutes to dissolve the 
gel slice. 1 gel volume of isopropanol was added to the sample for purifying DNA 
fragments <500 bp. The sample was then applied to the QIAquick column placed on a 
2 ml collection tube and centrifuged for 1 minute at 12,000g. 0.5 ml of buffer QG was 
pipetted into the column and centrifuged as before. To wash 0.75 ml of buffer PE was 
added to the column, left for 5 minutes at room temperature and centrifuged as 
before. The flow-through was discarded and the column was centrifuged for an 
additional 1 minute at 12,000g. To elute the DNA 30pl of buffer EB was added to the 
center of the column, left for 1 minute and then centrifuged as before.
2.13.3 Purification and concentration of DNA
DNA samples were concentrated and purified from restriction enzymes and 
salts using Wizard DNA clean up system kit (Promega) according to the 
manufacturer's protocol. 1 ml of Wizard DNA clean-up resin was added to the DNA 
sample (50-500 pi) and mixed by inverting several times. The Resin/DNA mix was 
pipetted into a 2 ml syringe barrel fitted to the Luer-Lock extension of the 
minicolumn. The slurry was then gently pushed into the minicolumn with the 
plunger. The syringe was detached and the plunger was removed. The syringe barrel 
was reattached to the minicolumn and 2 ml of 80% isopropanol was pushed through 
the minicolumn. The syringe was removed and the minicolumn was transferred to a
1.5 ml microcentrifuge tube and centrifuged for 20 seconds at 12,000 g to dry the 
resin. The minicolumn was left at room temperature for 15 minutes to evaporate the
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residual isopropanoL The minicolumn was transferred to a new microcentrifuge tube, 
45 pi prewarmed (70°C) water was added to the center of the column, left for 1 
minute and centrifuged at 12,000 g for 20 seconds.
2.14 Cloning of SBV-UK RNA
Figure 2.1 illustrates the cloning strategy employed for SBV-UK RNA.
2.14.1. First strand cDNA synthesis
RNA from purified or semi-purified virus was diluted to the required 
concentration in DEPC treated water, heated to 65°C for 10 minutes and then quickly 
chilled in ice. The first strand DNA was synthesised from RNA using Superscript II 
RNase H-reverse transcriptase (Gibco BRL) as per the manufacturer's instructions. 
This enzyme generally give higher yields of cDNA and more full length product than 
other reverse transcriptases. A 50 pi reaction volume was used for approximately Ipg 
RNA from purified virus or 10 pg RNA from semi-purified virus. 30 pi DEPC 
treated water containing RNA was mixed with 2.5 pi oligo (dT) 12-18 (500 pg/ml) or 
SBV-UK genome specific primer (500 pg/ml). The mixture was heated to 70®C for 
10 minutes and quickly chilled on ice. The contents of the tube were collected by 
brief centrifugation and then 10 pi 5X first strand buffer, 5 pi O.IM dithiothreitol 
(DTT) and 2.5 pi 10 mM dNTP mix (10 mM each of dATP, dGTP, dCTP and dTTP) 
were added. The contents of the tube were mixed gently and incubated at 42°C for 2 
minutes. 2.5pl (500 Units) of Superscript I reverse transcriptase was added to the 
reaction tube, mixed gently by pipetting up and down and then incubated at 42®C for 
50 minutes.
2.14.2 Second strand cDNA synthesis
The first strand reaction mix was used directly in the second strand synthesis 
reaction as per Gubler & Hoffman's (1983) modifications of the method of Okayama
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Figure 2.1: Cloning strategy of SBV-UK RNA.
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& Berg (1982) using 'BRL cDNA synthesis system' kit. In this method RNase H is 
used to cleave RNA which is in the RNA/DNA hybrid form and DNA polymerase I 
then uses the fragments of nicked RNA as primers to synthesise the second strand of 
cDNA.
The following components were thawed on ice and added to the chilled 50 pi 
first strand reaction mix: 7.5 pi 10 mM dNTP mix, 40pl lOX second strand buffer,
100 Units E. coli DNA polymerase I, 2.8 Units E. coli RNase H and water to 400 pi. 
The reaction mix was incubated at 16®C for two hours and terminated by the addition 
of 25 pi 0.2 M EDTA. The second strand reaction mix was then extracted with 400 pi 
phenol-chloroform, and the aqueous extract containing the double stranded cDNA 
was washed twice with equal volumes of ether to remove residual phenol. Residual 
ether was removed by heating at 65®C for 5 minutes. The cDNA was precipitated by 
the addition of 0.1 volumes of 3 M sodium acetate (pH 5.0) and 2.5 volumes of 
ethanol, followed by chilling at -70^0 for 40 minutes or overnight at -20®C. The 
precipitated cDNA was pelleted by centrifugation at 13000 g for 15 minutes. The 
pellet was washed in 70% (v/v) ethanol and the dried pellet was resuspended in 25 pi 
water.
2.14.3 Production of blunt ended DNA
The cDNA was blunt ended using T4 DNA polymerase. This enzyme 
possesses a 5' to 3' polymerase activity and a 3' to 5' exonuclease activity. Therefore, 
it fills a 5' overhang and chews back a 3' overhang. To 25 pi of double stranded 
cDNA , 3 pi lOX T4 DNA polymerase buffer, 1 pi 5 mM dNTPs (5 mM each of 
dATP, dGTP, dCTP and dTTP), Ipl bovine serum albumin (5 mg/ml) and 1 pi T4 
DNA polymerase (0.8 Unit) were added. The contents of the reaction were mixed 
briefly and incubated at 37®C for 30 minutes. Then the volume of the reaction mix 
was expanded to 100 pi with water and extracted with phenol/chloroform, washed 
with ether and the blunt ended double stranded cDNA was precipitated with sodium
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acetate and ethanol as before (section 2.14.1.2). The dried pellet was dissolved in 100 
pi water and further precipitated with 0.5 volumes of 7.5 M ammonium acetate and 
2.5 volumes of ethanol to remove excess dNTPs before the cDNA was ligated to 
EcoR 1/Not I adaptors. The pellet was dissolved in 30 pi water.
2.14.4 Adaptor ligation
The EcoR 1/Not I adaptor (Pharmacia Biotech) was ligated to the blunt ended 
cDNA as per the manufacturer's instruction. The sequence of the adaptor is as 
follows:
5-d[AATTCGCGGCCGCT]-3'
3'-[GCGCCGGCGA]p-5'
5 pi adaptor (0.01 Unit/pl), 10 pi lOX ligation buffer (appendix 2), Ipl ATP 
solution (100 mM) and 1 pi T4 DNA ligase (3 Units) were added to 30 pi blunt ended 
cDNA and finally made up to 100 pi with water. The contents of the reaction was was 
mixed gently, centrifuged briefly and incubated at 12°C for 16 hours. The reaction 
mix was then heated to 65®C for 10 minutes to denature the T4 DNA ligase and 
chilled on ice.
2.14.5 Phosphorylation of adaptor
To insert the adaptored DNA into dephosphorylated overhang of the EcoR I 
site of pcDNAU vector, the adaptor ends were phosphorylated. To the completed 
blunt-end ligation reaction, 10 pi of 100 mM ATP solution and 5 Units of T4 
polynucleotide kinase were added and incubated at 37®C for 30 minutes. The reaction 
was heated to 65°C for 10 minutes to denature the polynucleotide kinase. The 
reaction was extracted with equal volume of phenol/chloroform, washed with ether 
and the phosphorylated adaptored DNA was precipitated with sodium acetate and 
ethanol. The dried pellet was dissolved in 30 pi water. The removal of excess 
adaptors from the phosphorylated adaptored DNA were achieved by agarose gel
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electrophoresis (section 2.5). The cDNA of approximately 800-2000 bp range was 
harvested using QIAquick gel extraction kit (Quiagen) (section 2.13.2).
2.14.6 Ligation of cDNA into pcDNAII vector and transformation of competent
E. coli
The phosphorylated adaptored cDNA was inserted into dephosphorylated 
EcoR I site of pcDNAU (Figure 2.2). The dephosphorylation of pcDNAU vector was 
made as per section 2.9. The ligation reaction contained 6pl of phosphorylated 
adaptored cDNA and Ipl each of lOX ligation buffer (appendix 2), 50 % PEG , 
dephosphorylated pcDNAU vector (20ng/pl), 10 mM ATP and T4 DNA ligase. The 
mix was overlaid with liquid paraffin and incubated overnight at 16^C. 1 pi of 0.2 M 
EDTA and 9 pi water were added to stop the reaction. The competent bacterial cells 
were transformed with 5 pi of the ligation reaction as outlined in section 2.11.
2.14.7 Selection of virus specific clones
The vector pcDNAU contain genes both for ampicillin resistance and a- 
complementation of S-galactosidase. Therefore recombinant transformants were 
selected on the basis of white colonies on ampicillin-X-gal-IPTG containing solid 
agar media. Overlapping cDNA clones were identified by colony hybridisation using 
the inserted DNA of the preceding clone, labelled with a^2p dCTP.
2.14.7.1 Preparation of radiolabelled Probes
DNA was radiolabelled as per the method of Feinberg & Vogelstein (1984). 
10 ng of DNA in 8.8 pi water was boiled at lOO^C for 2 minutes and chilled 
immediately to separate the two strands. To this DNA was added 3 pi OLE (250 mM 
Tris-Hcl pH 8, 25 mM 2-mercaptoethanol, 0.1 mM each of dATP, dGTP and dTTP, 
IM Hepes pH 6.6), 1.2 pi BSA (5 mg/ml), 1 pi (1 mg/ml) random hexanucleotide 
primers, 20 pCi a  ^^ P dCTP and 0.5 unit of Klenow fragment of DNA polymerase.
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The reaction mix was incubated at room temperature for 16 hours. To the 
radiolabelled probe, 70 pi stop/Quench solution was added to stop the reaction. The 
probe was denatured at lOO^C for 5 minutes before use.
2.14.7.2 Colony hybridisation by radiolabelled probes
The recombinant clones were screened for SBV-UK cDNA by the 
method of Grunstein & Hogness (1975). White colonies were restreaked onto 
duplicate nitrocellulose membranes laid over ampicillin containing agar plates. The 
colonies were grown overnight before being prepared for hybridisation. One plate 
was stored at 4^C, while the colonies of the other membrane was prepared for 
hybridisation. The colonies on the nitrocellulose membrane were lysed by transferring 
it onto Whatman 3MM chromatography paper soaked in 0.5 M NaoH for 8 minutes 
followed by successive transfers to 3MM chromatography paper soaked in 0.5 M 
Tris-Hcl pH 7.4 for two periods of two minutes each and then to 0.5 M Tris-Hcl pH
7.4 plus 1.5 M NaCl for 4 minutes. The nitrocellulose membrane was blotted between 
two sheets of 3MM chromatography paper to remove bacterial debris and then 
transferred to 2X SSC saturated 3MM chromatography paper. The DNA was fixed on 
wet membrane by UV crosslinking in a UV Stratalinker 1800 (Stratagene).
The membrane was then prehybridised for 6 hours at 65 in 
prehybridisation buffer (appendix 2). The membrane was then hybridised with 
dCTP radiolabelled probe at 65®C overnight in the same buffer. After hybridisation 
the membranes were washed three times in 2X SSC plus 0.1% SDS at 65®C for 30 
minutes each and exposed to X-ray film (Fujifilm) for 12 hours to 24 hours at -70^C 
with an intensifier screen.
2.15 Sequence determination
The plasmid containing inserted DNA was sequenced using an Applied 
Biosystems 373A Automated Sequencer and ABI prism dye terminator ready reaction
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cycle sequencing kit according to manufacturer's instruction with either vector or 
virus specific primers. This is provided as a service within School of Biological 
sciences and was performed by Stephen Dyer, technician associated with the ABI 
machine.
2.16 Northern blots for RNA
Denaturing agarose gels for RNA were prepared as per the method of Lehrach 
et al. (1977). Electrophoresis grade agarose (3g) was dissolved by boiling in 190 ml 
of MOPS buffer (appendix 2) and allowed to cool to 60°C. After adding 30 ml of 
formaldehyde the gel was poured into a large (160 x 150 mm) flat bed apparatus and 
allowed to set for one hour. 5|xl of RNA sample containing appropriate amount of 
RNA was denatured for 5 minutes at 60°C after adding 15 |li1 of denaturing sample 
buffer (500 |xl formamide, 100 p.1 lOX MOPS buffer, 150 |il formaldehyde). Samples 
were mixed with 2X TBE and plus 20% glycerol and marker dyes (bromophenol blue 
and xylene cyanol FF) and loaded directly. Prokaryotic rRNA (23S and 16S) and 
eukaryotic rRNA (28S and 18S) samples were also processed as before and loaded as 
size markers. The gel was electrophoresed in IX MOPS buffer at 150 mAmps for 2 
hours in a fume cupboard. The RNA was then transferred to a nitrocellulose 
membrane by adaptation of the method of DNA transfer as described by Maniatis 
(1982). The gel was soaked in 3 changes of 20X SSC on a shaker for one hour and 
then the RNA was transferred to wet nitrocellulose membrane ('Gelbond' Gelman 
Sciences, USA) in 20X SSC by capillary blotting for 18 hours. The membrane was 
UV cross-linked as before (section 2.14.7.2). The tracks containing the rRNA size 
markers were removed and soaked in 5% acetic acid for 15 minutes at room 
temperature, followed by staining for 10 minutes in methylene blue (0.5 M sodium 
acetate pH 5.2 and 0.04% methylene blue). Then the membrane was washed in water 
for 10 minutes and the bands were visible. The remaining portion of the membrane
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was pre-hybridised to block non-specific absorption, hybridised, washed and exposed 
to the X-ray film in the same manner as described under colony hybridisation.
2.17 Preparation of oligonucleotide primers
Oligonucleotides were synthesised on an applied Biosystems 381A 
synthesiser. After synthesis oligonucleotides were deprotected by treatment with 
concentrated ammonia. 1.5 ml of 35% ammonia was passed through the column at a 
rate of 0.5 ml every 20 minutes. The released oligonucleotide in ammonia was 
incubated overnight at 55°C before the ammonia was removed by evaporation. 
Oligonucleotide was precipitated overnight by the addition of sodium acetate and 
ethanol (section 2.14.2). DNA was pelleted by centrifuging at 12000 g for 10 
minutes. The pellet was washed twice with 80% ethanol and resuspended in 
water/DEPC treated water. Occasionally synthetic oligonucleotide primers were 
purchased from Genosys Biotechnologies. These were supplied as freeze-dried 
primers which were dissolved in water/DEPC treated water. Oligonucleotide primers 
from both sources were adjusted to a concentration of 1.6 mg/ml (250 pM).
2.18 Polymerase Chain Reaction
The polymerase chain reaction (PCR) is an enzymatic method for the in vitro 
amplification of a particular segment of DNA (Saiki et al., 1986). It consists of 
repeated cycles of heat dénaturation of template DNA followed by, annealing of two 
oligonucleotide primers which flank the target DNA segment to be amplified and 
extension of the annealed primers by a heat stable DNA polymerase. The primers are 
designed to hybridise to opposite strands of the target sequence and are oriented such 
that DNA synthesis by the polymerase proceeds across the region between the 
primers, effectively doubling the amount of the target DNA sequence. The extension 
products are also complementary to the primers. As a result of this successive cycles 
of amplification continue to double the amount of DNA synthesised in the previous
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cycle leading to exponential accumulation of the target DNA fragments by 
approximately 2^, where 'n' is the number of cycles of amplification performed. 
When first developed, the PCR used the Klenow fragment of E. coli DNA 
polymerase I was used to extend the annealed primers. However, this enzyme is 
inactivated at the dénaturation temperature of 94^C needed to melt the DNA and 
therefore, fresh enzyme had to be added after the dénaturation step in each cycle. 
Subsequently, the introduction of thermostable DNA polymerase, Taq polymerase, 
isolated from Thermus aquaticus, transformed the process making it much simpler 
one and permitting the system to be automated in thermal cycling devices (Saiki et 
aZ., 1988).
PCR could also be used to amplify RNA by first producing a cDNA 
using reverse transcription. This technique is referred to as RT-PCR. The RT 
reaction was carried out as per section 2.14.1 but instead of 50 |xl RT-reaction 
volume, RT reaction was carried out for 20 |il volume and therefore, all the 
ingredients were scaled down by 2.5 times. The RT-reaction mix was heated to 70®C 
for 10 minutes.
A standard PCR reaction (50 jil) contained one-tenth of the RT mix (2 |xl), 5jil 
of lOX Taq DNA polymerase buffer (Boehringer), 5|il dNTP mix (2 mM each of 
dATP, dCTP, dGTP, dTTP), 5 (xl (final concentration 0.5 |iM) of each of sense and 
antisense primer and finally made upto 50 pi with water. The solution was then 
overlaid with 60pl of mineral oil to stop evaporation. Amplification was performed in 
a thermocycler (Quattro TC-40, Biosystems, U. K ). The amplification reaction mix 
was heated to 95®C for 2 minutes to denature any renatured RNA-cDNA hybrid and 
then, as the block cooled, 2.5 Units of Taq DNA polymerase (Boehringer) added 
beneath the mineral oil. The mixture was then subjected to 40 cycles consisting of a 1 
minute dénaturation at 94®C, a 1 minute annealing at 60®C and 40 seconds extension 
at 72®C, unless otherwise stated. The amplification was finished by a final extension 
of 72^C for 10 minutes. The PCR reaction using Pwo polymerase (Boehringer
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mannheim) was performed as recommended by the manufacturer. Two master mixes 
were prepared. Master mix 1 consisted of one fifth of the volume of RT reaction 
(4p,l), 1 p.1 of each primer (final concentration 0.5 pM), 5 pi of lOX PCR buffer, 4 pi 
of 10 mM dNTPs, and was made up to 50 pi with sterile distil water. Master mix 2 
consisted of 10 pi lOX PCR buffer with 20 mM MgS0 4 , 0.5 pi Pwo DNA 
polymerase (5 U/pl) and was made up to 50 pi with sterile distil water. Master mix 1 
and master mix 2 were mixed together and overlayed with 80 pi of mineral oil and 
the reaction cycled in a thermocycler as described before. The RT-PCR product was 
analysed by agarose gel electrophoresis.
2.19 Ligation of PCR products into the pT7BIue(R) vector
Ligation of the PCR products into pT7Blue(R) vector was performed, using 
fragments of DNA purified from agarose gels. This technique exploits the use of a 
phenomenon of the Taq DNA polymerase which adds a non-templated single 
deoxyadenosines to the 3' end of the amplified product. This is complemented by the 
pT7Blue(R) vector having a single 5' deoxythymidine as an overhang at the insertion 
sites of the plasmid (Figure 2.3). This procedure allows direct insertion of the PCR 
product without the need for klenow or T4 DNA polymerase treatment.
Purified PCR products were diluted in water so that when added to the 
ligation mix, the molar ratio of vector : insert was approximately 1:3. Ligation was 
performed by adding 5 pi amplified product (approximately 60 ng), Ipl lOX ligation 
buffer (appendix 2), 2 pi pT7Blue(R) vector (approximately 20 ng), 1 pi 50% PEG, 1 
pi 10 mM ATP and 1 pi T4 DNA ligase. The reaction mix was incubated overnight at 
16^C. Ligase was inactivated by heating the reaction mix at 70®C for 10 minutes. As 
the plasmid contained LacZ gene, recombinant plasmids were detected by blue /white 
screening after transformation.
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Figure 2.3: Schematic representation of the vector pT7BIue(R) and location of 
multiple cloning region for insertion of PCR product.
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2.20 Amplification of the 5' end of the SBV-UK genome
The complete sequence of the 5' end of the genome are rarely recovered from 
the cDNA libraries. However, recently using PCR it has been possible to specifically 
amplify the 5' end of the genome. This method is referred to as RACE (Rapid 
amplification of cDNA ends). To obtain the clone representing the 5' end of the viral 
genome 5-RACE was performed using Marathon cDNA Amplification Kit 
(Clontech) according to the manufacturer's instructions. This technique involves first 
strand cDNA synthesis with an antisense gene specific primer using reverse 
transcriptase followed by second strand synthesis using standard method. After blunt 
ending, the double stranded cDNA was ligated to a cDNA adaptor and then 5'-RACE 
PCR was performed with the SBV-UK genome specific primer and adaptor primer. 
The purified RACE-PCR product was cloned into a suitable cloning vector. Briefly, 
the method of 5 -RACE is described below.
2.20.1 First strand cDNA synthesis
For first strand cDNA synthesis 4 pi (approximately 1 pg) of RNA from 
purified SBV-UK was mixed with 1 pi (0.5 pg) of gene-specific antisense primer 
(P9) (Table 3.2) and heated to 70®C for 2 minutes cooled on ice. Then 2 pi 5X first 
strand buffer, 1 pi 10 mM dNTP mix, 1 pi DEPC treated water and 1 pi AMV reverse 
transcriptase (20 units/pl) were added and the reaction mix was incubated at 42^C for 
1 hour. The tube was placed on ice to terminate the first strand synthesis.
2.20.2 Second strand cDNA synthesis
10 pi of the first strand reaction was mixed with 48.4 pi water, 16 pi 5X 
second strand buffer, 1.6 pi 10 mM dNTP mix and 4 pi 20X second strand enzyme 
cocktail. The reaction mix was incubated at 16^C for 1.5 hour. To blunt end the 
double stranded cDNA ends 2 pi (10 units) of T4 DNA polymerase was added and 
further incubated at 16^C for 45 minutes. 4 pi of the EDTA/glycogen mix added to
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terminate second strand synthesis. The reaction mix was extracted with 100 pi 
phenol/chloroform, washed with ether and precipitated with ammonium acetate 
(section 2.14.2). The dried pellet was dissolved in 10 pi water.
2.20.3 Adaptor ligation
5 pi of the double stranded cDNA was mixed with 2 pi Marathon cDNA 
adaptor (10 pM), 2 pi 5X DNA ligation buffer and 1 pi T4 DNA ligase (1 unit/pl). 
The reaction mix was incubated overnight at 16°C and then heated at 70®C for 5 
minutes to inactivate the ligase.
2.20.4 5 -RACE PCR
A 5-RACE PCR reaction was performed to generate the 5' cDNA fragment. 
To 5 pi (1/50 dilution) of the adaptor ligated cDNA, 1 pi of adaptor primer 1 (API; 
5’-CCATCCTAATACGACTCACTATAGGGC-3’) (10 pM), 1 pi of SBV genome 
specific primer (10 pM) stock, 5 pi lOX PCR buffer (Boehringer), and 5 pi 2 mM 
dNTP mix were added and was made upto 50 pi with water. 60 pi of mineral oil was 
overlayed on top. 2.5 Units of Taq DNA polymerase were added after initial 
incubation at 94°C for 2 minutes. The thermal cycling conditions were similar to 
those described in section 2.18, except that an elongation time of 1 minute instead of 
40 seconds was used. A negative control without template was also set up.
2.21 Sequence analysis
Nucleotide and aminoacid sequence data were assembled and analysed using 
the PCGENE (Intelligenetics) and the University of Wisconsin Genetics Computer 
Group (GCG) package (Devereux et al., 1984). Multiple alignments of the sequences 
were performed with CLUSTAL W (Thompson et ah, 1994) and phylogenetic trees 
were drawn with NJplot program (Perriere & Gouy, 1996). The nucleotide and amino 
acid sequence data were also analysed with NCBI BLAST search. MFOLD program
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(Jacobson & Zuker, 1993) was used to draw the potential secondary structures at the 
5’ UTR and 3’ UTR.
2.22 Expression in E. coli
5 ml of rich broth plus glucose and ampicillin (appendix 2) was inoculated 
with 50 pi of an overnight culture of E. coli DH5a containing the fusion plasmid. The 
culture was grown at 37°C until the OD^oOnm was 0.4-0.6. 1 ml of the culture was 
removed, pelleted and resuspended in 50 pi SDS-PAGE sample buffer. This sample 
was used as uninduced sample. IPTG was added to the remaining culture to a final 
concentration of 0.3 mM (15 pi of 0.1 M stock solution). The incubation was 
continued at 37®C for 3 hours. 0.5 ml of the sample was removed, pelleted and 
resuspended in 100 pi SDS-PAGE sample buffer. The samples were boiled for 5 
minutes and 15 pi of each sample was loaded onto a 10% SDS-PAGE gel.
2.23 SDS-polyacrylamide gel electrophoresis
A 4% stacking gel was used with a 10 or 12% resolving gel (appendix 2) was 
used. Samples were boiled for 5 minutes in SDS-PAGE sample buffer (appendix 2). 
15 pi for the minigel (Biorad) and 20 pi for the large (30 ml) gel were loaded. 
Proteins of known molecular weight were used as molecular weight markers. 
Electrophoresis was carried out in Tris-glycine electrophoresis buffer (appendix 2) at 
150 V (mini gel) or 250 V (large gel) for 45 minutes to 4 hours depending upon the 
size of the gel or until the tracking dye was 1 cm from the bottom of the gel. Protein 
bands were detected by staining with Coomassie blue stain (appendix 2) for 45 
minutes followed by destaining in 20% methanol/7.5% glacial acetic acid.
2.24 Western blot and immunostaining of polyacrylamide gels
Following electrophoresis, separated proteins were transferred to 
nitrocellulose membranes. The gel was equilibrated with three changes of transfer
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buffer over 15 minutes for a minigel. One sheet of nitrocellulose filter Hybond-C 
super and 8 sheets of 3MM filter paper were cut to the size of the gel and soaked with 
transfer buffer. For the transfer of protein from the SDS-PAGE gel to the 
nitrocellulose filter, the gel, 3MM filter paper and the nitrocellulose filter were 
assembled in semi-dry electroblotting apparatus (Bio-Rad Trans-blot @ cell) in the 
following order: 4 sheets of 3MM in a stack on the bottom of the apparatus, 
nitrocellulose filter on the stack, buffer saturated SDS-PAGE gel on the nitrocellulose 
filter and remaining 4 sheets of 3MM on top. Care was taken to avoid trapped air 
bubbles between the layers. The top electrode and lid of the apparatus were replaced. 
Electroblotting was performed for 30 minutes (minigel) at 10-15 volts (current should 
not exceed 5.5 mAmps/cm^).
Following Western blotting, the filter was blocked overnight at 4®C with 
dried milk (5% Marvel in rinse buffer). The filter was washed with 3 changes in rinse 
buffer over 15 minutes. The filter was incubated for 2 hours at 37^C on shaking 
platform, in an appropriate dilution (in rinse buffer plus 10% fetal calf serum) of the 
primary antibody (anti-MBP serum or anti-SBV-UK serum). This was followed by 3 
washes with rinse buffer for 5 minutes each. Then the filter was incubated with 
1:1000 dilution (in rinse buffer plus 10% fetal calf serum) of anti-rabbit IgG 
(secondary antibody) conjugated with horseradish peroxidase. Unbound secondary 
antibody was removed by 6 washes in PBS for 5 minutes each and the filter 
developed using chemiluminescence reagents. Luminescent substrate (equal volume 
of A and B) (Pierce) was added on the filter and incubated at room temperature for 1 
minute. Excess substrate was drained from the filter which was then placed between 
cling film and exposed to X-ray film for about 30-60 seconds at room temperature.
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3.1 Introduction
Many small RNA viruses that have biophysical properties similar to those of 
members of the Picomaviridae have been isolated from a wide range of insect 
species (Moore et al., 1985). A large number of these viruses including SBV, ABPV 
and BQCV are presently considered to be possible members of the family 
Picomaviridae on the basis of morphology, capsid structure and genome type 
(Murphy et al., 1995). However classification is hampered because of insufficient 
information about the genome structure and thus remain as unassigned viruses, 
probable members of the Picomaviridae (Murphy et al., 1995). Recently, molecular 
data from some of these viruses has shown that despite resemblance above they are 
not true members of the Picomaviridae. Positive strand RNA insect viruses, which 
have so far been sequenced have been shown to possess two possible genome 
organizations: picornavirus-like or calicivirus-like . On the basis of the sequence of 3' 
terminal 1600 nucleotides of the cricket paralysis virus (CrPV) King et al. (1987) 
speculated that this region encoded the RNA-dependent RNA polymerase. However, 
amino acid sequence similarities to the picomavirus capsid proteins led Koonin & 
Gorbalenya (1992) to suggest that the 3' part of CrPV actually encodes capsid 
proteins, suggesting a similarity in gene order between CrPV and the caliciviruses. A 
similar genome organization has recently been determined for Acyrthosiphon Pisum 
Virus (APV) (van der Wilk et a l, 1997), Drosophila C virus (DCV) (Jhonson & 
Christian, 1998), Plautia stall intestine virus (PSIV) (Sasaki etal., 1998) and 
Rhopalosiphumpadi virus (RhPV) (Moon e ta l,  1998). However, infectious flacherie 
virus (IFV) of the silkworm has a genome organization quite similar to that of typical 
picornaviruses with structural proteins encoded at the 5' end (Isawa et a l, 1998).
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Thus it was not clear which genome pattern would be found in SBV. Therefore the 
aim of the studies in this chapter, is to determine the nucleotide sequence and genome 
structure of SBV.
3.2 Results 
3.2.1 Virus Purification
SBV-UK infected ApA mellifera larvae (scales) was obtained from a natural 
outbreak of sacbrood in the colonies from Devon, England. Six of these scales were 
used for purification of virus as described previously (section 2.3.1). SBV-UK yieled 
two bands on CsCl gradients. The buoyant densities of the upper and lower bands 
were 1.32 g/ml and 1.34 g/ml respectively. Buoyant density of SBV on CsCl has 
been reported to be 1.33-1.34 g/ml; empty particles of lower density have also been 
reported which are of lower density (Bailey et al, 1964). Such observation has also 
been made for other picornaviruses (Rueckert, 1996). Therefore, it is possible that 
lower density particles obtained in the present experiment may represent empty 
capsids. Virus from higher density band was used for RNA extraction and 
subsequent cDNA cloning.
3.2.2 SDS-polyacrylamide gel electrophoresis of SBV-UK
The purified SBV-UK (density 1.34 g/ml) was analysed by electrophoresis on 
12% SDS-polyacrylamide gel (section 2.23) and proteins were detected by 
Coomassie staining. Three major capsid protein bands were detected with molecular 
mass of 31.5, 30.5 and 29.5 kDa. These sizes resemble those already reported for
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SBV (Figure 3.1). In addition 3 fainter bands (73, 33.5 and 28.5 kDa) were seen 
which may represent partially processed or degraded proteins.
3.2.3 Cloning of SBV-UK RNA
3.2.3.1 Production and identification of SBV-UK clones
RNA extracted from purified SBV-UK was measured spectrophotometrically 
and 2 pg of this RNA was used for cDNA synthesis, the remainder was stored under 
ethanol at -70^C. cDNA cloning was carried out as described in section 2.14 using 
oligo (dT 12-18) ^  primer for the initial reverse transcription which should 
commence mainly at the 3’ end of the genome, at the poly (A) tail. Second strands 
were synthesised using RNase H and E. coli polymerase I. The cDNA was blunt 
ended and ligated to synthetic oligonucleotide EcoR I/Not I adaptors. Excess adaptors 
were removed by electrophoresis through 1.2% TBE agarose gel. Double stranded 
cDNA produced ranged from approximately 250-2000 bp in size. cDNA fragments of 
700-2000 bp were excised from the gel and purified as described (section 2.13.2).
Gel extracted cDNA was then inserted into the dephosphorylated EcoR I site of the 
vector pcDNAU for cloning into E. coli DH5a (section 2.11). The bacteria were 
spread on ampicillin-X-gal-IPTG containing solid agar plates. Some 200 ampicillin 
resistant white colonies were obtained. The colonies were designated as plSBV l to 
plSBV200. Out of these 18 white colonies (recombinant colonies) were used for 
isolation of plasmid DNA. The purified plasmid DNA from these recombinant 
colonies was digested by the EcoR I restriction enzyme to release inserted cDNA and 
analysed by electrophoresis through 1.2% TBE agarose gels in order to determine the 
size of inserted cDNA fragments (section 2.5).
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210 kDa
66 kDa
42.7 kDa
29 kDa
Figure 3.1: Polypeptide composition of SBV-UK particle.
Proteins of SBV-UK analysed on 12% SDS-polyacrylamide gel and stained with 
Coomassie blue. Migration was from top to bottom. Lanes 1 and 2, markers; lane 3, 
purified SBV-UK. 3 major protein bands indicated by'm ' (31.5, 30.5 and 29.5 kDa) 
and 3 faint protein bands indicated by 'f  (73.0, 33.5 and 28.5 kDa) are evident.
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The cDNA clones obtained were all relatively short, the largest was 1.8 kb 
(plSBV2). The size of the clones is presented in Table 3.1. Eight clones (plSBV2, 
plSBV15, plSBV5, plSBV9, plSBVV, plSBV21, plSBV25 and plSBV29) were 
selected for sequencing. Plasmid DNA was isolated from these recombinant clones 
using a modified minialkaline-lysis/PEG precipitation (section 2.13.1) and sequenced 
using an Applied Biosystems 373A automated sequencer with pcDNAII vector 
specific primers (SP6 and T7) and genome specific internal primers.
The nucleotide sequences of all these clones were compiled using the 
‘PCGENE’ ASSEMGEL program (Intelligenetics). As expected all of these clones 
had a poly (A) and this ranged in size from 9 to 43 residues. The sequences of all of 
these clones were very similar and they fell into two groups. The first group (Group I) 
consisted of 5 clones (plSBV2, plSBV5, plSBV9, plSBV7 and plSBV21). The 
second group (Group II) consisted of 3 clones (plSBVlS, plSBV25 and plSBV29). 
Sequences were identical in each group but substitutions were found at 297 positions 
between groups over a region of 1701 nucleotides (section 3.2.6). This indicated the 
presence of at least two different but related viruses in the sample used for cDNA 
cloning. Sequences of the second group will be discussed in section 3.2.6. The Group 
I clones were most plentiful and selected for genome sequencing. The longest clone 
(plSBV2) of the Group I was sequenced on both strands and found to be 1821 bp.
A second round of cDNA cloning was then performed using a synthetic 
oligonucleotide primer (termed P2) (Table 3.2) derived from the sequences towards 
the end of the plSBV2 clone. The sequences of the oligonucleotide were chosen at 
197 bp from the end of this clone so that the clones originating from the 
oligonucleotide could be screened for overlap. Virus specific clones containing
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Clone Size (kb)
plSBV2 1.8
plSBV15, 1.7
plSBV5andplSBV9 1.4
plSBV7 1.2
plSBV21, plSBV23 and plSBV41 0.9
plSBV25, plSBV29, plSBV35 and plSBV37 0.6
plSBV24, plSBV43, plSBV53,
plSBV63, plSBV67 and plSBV68 0.25-0.3
Table 3.1: The size of the cDNA clones from SBV-UK obtained using 
oligo (dTi2-l8) primer.
Primer Sequence Position in 
SBV-UK
PI Oligo (dTi2-i8)
P2 TATAAGACACATTAGTTTCAGG 7206-7227
P3 GGTAATAACGCCACTGTTC 6586-6604
P4 TCAACGAGCGAGCCACGTC 5859-5877
P5 CGATGACTTCACTAGA 5033-5049
P6 GGACAGTTAATAATAACTTTTG 4191-4212
P7 TAGAAGGCGGCATTATAGG 2640-2658
P8 TCTGGGTCCTTATAGGACC 633-651
P9 TCGGTTGGTATTTCTAACATC 231-251
Table 3.2: Oligonucleotide primers used for cDNA cloning of SBV-UK genome.
Sequences are shown 5’ to S’. Sequences of P2-P9 are the reverse compliment of the viral 
genome. The base positions of the SBV-UK genome to which the viral homologous 
portion of each primer (reverse compliment) corresponds are indicated.
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regions overlapping with plSBV2 were detected by colony hybridisation using 
plSBV2 as probe (section 2.14.7.2). About 150 recombinant colonies (designated as 
p2SBVl to p2SBV150) were screened. Two colonies from the plSBV2 clone were 
included as positive controls. A duplicate plate was stored at 4®C whilst the first was 
used for colony hybridisation. The membrane was processed and hybridised to 
inserted cDNA of the plSBV2 clone, labelled with dCTP (section 2.14.7.1). 
After hybridisation the membrane was washed and exposed to X-ray film. Plasmid 
DNA was isolated from 20 virus-specific overlapping clones, digested with EcoR I to 
release inserted fragments and analysed by electrophoresis through 1.2% TBE agarose 
gels as described before (section 2.5). The clones obtained were relatively short and 
the longest clone (p2SBV32) was approximately 800 bp long. The virus specific 
nature of these clones was further confirmed by Northern blot hybridisation (section 
3.2.4). This clone was sequenced as 811 bp. The sequence towards the start of this 
clone had 197 bp overlap with the sequence towards the end of the plSBV2 clone 
and differed at 12 positions (over a region of 74 nucleotides) from clones in Group 
n. Thus the plSBV2 clone contained sequences indicating it belonged to Group I.
The remainder of the virus genome except the very 5' end was cloned by 
repeating this process in 6 more successive rounds of primer extension, each using 
synthetic oligonucleotide primer (Table 3.2) designed according to the sequences 
towards the end of the preceding clone. In each of these cloning procedures, 
approximately 150 recombinant white and pale blue colonies were screened by 
colony hybridisation using a^^P dCTP labelled inserted cDNA of the preceding 
clone as described before. The result obtained from the P7 primed clones hybridised 
with p6SBV140 derived probe is shown in Figure 3.2. The longest clone of each
6 0
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#
Figure 3.2: Colony hybridisation of recombinant clones.
The membrane was hybridised with p6SBV140 derived probe. 1, 2, 3 and 4 are 
colonies used for further studies. ‘C’ indicates positive control (p6SBV140 clone).
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round varied from 897 bp to 2304 bp and this was used for sequencing. The last 
cDNA cloning round led to smaller clones (longest 583 bp), possibly because the 5' 
UTR of the genome had been reached. All primers were chosen so that the region of 
overlap was significant (106-297) and the overlapping region was tested for 100% 
identity with the previous clone in order to minimise possibilities of template 
exchange.
Thus eight overlapping cDNA clones (plSBV2, p2SBV32, p3SBV43, 
p4SBV88, p5SBV49, p6SBV140, p7SBVl and p8SBV108) were obtained which 
covered about 99% of the SBV-UK genome. Both strands of each of the cDNA 
clones were completely sequenced. Sequences in some areas were confirmed by 
sequencing of the multiple smaller clones.
3.2.3.2 Amplification of the 5' end of SBV-UK by RACE
The 5' end of the viral genome was cloned using the 5' RACE kit (Clontech).
1 pg of SBV-UK RNA obtained from naturally SBV-UK infected larva scales 
(section 2.4.1) was reverse transcribed using SBV-UK genome specific 
oligonucleotide primer (termed P9) derived from the sequences towards the end of 
the p8SBV108 clone. Second strand cDNA was synthesised, blunt ended and ligated 
with cDNA Marathon adaptor. Then the adaptor ligated cDNA was amplified by 
PCR using SBV-UK genome specific antisense primer (P9) and the Marathon adaptor 
primer l(APl).
The PCR product was analysed by electrophoresis through a 2% TBE 
agarose gel and a product of approximately 260 bp was observed (Figure 3.3). This 
was purified and cloned into pT7Blue(R) cloning vector (section 2.19). 11
6 1
kbp
21.7
1.90
1.59
1.37
0.94
&83
0.56
0.247
0.146
Figure 3.3: Amplification of 5' end of SBV-UK genome by 5' RACE.
The PCR products obtained from 5' end of the SBV-UK genome using RACE 
system were electrophoresed through a 2% agarose gel, stained with ethidium 
bromide and photographed under UV light. Lane 1, control reaction (no 
template); lane 2, 5' RACE product generated with primers P9 and API; 
lane 3, DNA size markers.
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recombinant colonies (designated as prSBVl to prSBVll) were analysed. The 
plasmid DNA was digested with Hind m  and EcoR I, analysed on 2% TBE agarose 
gel in order to determine the size of the inserted DNA fragments. All clones were 
sequenced to determine the 5' terminal nucleotides of the SBV-UK genome. All these 
clones were derived from the same start point. However, sequence heterogeneity was 
found in these clones. The longest clone (prSBVlO) was 251 nucleotides. The length 
of the other 10 clones varied from 241-249 nucleotides. The nucleotide sequence of 
all these 11 clones were compared using ClustalW multiple sequence alignment 
program (Figure 3.4). These size differences were accounted for by overlapping 
internal deletions of 2-10 nucleotides compared to the longest clone (prSBVlO).
Some substitutions were observed. The nucleotide sequence of the longest clone was 
incorporated to compile the complete nucleotide sequence of the SBV-UK genome.
3.2.4. Specificity of SBV-UK cDNA clones
The nature of RNA encapsidated in SBV-UK particles was investigated by 
Northern blot hybridisation. RNA was extracted from both purified and semi-purified 
SBV-UK obtained from SBV-UK infected larvae (scales) (section 2.4.1). 0.5 pg of 
RNA from purified SBV-UK and 10 pg of RNA from semi-purified SBV-UK 
electrophoresed through a denaturing agarose gel (section 2.16). Since no SBV-free 
healthy larvae were available, 10 pg total RNA from uninfected sf21 cells was used 
as a general control for insect cell RNA. Eukaryotic and prokaryotic rRNAs were co- 
electrophoresed as size markers. After separation the nucleic acids were transferred to 
nitrocellulose membrane by Northern blotting and the membrane was processed as 
described before (section 2.16). The tracks containing the rRNA size markers were
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p rS B V lO
p r S B V ll
prSB V 4
prSB V 9
prSB V S
p r S B V l
prSBVV
prSB V 6
prSB V 2
prSB V S
prSB V S
p r S B V l0
p r S B V ll
prSB V 4
prSB V S
prSB V S
p r S B V l
prSBVV
prSB V 6
prSB V 2
prSB V S
prSB V 3
p r S B V l0
p r S B V ll
prSB V 4
prSB V S
prSB V S
p r S B V l
prSBVV
prSB V 6
prSB V 2
prSB V S
prSB V 3
p r S B V l0
p r S B V ll
prSB V 4
prSB V S
prSB V S
p r S B V l
prSBVV
prSB V 6
prSB V 2
prSB V S
prSB V S
6 0
TCGAGCGGCCGCCCGGGCAGGTTACGAATCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT--CGAATCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGCCCGCCCGGGCAGGT--------------------- GATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGCCCGCCCGGGCAGGT---------- ATCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT---------- ATCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT---------- ATCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGA------------ TCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT---------------CGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT---------------CGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT------------ TCGTGATTCGATTCATTATTTCGCCTGAGTAA
TCGAGCGGCCGCCCGGGCAGGT------------ TTGTGATTCGATTCATTATTTCGCCTGAGTAA
* * * * * * *  * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * *
120
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT
ATCGAGATTTACCTTGACGGGGTTTGCTTGACGTTGCGTCAGACCCGTTATCTTTGTGAT************************************************************
ISO
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGGGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
TTTTAGGTTGTGAAGATTTATTCGAGTAAGTTTATTAAACGTAGAGTTTATAATATAGAA 
* * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
200
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
AGAGGCATAATAAGTTTATT
* * * * * * * * * * * * * * * * * * * *
Figure 3.4: Comparison of the nucleotide sequences of 11 independent clones 
obtained by 5’ RACE.
The nucleotide sequences of 11 independent clones obtained by RACE were aligned 
using Clustal W program. In the bottom line of each aligned row of nucleotides, 
identical nucleotides are indicated by * and nucleotide differences by a gap.
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removed and stained with methylene blue. The remainder of the membrane was 
hybridised to the inserted cDNA of the clone p2SBV32 labelled with dCTP. 
This probe recognised SBV-UK RNA (Figure 3.5). No hybridisation was observed 
with the sf21 cellular RNA. The SBV-UK RNA used here appeared to be degraded. 
However the top of the hybridisation smear was found at about 8.5 kb which is 
similar to the size of the SBV-UK genome obtained by sequencing.
The relationship between SBV-UK and other honey bee picoma-like viruses 
was examined using RNA extracted from SBV-G, TSBV, BQCV and ABPV derived 
from independent infections. Total RNA was extracted from semi-purified samples of 
SBV-G, TSBV, BQCV and ABPV (section 2.4.1). Approximately 0.5 jig RNA from 
SBV-G and TSBV and 1 p,g of RNA from BQCV and ABPV samples were denatured 
and electrophoresed through denaturing agarose gels. The RNA was transferred to a 
nitrocellulose membrane and the membrane was processed as before. Inserted cDNA 
from clone p2SBV32 was labelled with a^^P dCTP and used as probe. The results of 
these hybridisations are shown in Figure 3.6. SBV-G RNA appeared largely degraded 
and TSBV RNA hybridised weakly. No cross hybridisation was found with BQCV 
and ABPV. This also rules out the possibility of contamination of BQCV and ABPV 
samples with SBVs. The hybridisation to SBV-G (and to a lesser extent) TSBV RNA 
derived from an independent infection in a different country supports the conclusion 
that the virus cloned and sequenced was indeed SBV rather than any adventitiously 
associated agent.
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#28S'
23S'
18S,
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Figure 3.5: Northern blot analysis of SBV-UK RNA.
RNA was extracted from purified, semipurified SBV-UK and sf21 cells, 
electrophoresed through a denaturing agarose gel and blotted to a nitrocellulose 
membrane. The blot was hybridised with virus specific cDNAfrom clone 
p2SBV32. Lane 1, RNA from sf21 cell; lanes 2 and 3 are RNA from semipurified 
and purified SBV-UK respectively. The positions of the unlabelled rRNA 
markers (28S, 4.7 kb; 23S, 2.9 kb; 18S, 1.9 kb; and 16S, 1.5 kb) are indicated.
28S 
23S 
18S
16S
Figure 3.6: Northern blot analysis of SBV-G, TSBV, BQCV and ABPV RNA.
RNA was extracted from semipurified samles of SBV-G, TSBV, BQCV and ABPV, 
electrophoresed, blotted and hybridised using p2SBV32 clone as in Figure 3.5. 
Lanes 1, 2, 3 and 4 are RNAs from SBV-G, TSBV, BQCV and ABPV respectively. 
The positions of unlabelled rRNA markers (28S, 4.7 kb; 23 S, 2.9 kb; 18S, 1.9 kb; 
and 16S, 1.5 kb) are indicated. Hybridisations are evident with SBV-G and TSBV 
RNA.
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3.2.5 Sequence analysis
Graphic representation of the sizes and relative positions of the cDNA 
fragments used in the cloning of SBV-UK is presented in Figure.3.7. The complete 
genome of SBV-UK was determined as 8854 nucleotides excluding the poly (A) tail 
(Figure 3.8). Base composition is A (29.79%), C (16.35%), G (24.36%) and U 
(29.48%). SBV-UK thus resembles other insect picornaviruses in being A/T rich.
3.2.5.1 Non-coding and coding region
The SBV-UK genome is larger than those of other mammalian 
picornaviruses, a feature it shares with other insect picorna-like viruses. A computer 
assisted analysis of the nucleotide sequence of the SBV-UK genome revealed that the 
genomic RNA contains one large ORF of 8574 nucleotides encoding 2858 amino 
acids (Figure 3.9). The analysis of the SBV-UK sequence data predicts a 5' UTR of 
only 200 nucleotides, much shorter than that found in mammalian picornaviruses 
(600-1250 nucleotides). In contrast, the SBV-UK 3' UTR (80 nucleotides) is of a 
similar size to those of mammalian picornaviruses (40-126 nucleotides). There are 
two in frame AUG codons (201 and 219 nucleotides) within the first 21 nucleotides 
of the long ORF. The first AUG codon at nucleotide 201 (AUG 201), may be the 
translation initiation site since unlike AUG codon at 219 (AUG 219) it occurs in a 
context (AUUAUGG) identical to that of many invertebrate initiating codons 
(ANNAUGG) (Cavener & Ray, 1991). The ORF ends with a UAG stop codon at 
nucleotide 8775, encoding a product of molecular mass 320.698 kDa.
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1 UCGAGCGGCCGCCCGGGCAGGUUACGAAUCGUGAUUCGAUUCAUUAUUUC 50
51 GCCUGAGUAAAUCGAGAUUUACCUUGACGGGGUUUGCUUGACGUUGCGUC 100
101 AGACCCGUUAUCUUUGUGAUUUUUAGGUUGUGAAGAUUUAUUCGAGUAAG 150
151 UUUAUUAAACGUAGAGUUUAUAAUAUAGAAAGAGGCAUAAUAAGUUUAUU 200
2 01 gEgGACGAUAUUUCUCCUAUGUUUUAUGGAGAUGUUAGAAAUACCAACCG 250
M D D I S P M F Y G D V R N T N R  
251 AUUCCUCAGUAGUGGAGGAAUCAGAAGAAAUCAGUCUUCUGAAUAUAGUU 3 00
F L S S G G I R R N Q S S E Y S S
3 01 CACGCGCCAGAAUCUAUAAAACCAAGUUGGAGGCGCGUAAUUGCGGAGUG 350
R A R I Y K T K L E A R N C G V  
3 51 GAAAGAUUAUCUACAAUCCUUACCUCUAGUAAGAAGACAUUUGAUACAGU 400
E R L S T I L T S S K K T F D T V  
401 GGACUCUUAUACCGAUUUGUUUAAUGGUUGGGUUUCUGGUAUGUUUGUUG 450
D S Y T D L F N G W V S G M F V D  
451 ACAAGAACGUCCACUACACCGAAAUGUCCAGUGAUGAGAGUGGACGAAGA 500
K N V H Y T E M S S D E S  G R R  
501 AUCUGGAAUGUUAGACGCGCAGUGUCAAUUAAGACCACAGAAGGAACUAU 550
I W N V R R A V S I K T T E G T I  
551 AGUGUGGCGAAAAGUUAUUACUUCGUACAGUUGUAAGGUAGCUUCAGAAC 600
V W R K V I T S Y S C K V A S E L  
601 UAGCUGCUAAGAGUAUAUUGGUACAAUUUUUAGGUCCUAUAAGGACCCAG 650
A A K S I L V Q F L G P I R T  Q 
651 AGUGAUGAGGUACCCUCGAAGGAAUCUAUUCAGGGGGACGCUACACAGCA 700
S D E V P S K E S I Q G D A T Q Q  
7 01 GAGUUCCAAGGAGGAGAAUACAAUAAUUACACGAGAUCAGCAACAAACUG 750
S S K E E N T I I T R D Q Q Q T V  
751 UUUCGGAAAAGAUACCAUCAACAGUUGGGGAUUUGGUAAUAGCAUCUUCC 800
S E K I P S T V  G D L V I A S S  
801 GAACCAACGCAACAAUUUAGGAGUUUAACUAACCGUUGGAUGCCUAUUAA 850
E P T Q Q F R S L T N R W M P I N  
851 UUCAAUUAGAGUAACAGUAAAUGGUAAAAGGAAUGAUCUUUUGGCACAAU 900
S I R V T V N G K R N D L L A Q Y  
901 ACUAUAUCCCAGAAGAUUUUCUGUCAACUCACGCUAAGUGUGCACCCAAC 950
Y I P E D F L S T H A K C A P N  
951 ACUAUACCAUUUGAGACUUACGUGUAUGGAAAAUACGAGUUGGAAAUGAA 1000
T I P F E T Y V Y G K Y E L E M K  
1001 GUUUGUAGCUAAUGGUAAUAAGUUCCAGUGUGGGAAAGUUAUUAUUUCCG 1050
F V A N G N K F Q C G K V I I S V  
1051 UAAAGUUUGAUAGUUACCAAGCAGAUAAUAUAAAUACAGGGUUCCAGGCA 1100
K F D S Y Q A D N I N T G F Q A  
1101 GCGUUAUCGCGACCGCAUAUUAUGUUAGACUUGUCUACCAAUAAUGAGGG 1150
A L S R P H I M L D L S T N N E G  
1151 AGUUCUUAAAAUACCAUUUAGAUAUCAUCGCGCCUUUGUUAGGAACCAAA 12 00
V L K I P F R Y H R A F V R N Q T
12 01 CGCAUAAAACAGCUACGGCAGGGAUAAGACCCGGGAAGUUUGCUAGUAUC 1250
H K T A T A G I R P G K F A S I  
1251 UAUGUGC AAGUGUUAUCACCGUUACAAACAGGAGAGGGAGGAGCGAAUGA 13 00
Y V Q V L S P L Q T G E G G A N D
13 01 UAUGUUUAUACGACCUUUUUACCGUUAUACGCGUGCUGAAUUUGCGGGAA 13 50
M F I R P F Y R Y T R A E F A G M  
1351 UGUCAUACAAAGUCCCAUUGACCCAGAUGGAUGUUAUAGGUACUUUAAUA 1400
S Y K V P L T Q M D V I G T L I  
1401 UCCGGGGGGCCAACGCCAGCUCUUAAGGAUAUUUUAGUAGGUGUUGAAAG 1450
S G G P T P A L K D I L V G V E R  
1451 AACACUAGAUCAAUUGGGCCGAAGUAAUAAUCAAGACAAACCGAAGGAUA 1500
T L D Q L G R S N N Q D K P K D I  
1501 UAAGUAGUAUAACUAUAAUCCCGAAACCUCGCUUGGGUUUUCCUCAUGGG 1550
S S I T I I P K P R L G F P H G
Figure 3.8
1551 AAAGGUAAGAGUGAUGCAGUAGCUAUGCGAGUGAACCCGGUAGCAUUAAC 1600 
K G K S D A V A M R V N P V A L T  
1601 AUCAUUUCAAGAUGUGGGUGCUUAUCCUGAUGAGCCGCGCACUACGUUAG 1650
S F Q D V G A Y P D E P R T T L D  
1651 AUAUAGCUCGUAUAUGGGGUUUGAGAAGCACGUUUAAUUGGGGAUCAGGA 1700
l A R I W G L R S T F N W G S G  
1701 GAUGAUCAUGGGAAAGAAUUAUUUAAUACAGUUUUGGAUCCAGGUUUGAG 1750
D D H G K E L F N T V L D P G L R  
1751 AUUUUAUGACCAAGAUUAUGAAGGGCAAAUAACACCGAUGGAAUAUGUAA 1800
F Y D Q D Y E G Q I T P M E Y V T  
1801 CUGGGUUGUAUAACUUUUGGUCAGGACCAAUAGAAUUACGUUUUGAUUUU 1850
G L Y N F W S G P I E L R F D F  
1851 GUUUCGAAUGCGUUUCAUACUGGAACUGUAAUUAUAUCAGCUGAGUAUAA 1900
V S N A F H T G T V I I S A E Y N  
1901 UCGAUCAUCUACUAAUACGGAUGAGUGUCAGUCCCACUCAACUUACACAA 1950
R S S T N T D E C Q S H S T Y T K  
1951 AAACGUUCCAUUUGGGAGAACAAAAAUCAGUACAUUUUACUGUGCCUUAC 2000
T F H L G E Q K S V H F T V P Y  
2001 AUAUAUGACACUGUAGUACGCAGAAAUACGGCUAGCGCCUAUUUACCGGU 2050
l Y D T V V R R N T A S A Y L P V  
2 051 UACUGAUUAUGAUAAGGUAGAUAAUGUUAGUAGGGCACAGGCUAUGGGGA 2100
T D Y D K V D N V S R A Q A M G I  
2101 UUAGAGCAGAAUCUAAAAUGAGAGUGAAAGUGAGAGUAGUUAAUGUUUUG 2150
R A E S K M R V K V R V V N V L  
2151 AGGCCCGUAGCCUCCACUACUUCAACUAUAGAAGUUUUGGUAUAUAUGCG 2200
R P V A S T T S T I E V L V Y M R  
22 01 AGGAGGGAAAAACUACGCAUUGCAUGGAUUAAAACAGUCGACUUAUUGGC 2250
G G K N Y A L H G L K Q S T Y W P
22 51 CGUCAAAUAGUGUGGUACCCAUGGAUAGUUUUCCACCUGAUGGCUAUGAU 23 00
S N S V V P M D S F P P D G Y D
23 01 CCAGUUAAGCCACCAAAUAGAUCAAGAAGGGAGGCCUCUCCGAAUAGUGA 2350
P V K P P N R S R R E A S P N S D  
23 51 UGGAGGUAAGGGACAACCUGAGGUGGCAGUGUCAGAUAAUCCGCAUAGAU 2400
G G K G Q P E V A V S D N P H R F  ^
2401 UUUUGCCCGCAAACGUGUCUAAUCGUUGGAAUGAAUAUUCUAGCGCUUAU 2450
L P A N V S N R W N E Y S S A Y  
2451 CUGCCACGGGUACAGAUGGACACUGGGGCUAAGGAAGAUGAAGAUGAAAC 2500
L P R V Q M D T G A K E D E D E T  
2501 UGCAAACUUCAGUGAUGGGGUUACUGCGAUGGGUUUUCAAUCUUUGGAUA 2550
A N F S D G V T A M G F Q S L D T  
2551 CCCAAGUGUCAAUUAAGGAUAUUUUGCGUAGACCAGUGUUGUUGUUUAAU 2600
Q V S I K D I L R R P V L L F N  
2 601 CAUGUAGAGUUGGACCCCGAUUACACAGGUUUCUUUAUACCUAUAAUGCC 2650
H V E L D P D Y T G F F I P I M P  
2 651 GCCUUCUAGAAUGAUGCAAUAUAAAUCAGGAGAUAAAGAAACAUCUUUUC 2700
P S R M M Q Y K S G D K E T S F Q  
27 01 AGCGGUUAAUUGGGCGUACUCCCCAAGCAGCCAUAAUGAAUUUAUUCAGG 2750
R L I G R T P Q A A I M N L F R  
2751 UUUUGGAGAGGGUCAUUGCGUUAUACUAUAAUUAUACAUAGCACCGAUGG 2 800
F W R G S L R Y T I I I H S T D G  
2801 UCACCCUAUAUAUGUGACACAUGUACCCCAUACGGGAAAUAGAGUGUAUG 2 850
H P I Y V T H V P H T G N R V Y G  
2 851 GUUUAAUGAAAGUUAAUAAUUUACACGAGUAUACUAAGGUUCCCAUUUUU 2900
L M K V N N L H E Y T K V P I F  
2901 GGGUGUGGGUUAACAACUGAAAUGAUUAUUCCUAGUGUGAACCCGAGUAU 2950
G C G L T T E M I I P S V N P S I  
2951 AUGUGUAGAAGUACCAUUUGAUACGGAAAAUAAUUGGGCCGUGACAUUUG 3 000
C V E V P F D T E N N W A V T F D
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3 001 AUGAGGACGCUCAAAGGAAUUACUCAUGGCGAGAUAAAGGGGAUACCGUG 3050
E D A Q R N Y S W  R D K G D T V  
3 051 ACCGGGCACUUGGUUGUGACACCUGUAGUAUCAGUUUAUAUGUCUGUGUG 3100
T G H L V V T P V V S V Y M S V W  
3101 GGUAGAAGCUGGGGAUGAUUUUGAGGUUUCUAACUUUUAUGGGCCACCAA 3150
V E A G D D F E V S N F Y G P P S  
3151 GUGUAAAGACGAAUGAUUGGAACUACGCAUUCUCUGACGAGCAUGUACAA 3200
V K T N D W N Y A F S D E H V Q
32 01 GUUCAGAUGGAUGAUAGUGUAGAAAGAGUUUAUGAUGAAGGGAACCAAGU 3250
V Q M D D S V E R V Y D E G N Q V  
3251 CUAUUACUAUCCGCCCCCUAAACCAGAGGGUUUUAGUUUGAACAAUGUAC 33 00
Y Y Y P P P K P E G F S L N N V R
33 01 GGACUUCGGUUAGUACGUUGUGUAAUAUGCUUGGAAAAGUAGUAACUCCU 3350
T S V S T L C N M L G K V V T P  
33 51 GAGAGAGCAAUGAAAACAGCGCUGUGUGCAACUCCUUAUUUUGGAUCAGC 3400
E R A M K T A L C A T P Y F G S A  
3401 UUAUAUGACAGCUACUACCCUAGACGCUAUAGGUAGUAUGCAGAAUACCG 3450
Y M T A T T L D A I G S M Q N T V  
3451 UUACGGGAGCUGCACACCAGUUGACUGCAUCUGUUGAUGCGAGGUUAGAG 3 500
T G A A H Q L T A S V D A R L E  
3 501 CAAUUGUCAGCUAAAUUUGGAGAUUCAAUUGAUGUAAUUACUACAGCGGU 3550
Q L S A K F G D S I D V I T T A V  
3 551 UAAGGAGGCUAUAGGUAAAAUUUCUUCCGGUAUGUUCAAUAUGGUUAAUU 3 600
K E A I G K I S S G M F N M V N Y  
3 601 AUACUGGUUAUUGUAUAAACGUGAUCUUGGAUAUAUUGGUGGCAUGGAUU 3 650
T G Y C I N V I L D I L V A W I  
3 651 GAUCGAAGUUGGACUGCAGUCGGAGUGGGAAUUAUUCGAUUCGUGACUAA 37 00
D R S W T A V G V G I  I R F V T K  
37 01 GGUUCUAGGGUUGGGUGCAAUUUCUAAAGUUAUGAAUAUGGCCACAUCUU 3750
V L G L G A I  S K V M N M A T  S F  
3751 UUGGGCAGCUUAUAGCCAGAGUAUAUGAACCUCCACGCCCAGUUGUGCAG 3 800
G Q L I A R V Y E P P R P V V Q  
3 801 GCACCACCUCCCACUGAAGCUACAUUAACUGGAGCUUUGGCGGGUAUACU 3 850
A P P P T E A T L T G A L A G I L  
3 851 GGGUACGCUUAUGGGGGUUUAUAUAUCACCGUUGUCUGGAGGUAGUUAUU 3 900
G T L M G V Y I S P L S G G S Y F  
3901 UUAAAAAUUUGAUGCUCAGGAUGACUAGUUCGGCUGGGCCUUCUUAUUUG 3950
K N L M L R M T S S A G P S Y L  
3 951 GUGGGGGUUUUACGUUUUGUCGAGGCAACUUUUAAUACAGUAAAGGAUAU 4000
V G V L R F V E A T F N T V K D M  
4001 GACAUUGAAUGCUUUGGGCUAUGUAUCUCCAGAAAAUGCGGCGCUGAAAA 4050
T L N A L G Y V S P E N A A L K M  
4051 UGCUGUCCGGAACAUCGACUACGAUACAGAAUUUUAUAACUGAUGCUCAG 4100
L S G T S T T I Q N F I T D A Q  
4101 CUUAUUACUACAGAAGCUAAUGCGGCAUUGGUGGGACAUCCUAGUUUUCG 4150
L I T T E A N A A L V G H P S F R  
4151 AGCUAAGUACUGGAACACGGUAAUGCAAGCGUAUCAAAUACAAAAGUUAU 4200
A K Y W N T V M Q A Y Q I Q K L L
42 01 UAUUAACUGUCCCUCAAUCUAGCGCCUCCCCAAUUCUAUCUAGAUUAUGU 4250
L T V P Q S S A S P I L S R L C  
4251 AGUGAUGUUAUACGUAAUAGUAAUGAAAAGUUUAUUGAUAUUUCAUCUUC 43 00
S D V I R N S N E K F I D I S S S
43 01 ACCGGUGCGUUAUGAACCUUUUGUAAUUUGUAUCGAGGGCCCAGCGGGUA 43 50
P V R Y E P F V I C I E G P A G I  
43 51 UAGGGAAAUCGGAAAUAGUUGAAACCCUGGCUACUGAAUUAUUGAAGGGA 4400
G K S E I V E T L A T E L L K G  
4401 GUUAAUUUAAAACGACCGCAUAGUGGGGCUACGUAUUUCCGAAUGCCUGG 4450
V N L K R P H S G A T Y F R M P G
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4451 UUCUCGAUUCUGGUCUGGUUAUAGGGAUCAACCCGUGGUGGUUUACGAUG 4500
S R F W S G Y R D Q P V V V Y D D  
4501 AUUGGGCGAAUUUAACGGAACCCCAAGCUUUAAUGCAGCAAAUAUCGGAA 4550
W A N L T E P Q A L M Q Q I S E  
4551 UUAUAUCAGCUUAAAUCAACUUCUACUUUUAUUCCGGAAAUGGCUCAUUU 4600
L Y Q L K S T S T F I P E M A H L  
4601 AGAAGAAAAGAAAAUUAGGGGUAAUCCCCUCAUCGUGAUAUUAUUGUGUA 4650
E E K K I R G N P L I V I L L C N  
4651 AUCACGCUUUUCCAGAUAGUGCAGUUACUAAUAUGUCUCUUGAACCUAGU 4700
H A F P D S A V T N M S L E P S  
4701 GCAAUUUAUCGUAGGAGAGAUGUGUUACUGUAUGCGGAAAGAAAACCAGA 4750
A I Y R R R D V L L Y A E R K P E  
4751 AUAUGAAGGAGUUAGUUUGAGAGAUAUGAGUGUUAAUGAACAAACCACGU 4800
Y E G V S L R D M S V N E Q T T F  
4801 UUGCUCAUUUGAAUUUUUAUAAGUAUAAGGAUUCCACCAACUCAUCUUCG 4850
A H L N F Y K Y K D S T N S S S  
4851 UGCACAUCCAAACCCGUUGGAUAUGAGUUAACUAAGGAUUGGUUGGUUGC 4900
C T S K P V G Y E L T K D W L V A  
4901 GAAGUUUGCUAAAUGGCACGCGCAGGAGCAAAUUAAAGUACAGAGACGUA 4950
K F A K W H A Q  E Q I K V Q R R M  
4951 UGGAGAAUAUACGAGCAGGAAUGUACGACGCUGAGGUAGGAUCUUUGCGU 5000
E N I  R A G M Y D A  E V G  S L R  
5001 UUGGAAGAUCCAUUUAGUUUAUAUUACUCAGUUUCUAGUGAAGUCAUCGA 5050
L E D P F S L Y Y S V S S E V I E  
5051 AAAUAAUGAAGAUGUUACGACUGGGUUUCUUCCUAGUGAGAUUUUGGCUU 5100
N N E D V T T G F L P S E I L A F  
5101 UUGAGUGUAAGCGUAUAGCAAAUGUGAUAGAUGCCCAUCAGUCCUCGGUA 5150
E C K R I A N V I D A H Q S S V  
5151 AGGGAAAUUGUGAUUCCAGAUGAGCCAAAAGAUCCAUUUGUUACUACACA 5200
R E I V I P D E P K D P F V T T Q  
52 01 GGGUGAUUUGGCGGGGGUAUUUAUGGGAGCUGCUUUGGGUCGAGUGGUAC 5250
G D L A G V F M G A A L G R V V L
52 51 UGGAAAAAGUUUGUAGCUUUUCAUCGGAACUUAUUAAUUAUGCGGUUGAU 53 00
E K V C S F S S E L I N Y A V D
53 01 UGGAUAAUCAGUAAGCAUAAUGUCACCCACGAGUGUUGUGUGUGUAAAGA 5350
W I I S K H N V T H E C C V C K E  
5351 GACAAAAGGUAUCUCAUGGUACUGCUUGGAUUCUGCGCAACUUGCACCUC 5400
T K G I S W Y C L D S A Q L A P Q  
5401 AAGCUACGCAUUAUAUGUGUAACAGUUGUAUGGUUGCAUCGCGCGCAGCA 5450
A T H Y M C N S C M V A S R A A  
5451 AACCGAGAAGUAGUCCAGUGCCCGAUGUGUAGGAGUCCAAAUUUUGAAAG 5500
N R E V V Q C P M C R S P N F E R  
5501 AUGGGGUACGUAUCAACAGAUGACAGGAAUAACGAUUGUGGGGCGUGCAU 5550
W G T Y Q Q M T G I T I V G R A L  
5551 UAAUUAUGGGAUUGAUAACAGUUGAUAAGGGAGUUAAUGUAUUACGUCGA 5600
I M G L I T V D K G V N  V L R R  
5601 AUGUUGGGAGGUACUUUUGGUGCUAUGUAUGCGGCUAUAAUGCGCAUAGC 5650
M L G G T F G A M Y A A I M R I A  
5651 UGCUACACUUCACCCUUCGAUGAGUGAGAGAACAGCGGAUUUAUUAAGGA 5700
A T L H P S M S E R T A D L L R M  
5701 UGACAGGGGCCUUGGUAGAUAUGAGUGAAUAUACGGUGCGAGAACUGCAA 5750
T G A L V D M S E Y T V R E L Q  
5751 CAUGUGGUUACUCAAAUGGAUGAUCCCUUUGAAUCGGAUGGUGAAGAUGA 5800
H V V T Q M D D P F E S D G E D D  
5801 UGAUGUUGGUACAAGUAAGGUACAUUGGCGAGAUAUUGUAACUUUUGAUU 5850
D V G T S K V H W R D I V T F D F  
5 851 UCGAGGAAGACGUGGCUCGCUCGUUGAUGCGAGAGAGGGAAAUUACUAAU 5900
E E D V A R S L M R E R E I T N
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5901 AUACCUUGCCUUCAUAUAUUGUUGGGGGGUGCUUUGCAUCAUGUCUCGUA 5950
I P C L H I L  L G G A L H H V S Y  
5951 UCGUGAUGGAGGUUACAACGUACCCAAUGGGGGAACUAUGGUGAGAGUAC 6000
R D G G Y N V P N G G T M V R V P  
6001 CGGAGUUGCCGUGUACAUCAGAUUGUUACUUUUCUGAUAUGGAAGCAUUU 6050
E L P C T S D C Y F S D M E A F  
6051 AAAAGUUUUGCCCAGCGGUACAAAGAGGAAAAGAAGAUUGAGAUCCAAUC 6100
K S F A Q R Y K E E K K I E I Q S  
6101 CCAUUUAUUAGGUUUUAUUAACAAUCAGCACUCUCAAGAUUAUUAUAGGA 6150
H L L G F I N N Q H S Q D Y Y R K  
6151 AGCGAGUCCCGCGUAUUUUCCAGCCUCACUGGAUGAGAGCGAAUGAAGAU 62 00
R V P R I F Q P H W M R A N E D
62 01 UUAGCUUUGGAAAUUUCUAAUAUUACAGCGGAUGGUUGGUACCAGAGAGU 6250
L A L E I S N I T A D G W Y Q R V  
6251 AGGUGAUUCGUUUGUGAAUUAUAGAACUUUGAUAGUGGCGGCUGCGGGUU 63 00
G D S F V N Y R T L I V A A A G L
63 01 UAGUGAUGGCAGUGGGGAGUAUAUUUGGAAUGUAUAAAUUCUUCUCUAUC 6350
V M A V G S I F G M Y K F F S I  
63 51 GGUACGAAUCCAGCGCGUGUUGAGUUUGUACCUAGUGGGGAUGAAAUUAC 6400
G T N P A R V E F V P S G D E I T  
6401 UAGAAACUUGAAGCGAACAACUAGGACUCUGCAAAGGACCCGAACGGAGA 6450
R N L K R T T R T L Q R T R T E R  
6451 GGCCUCACUUUCAACAAGUGAACGAACACCCAUCCCUUGAUUCAGUGGUU 6500
P H F Q Q V N E H P S L D S V V  
6501 AAGAAGUAUGUGGCUCGUAACUAUAUUACUAUUAGUUUGUAUAAACCCGC 6550
K K Y V A R N Y I T I S L Y K P A  
6551 GGGGCGUGUGAAGUUAACCGCAUGCGGUAUUUAUGGAACAGUGGCGUUAU 6600
G R V K L T A C G I Y G T V A L L  
6601 UACCGAGGCAUUAUGUGCGUGCCAUUAAGGAGGCUUGGGAAAAGAGUGUG 6650
P R H Y V R A I K E A W E K S V  
6651 AAAAUAACUAUAACUCCGGCACUCUUGGAGCAUGAGGAGCAUGUCUAUAC 6700
K I T I T P A L L E H E E H V Y T  
6701 UUAUGAUGCUGCUGAUUUCACUAUAUCUGAGUCUACAGAUUUGGCUAUUU 6750
Y D A A D F T I S E S T D L A I W  
6751 GGGUAUUGUCUCCGUCAUUUGGAAUGUUUAAGGAUAUAAGGAAGUUUAUA 6800
V L S P S F G M F K D I R K F I  
6801 GCCACAGAUGAGGACCUAUCUAAACCAAUUACUACGGAAGGGUCCUUGUU 6850
A T D E D L S K P I T T E G S L L  
6851 GUUGGCUCCAACCAAUCGUAAUCCAGUGCUUAAGGAACAGAGUAUAGAGA 6900
L A P T N R N P V L K E Q S I E I  
6901 UACUGGGACUACAAAAUGAAAUGCAAGUAUCUGAGUUAAAUGGCACGGUA 695 0
L G L Q N E M Q V S E L N G T V  
6951 UUUUAUGCGAAUGAUGUAAUCUGUUAUGAUUAUUCACAACAAGGAGCUUG 7000
F Y A N D V I C Y D Y S Q Q G A C  
7 001 UGGAUCUUUGUGUUUUUUGUCCCGCUCGCAAAGACCUAUUGUGGGAAUGC 7050
G S L C F L S R S Q R P I V G M H  
7051 AUUUUGCUGGUCGGGGCGAAGGAUCCUGUGGAGAAGGUUAUGGAGUUAUU 7100
F A G R G E G S C G E G Y G V I  
7101 UUAACUAAAGAAGCCAUUGGGGACAUUUUAGCACUUAAGUCCCAACCUGU 7150
L T K E A I G D I L A L K S Q P V  
7151 AGUGCAGUUAGAAGAUUGGGAAGGACCCAGUUUAGAAGAAGCAAAAAUAA 7200
V Q L E D W E G P S L E E A K I I  
7201 UUUUACCUGAAACUAAUGUGUCUUAUAUUGGGGCGGUGACAAAGGAGCAA 7250
L P E T N V S Y I G A V T K E Q  
7251 ACUCCUUACCUCCCCAGGAAAACGAAGAUAAGGCCAAGUCUUAUUCAGAA 73 00
T P Y L P R K T K I R P S L I Q N  
73 01 UGUUGGUGACCUUCACCCAGUGUCAGAACCGUGUAUAUUGGAUAAAACGG 73 50
V G D L H P V S E P C I L D K T D
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73 51 AUCCCAGAUACCAACAUGAUGAUACUCCUCUAGUAGCGGGGUGUAAGAAA 7400
P R Y Q H D D T P L V A G C K K  
7401 CAUGGAAGGCUUACUGUGGAUUUUGGUACUACUAGAGUAGAAAGUGCUAA 7450
H G R L T V D F G T T R V E S A K  
7451 GGAAGCUCUUUGGGAUGGAUGGCUAUCGAAAAUGAAACCCCUGGUAGUAA 7500
E A L W D G W L S K M K P L V V K  
7501 AACCUAAGUUAUUAACGCCCGAGGAGGCUGCUAGUGGUUUUCCAGAUAUA 7550
P K L L T P E E A A S G F P D I  
7551 CAGUACUAUGAUCCUAUGAUUCUCAACACCAGCGCGGGUUUUCCUUAUGU 7600
Q Y Y D P M I L N T S A G F P Y V  
7 601 GGCAACAGAAAAGAAGCGUAAAGAAGAUUAUAUAGUAUUUGAGCGCAAUG 7650
A T E K K R K E D Y I V F E R N E  
7651 AGAACGAGCAACCGAUUGGUGCCACUAUAGAUCCUGGUGUUUUGGAGGAG 7700
N E Q P I G A T I D P G V L E E  
77 01 AUGAAGCGAAAAUCUGAGUUGAGAAAGCAAGGGGUGCAGCCUAUUACGCC 7750
M K R K S E L R K Q G V Q P I T P  
7751 UUUUAUUGAUACACUUAAGGAUGAAAGGAAAUUACCAGAAAAAGUACGAA 7 800
F I D T L K D E R K L P E K V R K  
7801 AGUAUGGUGGAACCCGAGUGUUUUGUAACCCUCCUAUCGAUUAUAUUGUA 7850
Y G G T R V F C N P P I D Y I V  
7 851 UCAAUGAGGCAAUAUUAUAUGCACUUUGUUGCUGCAUUUAUGGAACAGCG 7900
S M R Q Y Y M H F V A A F M E Q R  
7901 UUUUAAGCUAAUGCAUGCAGUGGGAAUUAAUGUUCAGAGUACAGAGUGGA 7950
F K L M H A V G I N V Q S T E W T  
7951 CGCUUUUAGCUUCUAAGUUGCUAGCGAAAGGGAAUAACAUUUGCACCAUU 8000
L L A S K L L A K G N N I C T I  
8001 GAUUAUUCAAAUUUUGGUCCGGGUUUUAAUGCUCAAAUAGCGAAAGCUGC 8050
D Y S N F G P G F N A Q I A K A A  
8051 UAUGGAAUUAAUGGUGCGGUGGACUAUGGAGCAUGUUGAGGGCGUAAACG 8100
M E L M V R W T M E H V E G V N E  
8101 AGAUAGAGGCGUAUACUUUAUUACAUGAGUGUUUAAAUUCGGUUCACUUA 8150
l E A Y T L L H E C L N S V H L  
8151 GUGUCUAAUACGCUGUACCAACAAAAGUGUGGAUCACCUAGUGGCGCGCC 8200
V S N T L Y Q Q K C G S P S G A P  
8201 CAUUACUGUAGUGAUAAAUACUUUGGUUAAUAUUUUAUAUAUAUUCGUAG 8250
I T V V I N T L V N I L Y I F V A  
8251 CUUGGGAGACGUUAGUAGGAAGUAAAGAACGAGGGCAAACUUGGGAAUCC 83 00
W E T L V G S K E R G Q T W E S  
83 01 UUUAAACAAAAUGUAGAAUUGUUUUGCUAUGGUGAUGAUUUAAUAAUGUC 8350
F K Q N V E L F C Y G D D L I M S  
83 51 AGUAACAGAUAAAUAUAAGGAUGUUUUUAACGCAUUAACAAUAAGUCAAU 8400
V T D K Y K D V F N A L T I S Q F  
8401 UUUUGGCACAAUAUGGAAUAGUAGCCACUGAUGCAAAUAAAGGAGACGAA 8450
L A Q Y G I V A T D A N K G D E  
8451 GUUGAGGCUUAUACGACGUUGUUAAAUAGUACGUUUUUAAAACAUGGGUU 8500
V E A Y T T L L N S T F L K H G F  
8501 UCAUCCCCACGAAGUGUAUCCGCAUUUGUGGCAAUCUGCGCUGGCUUGGA 8550
H P H E V Y P H L W Q S A L A W  S 
8551 GUUCUAUCAAUGAUACUACACAAUGGAUAUGGGAAUGUGCUGACUUGAAG 8600
S I N D T T Q W I W E C A D L K  
8601 CUGGCUACUAGGGAGAAUUGUCGAGCCGCUCUGUAUCAAGCGCAUGGUCA 8650
L A T R E N C R A A L Y Q A H G H  
8651 UGGAAGCGUCGUUUACAAUAAGUUUAAGCAACAAGUAAACCAAGCAUUAA 8700
G S V V Y N K F K Q Q V N Q A L I  
87 01 UUAAGCGGAAAAUACAACCAAUUGCUUUAUCUUGGAAAGAAAUUGAUGAU 8750
K R K I Q P I A L S W K E I D D  
8751 UUAUUUUAUCCUGAAAUUAGUUAUg^ UGUUUUUUAAGGUCUCAUAUAAG 8800
L F Y P E I S Y
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8801 CUAUAAAGGUUAUGGGUACUAAUAUAGUGGAUUAAUAUCGAUAUAUGGCA 8850 
8851 UUUU 8854
Figure 3.8: Nucleotide sequence of SBV-UK genomic RNA.
The RNA sequence for SBV-UK was produced by transforming the cDNA sequence. 
The deduced amino acid sequence of the putative polyprotein is shown beneath the 
nucleotide sequence.The initiation and termination codons are indicated by reverse- 
type face. The GenBank accession number of the sequence reported here is 
AF092924.
ro un
r .
r .
TI.
Oo  — o
cz>CD
CD
CDO
CDCD
CD
D
L O ro
Chapter 3
3.2.5.1.1 Capsid proteins
A comparison of SBV-UK with other picomaviruses found that the N- 
terminal region of the SBV-UK polyprotein was most similar to the N-terminal 
region of the IFV polyprotein, which contains the capsid proteins (Isawa et a l, 1998). 
The amino acid sequence deduced from the N-terminus of the SBV-UK polyprotein 
was aligned with structural genes from mammalian picomaviruses, insect picoma- 
like vimses (DCV, CrPV, RhPV and PSIV) and a plant picoma-like vims (PYFV- 
Parsnip yellow fleck vims).
The alignment (Figure 3.10a) showed that amino acids 257-419 of SBV-UK 
exhibited similarity to the stmctural proteins of mammalian picomavimses (PV, 
EMCV and HAV) and insect picoma-like vimses of both genome organizations 
(IFV, DCV, RhPV and PSIV). However, the nomenclature of these proteins derives 
from their size rather than their function, and this region has been designated 
previously as VP2 region of mammalian picomavimses (PV, EMCV and HAV), VP3 
of IFV (Isawa e ta l,  1998), DCV (Jhonson & Christian, 1998) and RhPV (Moon et 
a l, 1998) and the VPl of PSIV (Sasaki et a l, 1998).
A second region of homology was found between amino acids 528- 612 of 
SBV-UK which resembled the VP3 region of mammalian picomavimses (PV, 
EMCV, HRV, and HAV), VPl of IFV and DCV and VP2 of PSIV, RhPV and 
PYFV, a plant picoma-like vims (Turnbull-Ross et a l, 1992) (Figure 3.10b).
A third region of homology was found between amino acids 835-931 of SBV- 
UK with VPl like proteins of selected mammalian picomavimses (EMCV, FMDV 
and HAV), VP2 of IFV and DCV, VPl of RhPV and a protein encoded in the 
published 3' end sequence of the CrPV genome (Figure 3.10c).
6 5
a.
PV
EMCV
HAV
DCV
RhPV
PSIV
IFV
SBV
PV
EMCV
HAV
DCV
RhPV
PSIV
IFV
SBV
1 6 8  HYLGSSGYTVHBfflcgASKraHQfflAfflGVFAVBE MCLAGDSNTTTMHTSYQ
2 3  8 HYLVKTGWRVQggC^ SOgiÿgGgLVFMAgE---------YPTL----DAFAMDNRWS
1 2 3  HTYASFGIEIQ®lS|PTPi®QBGIlICAMvSG---------DQSY----GSIASLTVYP
1 0 9  0VGLSATi2viKEivHSQP[^ Q|R3MLQYYgYAQYMP-NRVSLVN STLQG
lLGLSAD@WR#)vBlAOPBHA@R@MLSWTBFLDYLGTNRKYYYTDPSSTFLTS100
1 1 8
2 5 6
257 yvygkyehemkfvaign:
SQPÜft
SNQAS
ÏSSFSATVEFKLI
itlmkt:
jlMGALjaSKDL IGSRNTDVKVAVDKSLYIP
JRYVLASYBCR RQAFGVADSVFQQIQRE
CgKVI ISVKFDS------ YQADNINTGFQAALSRP
216 NANP—GEKGGTFTGT—FTB-DDNQTS PARRFC PVDYLFGNGElLGNAFVFPHQIi ElR
2 83 KDN LPNGTRTQTNKgGg------------------FAMDHQNFWQwjlLY---------PHQFgLR
1 6 9  SÎGLL—NCNINNWRI—SvB—FIYTRGAYHFKDPQYPVWEL0IR--------^wBfBStG
1 5 7  RSGCPR-TDLDLSVGTEVEMRIPYVSP----HVYYNLITGQGSF----GAIYLVEy|Q0RDQ
1 5 3  VSGNPRVEID-LSTTTEATMTIPFVSP----FLYYNLVTGSGDI----GTFQLij
Htlfdisktseitls vB--yvspfpqynlvlepinwsnffik---------L
VEVDVSTSADAILQI—(SyE-NLRNFMPILTNEVGETTGESFBtLT LTClE
Iimldlstnnegvl kiBfryhrafvrnqthktatagirpgkfasiyvqÊlÉ
1 7 1
3 0 5
3 0 6
PV 2 7 1  tnncatlvlpyvnslsidsmvkhnnwgiailplaplnfas- essBeipitltiapmcceH 
EMCV 3 2 2  tnttvdlevpyvniaptsswtqhaswtlviawapltyst-gastslditasiqpErpv|| 
HAV 2 1 7  tgtsaytslnvlSSftdlelhgltplstqmmrnefrvstt- enwnlsnyedar-akmsS
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Figure 3.10: Comparison of putative capsid proteins among SBV-UK, mammalian 
picomaviruses and insect and plant picorna-like viruses.
a .  Alignment of the amino acid sequences of SBV-UK (amino acid 249-419) and VP2 
of PV (Nomoto et al., 1982), EMCV (Palmenberg et al., 1984), and HAV (Najarian et 
a l, 1985), VPl of PSIV (33 kDa) (Sasaki et a/.,1998), and VP3 of RhPV (28 kDa), 
(Moon et a l, 1998) DCV (28 kDa) (Jhonson & Christian, 1998) and lFV(lsawa et a l, 
1998). Residues identical in at least four viruses are shown in reverse type face.
b. Alignment of the amino acid sequences of SBV-UK (amino acid 528-612) and VP3 
of PV, EMCV, HRV (Stanway et a l, 1984) and HAV, VP2 of PSIV (30 kDa), RhPV 
(29 kDa) and PYFV (26kDa)(Tumbull-Ross et a l, 1992), VPl of IFV and DCV 
(33.3kDa) and 3' part of the CrPV genome (King et a l, 1987). Residues conserved in at 
least six viruses are shown in reverse type face.
C. Alignment of the amino acid sequences of SBV-UK (amino acid 835-931) and VPl 
of EMCV, FMDV (Forss, et a l, 1984) and HAV, VP2 of IFV and DCV, VPl of RhPV 
and 3’ part of the CrPV genome. Residues conserved in atleast four viruses are shown in 
reverse type face.
Numbers on the left show amino acid position of the aligned sequences from the N- 
terminus of the polyprotein. The sequence of SBV-UK is represented by ‘SBV’.
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3.2.5.1.2 Non-structural proteins
The SBV-UK polyprotein was found to have the characteristic 
functional motifs attributed to helicases, proteases, and RNA-dependent RNA 
polymerase of viruses in the picorna-like super family (Koonin & Dolja, 1993).
A region (amino acids 1369-1489) of SBV-UK polyprotein specified a 
putative NTP binding domain (Figure 3.1 la). All the three conserved helicase domain 
motifs (A, B and C) identified by Koonin & Dolja (1993) were found in this region, 
but motif "C" in SBV-UK appears to deviate from the consensus sequence in having 
lysine (amino acid 1471), proline (amino acid 1476), leucine (amino acid 1481) and 
cysteine (amino acid 1482) where as the consensus indicates glycine, serine, 
serine/threonine and threonine/serine respectively in these positions but the motif is 
still recognisable.
The sequence (amino acid 2157-2287) shows similarity to 3C protease of 
mammalian picomaviruses, insect picorna-like vimses, a sequivims and a comovims 
(Figure 3.1 lb). The cysteine protease motif GXCG was identified at amino acid 2265 
to 2269 in the SBV-UK polyprotein. The alignment of the amino acid sequences with 
other conserved cysteine protease motifs of positive strand RNA vimses suggested 
that Ü 2164, E2204 and Ciiei of SBV-UK might form the catalytic triad (Koonin &
Dolja, 1993). The residues thought to be involved in substrate binding are also 
conserved in the putative protease domain of SBV-UK (indicated with exclamation 
marks in Figure 3.1 lb)
The C-terminal region (amino acid 2460-2829) of the SBV-UK polyprotein 
was similar to sequences of RNA-dependent RNA polymerases of vimses of the 
Picomaviridae, Sequiviridae, Comoviridae and insect picorna-like vimses (Figure
66
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Figure 3.11: Comparison of putative non-structural protein sequences among SBV- 
UK, mammalian picomaviruses and insect and plant picorna-like viruses.
a .  Alignment of conserved regions of putative RNA helicase of SBV-UK with PV, 
EMCV, HRV, HAV, FMDV, HPeV (human parechovirus 1) (Hyypia et al., 1992), DCV, 
PSIV, RhPV, APV (van der Wilk et al., 1997), CPMV (cowpea mosaic virus) 
(Lomonossof & Shanks, 1983), PYFV and IFV. References of other viruses are as in 
figure 3.11. Residues identical in at least eight viruses are shown in reverse type face. The 
motifs identified by Koonin & Dolja (1993) are labelled A, B and C.
b. Alignment of the putative protease domain of SBV-UK with those of other viruses. 
Residues identical in at least six viruses are shown in reverse type face. Residues believed 
to be involved in forming the catalytic triad (Koonin & Dolja, 1993) are shown by 
asterisks. Residues reported to be involved in substrate binding are shown by exclamation 
mark.
C. Alignment of the putative RNA-dependent RNA polymerase domain of SBV-UK with 
those of other viruses. Residues identical in at least eight viruses are shown in reverse 
type face. The motifs identified by Koonin &Dolja (1993) are labelled I-VIII.
Numbers on the left show amino acid position of the aligned sequences from the N- 
terminus of the polyprotein. The sequence of SBV-UK is represented by ‘SBV’.
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3.1 le). All the 8 conserved motifs common to the RNA-dependent RNA polymerase 
of positive strand RNA viruses (Koonin & Dolja, 1993), were also found in this 
region of the SBV-UK genome, with only one exception: motif IV contains a glycine 
(amino acid 2606) where as the consensus indicates that this residue should be 
aspartic acid.
3.2.5.2 Comparison of the putative SBV-UK polyprotein with those of other 
viruses
The derived polypeptide sequence of SBV-UK was compared to those of 
mammalian picomaviruses (PV, HRV, HAV, FMDV and EMCV), an insect picorna- 
like vims (IFV) and a plant picoma-like vims (PYFV) using the GAP program of the 
GCG package (Table 3.3). The SBV-UK sequence was most similar to IFV (23.1% 
identity and 45.3% similarity). The dot matrix comparison of these sequences were 
performed using COMPARE (window = 30, stringency =17) and DOTPLOT 
programs from the GCG package. Four regions of homology were found in IFV 
(Figure 3.12a) which were similar in PYFV and less extensive in mammalian 
picomavimses (Figure 3.12b, c and d ).
3.2.6 Nucleotide sequence of Group II clones
Three cDNA clones (plSBV15-1700 bp, plSBV25-600 bp and plSBV29-540 
bp) obtained during the initial cDNA cloning of SBV-UK RNA using oligo (dT i2- 
Ig) as primer were found to have sequences identical to each other, but different 
from those of all other clones sequenced (section 3.2.3.1). However, the sequence of 
these three clones was identical in the region of overlap. The longest clone
6 7
Virus % Amino acid identity % Amino acid similarity
IFV :%ki8 45.39
HRV 22.92 46.94
PV 22.78 46.61
HPeV 21.2 45.76
HAV 20.83 46.32
EMCV 20.71 45.15
FMDV 19.78 44.64
PYFV 19.68 44.69
Table 3.3: Comparison of polypeptide sequence of SBV-UK with mammalian 
picomaviruses and insect and plant picorna-like viruses.
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Figure 3.12: Dot plot comparison of the putative polyprotein with a. IFV, 
h. PYFV, c. HRV and d. FMDV.
The virus references are as in Figure 3.11. The COMPARE (window = 30, 
stringency =17) and DOTPLOT programs from the GCG package were used. 
I, II, III and IV denote 4 regions of polyprotein sequence similarity between 
SBV-UK and the other viruses compared.
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(piSBV 15) was completely sequenced in both strands and revealed it to be 1701 bp 
long. The complete sequence of this clone has been presented in Figure 3.13. Coding 
frame analysis of this sequence revealed a single continuous open reading frame 
which terminated at 80 bases from the poly (A) tail (Figure 3.14). The complete 
nucleotide sequence of this clone had 82.12% identity with the same region in the 
Group II which we designated SBV-UK. However the predicted amino acid 
sequence encoded in this region of the clone showed 93.88% identity and 97.22% 
similarity. A comparison of the two sequences (both nucleotide and deduced amino 
acid) is presented in Figure 3.15 and Figure 3.16. All the characteristic functional 
motifs (I to VIII) attributed to RNA-dependent RNA polymerase (Koonin & Dolja, 
1993) are conserved in the deduced amino acid sequences of the plSBV15 clone, 
except that the consensus residue aspartic acid in motif IV is substituted by glycine as 
in the sequences derived from Group I clones. The characteristic RNA-dependent 
RNA polymerase motifs have been underlined in Figure 3.13.
Separate serotypes within the Picomaviridae generally share <85% nucleotide 
or amino acid identity through out the capsid regions but the differences are less 
obvious in the non-structural proteins or noncoding regions (Palmenberg, 1989). The 
length of the 3' UTR of plSBV15 clone was 80 nucleotides, same as SBV-UK. 
However, 6 substitutions were found in the 3' UTR of the p i SB V I5 clone. 
Therefore, it appears that the plSBV15 clone might have been derived from a 
different strain of SBV.
68
1 GCAGTTGGAGGACTGGGAAGGGCCGAGTTTGGAGGAAGCTAAGATCATTT 50
Q L E D W E G P S L E E A K I I L  
51  TGCCTGAAACTAATGTTTCTTATATTGGCGCTGTAACAAAGGAGCAGACG 1 0 0
P E T N V S Y  I G A V T K E Q T  
1 0 1  CCTTACCTCCCAAAGAAGACTAAGATTAGACCAAGTATGATTCAGAATGT 1 5 0
P Y L P K K T K I R P S M I Q N V  
1 5 1  TGGTGATCTTCATCCGGTGTCGGAACCTTGTATATTGGATAAAACCGATT 2 00
G D L H P V S E P C I L D K T D S
2 01  CCAGATACCAACATGATGACACTCCTTTGGTGGCCGGATGTAAGAAGCAT 2 5 0
R Y Q H D D T P L V A G C K K H  
2 5 1  GGTCAACTTACAGTAGATTTTGGTACTACGAGAGTGGAAAGCGCTAAGGA 3 00
G Q L T V  D F G T T R V E S A K E
3 01  GGCTTTGTGGGATGGATGGTTGTCTAAGATGAAGCCTCTGGTGGTGAAAC 3 5 0
A L W D G W L S K M K P L V V K P  
3 5 1  CAAAACTATTAACACCAGAGGAGGCAGCTAGTGGTTTTCCCGATATACAG 4 0 0
K L L T P E E A A S G F P D I Q  
4 0 1  TACTATGACCCCATGATTCTAAATACAAGCGCGGGTTTTCCTTACGTATC 4 5 0
Y Y D P M I L N T S A G F P Y V S  
4 5 1  TACCGAGAAGAAACGTAAGGAGGATTATATAGTATTTGAACGCAATGAAA 5 0 0
T E K K R K E D Y I V F E R N E N  
5 0 1  ATGAACAACCTGTAGGGGCGATTATAGATCCTAGCGTTTTAGAGGAGATG 5 5 0
E Q P V G A I I D P S V L E E M  
5 5 1  AAAAGGAAGTCCGAATTAAGAAAACAAGGGGTACAGCCTATTACCCCATT 6 0 0
K R K S E L R K Q G V Q P I T P F  
6 0 1  TATTGATACGCTCAAAGATGAAAGAAAGCTACCCGAAAAAGTACGTAAAT 6 5 0
I  D T L' K D E R K L P E K V R K Y  
I
6 5 1  ACGGAGGAACTCGAGTATTTTGTAATCCTCCCATAGACTATATTGTCTCG 7 00
G G T R V F C N P P I D Y I V S
I I
7 01  ATGAGGCAATATTATATGCATTTTGTAGCTGCTTTTATGGAACAGCGATT 7 50
M R Q Y Y M H F V A A F M E Q R  F
7 5 1  CAAACTAATGCATGCGGTAGGTATAAATGTGCAAAGCACAGAGTGGACAT 8 0 0
K L M H A V G I N V Q S T E W T L
I I I
8 0 1  TGCTAGCTTCGAAGTTGTTATCGAAAGGAAACAATATTTGCACTATTGAC 8 5 0
L A S K L L S K G N N I C T  I  D
8 5 1  TATTCCAATTTTGGTCCGGGATTTAATGCCCAAGTTGCAAAAGCGGCTAT 9 0 0
Y S N F G P G F N  A Q V A K A A M  
IV
9 0 1  GGATTTAATGGTACGTTGGACCATTGAACACGTAGACGGTATCAATGAAG 9 5 0
D L M V R W T I  E H V D  G I N E V  
9 5 1  TGGAAGCGTATACATTGTTACATGAATGTTTAAATTCAGTACATTTGATG 1 0 0 0
E A Y T L L H E C L N S V H L M  
1 0 0 1  TCTAATACTTTGTATCAGCAGAAGTGTGGGTCGCCAAGTGGGGCTCCTAT 1 0 5 0
S N T L Y Q Q K C G S P S G A  P I
V
1 0 5 1  TACTGTGGTGATAAACACTTTGGTTAATATTTTATATATTTTTATTGCCT 1 1 0 0
T V V I N T L V N I L Y I F I A W  
1 1 0 1  GGGAAACTTTAGTAGGAGTAAAAGAAAAAGGCCAAACTTGGGAAATTTTT 1 1 5 0
E T L V G V K E K G Q T W E I F  
1 1 5 1  AAACAAAATGTAGAGTTGTTTTGTTATGGTGATGATTTAATAATGTCTGT 1 2 0 0
K Q N V E L F C Y G D D L I M  S V
V I
12 01  TACTGATAAGTACAAGGACGTATTTAACTCTTTGACTATAAGTGATTTTC 1 2 5 0
T D K Y K D V F N S L T I S D F L
Figure 3.13
1251 TGGCGCAGTATAAGATAGTAGCTACAGATGCTAACAAGGGAGAGGATGTC 13 00
A Q Y K I V A T D A N K G E D V
13 01 GAGGCTTATACAACATTACTATCGAGTACTTTTCTGAAGCATGGTTTTCG 1350
E A Y T T L L S S T F L K H G  F R
VII
1351 TCCGCATGAAGTGTATCCACATTTGTGGCAGTCGGCGTTGGCTTGGAACT 1400
P H E V Y P H L W Q S  A L A W N S
VIII
1401 CTATAAATGACACCACCCAATGGATTTGGGAATGTGCTGATATGAAGTTA 1450
I N D T T Q W I W E C A D M K L
1451 GCCACTAGGGAGAACTGTCGGGCAGCTCTTTACCAGGCTCATGGTCATGG 1500
A T R E N C R A A L Y Q A H G H G  
1501 AAGCGCAGCTTATAATAAATTTAAGCAGCAGGTTAATAAAGCATTAATCA 1550
S A A Y N K F K Q Q V N K A L I K  
1551 AACGGAAAATACAACCTATAGCTTTATCTTGGAAGGAGATTGATGATTTA 1600
R K I Q P I A L S W K E I D D L  
1601 TTTTACCCGGAAATTAACTACg0@TGTTTTTTAAAATTTTATATATGCTA 1650
F Y P E I N Y
1651 TAGAGGTTATGGGTACTAATATAGTGGATTAATATCAATATATGGCATTT 1700
1701 T 1701
Figure 3.13: Nucleotide sequence of plSBVlS clone.
The deduced amino acid sequence of the ORF is shown beneath the nucleotide 
sequence. The stop codon (reverse-type face) is located at 80 nucleotides from 
the 3’ end. The motifs identified by Koonin & Dolja (1993) are labelled I-VIII.
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SBV-UK GCAGTTAGAAGATTGGGAAGGACCCAGTTTAGAAGAAGCAAAAATAATTT 7203
m i l l  I I  I I  l l l l l l l l  I I  M i l l  I I  M i l l  I I  I I  M M
plSBVlB GCAGTTGGAGGACTGGGAAGGGCCGAGTTTGGAGGAAGCTAAGATCATTT 50 
SBV-UK TACCTGAAACTAATGTGTCTTATATTGGGGCGGTGACAAAGGAGCAAACT 7253
I M M M M M M M  M M M M M I  I I  I I  M M M M M I  I I
plSBV15 TGCCTGAAACTAATGTTTCTTATATTGGCGCTGTAACAAAGGAGCAGACG 100 
SBV-UK CCTTACCTCCCCAGGAAAACGAAGATAAGGCCAAGTCTTATTCAGAATGT 7303
M M M M M I  I M l  I I  M i l l  I I  M M M  I M M M M M I
plSBV15 CCTTACCTCCCAAAGAAGACTAAGATTAGACCAAGTATGATTCAGAATGT 150 
SBV-UK TGGTGACCTTCACCCAGTGTCAGAACCGTGTATATTGGATAAAACGGATC 7353
M M M  M i l l  I I  M i l l  M i l l  M M M M M M M M I  M l
plSBV15 TGGTGATCTTCATCCGGTGTCGGAACCTTGTATATTGGATAAAACCGATT 200 
SBV-UK CCAGATACCAACATGATGATACTCCTCTAGTAGCGGGGTGTAAGAAACAT 7403
M M M  M M M M M I  I I  M M M  I I I  I I  I I  l l l l l l l l  M l
pISBVl5 CCAGATACCAACATGATGACACTCCTTTGGTGGCCGGATGTAAGAAGCAT 250 
SBV-UK GGAAGGCTTACTGTGGATTTTGGTACTACTAGAGTAGAAAGTGCTAAGGA 7453
I I  M i l l  I I  M M M M M M M  M i l l  M i l l  l l l l l l l l
p1SBVl5 GGTCAACTTACAGTAGATTTTGGTACTACGAGAGTGGAAAGCGCTAAGGA 3 00 
SBV-UK AGCTCTTTGGGATGGATGGCTATCGAAAATGAAACCCCTGGTAGTAAAAC 7503
M l  I M M M M M M  I I I  I I  M i l l  I I  M i l l  I I  M M
piSBVl5 GGCTTTGTGGGATGGATGGTTGTCTAAGATGAAGCCTCTGGTGGTGAAAC 350 
SBV-UK CTAAGTTATTAACGCCCGAGGAGGCTGCTAGTGGTTTTCCAGATATACAG 7553
I I I  M M M I  I I  l l l l l l l l  M M M M M M M  M M M M I
piSBVl5 CAAAACTATTAACACCAGAGGAGGCAGCTAGTGGTTTTCCCGATATACAG 400 
SBV-UK TACTATGATCCTATGATTCTCAACACCAGCGCGGGTTTTCCTTATGTGGC 7603
l l l l l l l l  I I  l l l l l l l l  I I  I I  M M M M M M M M I  I I  I
piSBVl5 TACTATGACCCCATGATTCTAAATACAAGCGCGGGTTTTCCTTACGTATC 450 
SBV-UK AACAGAAAAGAAGCGTAAAGAAGATTATATAGTATTTGAGCGCAATGAGA 7653
I I  I I  M i l l  M i l l  I I  M M M M M M M M I  l l l l l l l l  I
p1SBVl5 TACCGAGAAGAAACGTAAGGAGGATTATATAGTATTTGAACGCAATGAAA 500 
SBV-UK ACGAGCAACCGATTGGTGCCACTATAGATCCTGGTGTTTTGGAGGAGATG 7703
I I I  M i l l  I I I  I I  I M M M M M  I M i l l  M M M M I
plSBV15 ATGAACAACCTGTAGGGGCGATTATAGATCCTAGCGTTTTAGAGGAGATG 550 
SBV-UK AAGCGAAAATCTGAGTTGAGAAAGCAAGGGGTGCAGCCTATTACGCCTTT 7753
I I  I I I  I I  I I  I I  M i l l  l l l l l l l l  M M M M M I  I I  I I
p1SBVl5 AAAAGGAAGTCCGAATTAAGAAAACAAGGGGTACAGCCTATTACCCCATT 600 
SBV-UK TATTGATACACTTAAGGATGAAAGGAAATTACCAGAAAAAGTACGAAAGT 7803
M M M M I  I I  I I  l l l l l l l l  I I  M M  M M M M M I  I I  I
piSBVl5 TATTGATACGCTCAAAGATGAAAGAAAGCTACCCGAAAAAGTACGTAAAT 650 
SBV-UK ATGGTGGAACCCGAGTGTTTTGTAACCCTCCTATCGATTATATTGTATCA 7853
I I I  M i l l  M i l l  l l l l l l l l  M i l l  I I  I I  l l l l l l l l  I I
plSBV15 ACGGAGGAACTCGAGTATTTTGTAATCCTCCCATAGACTATATTGTCTCG 700 
SBV-UK ATGAGGCAATATTATATGCACTTTGTTGCTGCATTTATGGAACAGCGTTT 7903
M M M M M M M M M M  M i l l  M i l l  M M M M M M M  I I
p1SBVl5 ATGAGGCAATATTATATGCATTTTGTAGCTGCTTTTATGGAACAGCGATT 750
Figure 3.15
SBV-UK TAAGCTAATGCATGCAGTGGGAATTAATGTTCAGAGTACAGAGTGGACGC 7953
I I  l l l l l l l l l l l  I I  I I  I I  M i l l  I I  I I  l l l l l l l l l l l
p1SBVl5 CAAACTAATGCATGCGGTAGGTATAAATGTGCAAAGCACAGAGTGGACAT 800 
SBV-UK TTTTAGCTTCTAAGTTGCTAGCGAAAGGGAATAACATTTGCACCATTGAT 8003
I i i i i i i i  m i l l  I I  i i i i i i i  I I  I I  i i i i i i i i  M i l l
plSBVlS TGCTAGCTTCGAAGTTGTTATCGAAAGGAAACAATATTTGCACTATTGAC 850 
SBV-UK TATTCAAATTTTGGTCCGGGTTTTAATGCTCAAATAGCGAAAGCTGCTAT 8053
M i l l  M M M M M M M  I I I I I I I I  M l  I I I  M i l l  M i l l
piSBVl5 TATTCCAATTTTGGTCCGGGATTTAATGCCCAAGTTGCAAAAGCGGCTAT 900 
SBV-UK GGAATTAATGGTGCGGTGGACTATGGAGCATGTTGAGGGCGTAAACGAGA 8103
M l  I I I I I I I I  I I  M i l l  I I  I I  I I  I I  I I  I I  I I I  I I
piSBVl5 GGATTTAATGGTACGTTGGACCATTGAACACGTAGACGGTATCAATGAAG 950 
SBV-UK TAGAGGCGTATACTTTATTACATGAGTGTTTAAATTCGGTTCACTTAGTG 8153
I I I  I I I I I I I I  I I  I I I I I I I I  l l l l l l l l l l l  I I  I I  I I  I I
piSBVl5 TGGAAGCGTATACATTGTTACATGAATGTTTAAATTCAGTACATTTGATG 1000 
SBV-UK TCTAATACGCTGTACCAACAAAAGTGTGGATCACCTAGTGGCGCGCCCAT 82 03
I I I I I I I I  M M  I I  I I  I I I I I I I I  I I  I I  M i l l  I I  I I  I I
piSBVl5 TCTAATACTTTGTATCAGCAGAAGTGTGGGTCGCCAAGTGGGGCTCCTAT 1050 
SBV-UK TACTGTAGTGATAAATACTTTGGTTAATATTTTATATATATTCGTAGCTT 8253
M M M  I I I I I I I I  M M M M M M M M M M M I  I I  I I I  I
plSBV15 TACTGTGGTGATAAACACTTTGGTTAATATTTTATATATTTTTATTGCCT 1100 
SBV-UK GGGAGACGTTAGTAGGAAGTAAAGAACGAGGGCAAACTTGGGAATCCTTT 8303
M M  I I  M M M M I  M M M  M l  M M M M M M  M l
p1SBVl5 GGGAAACTTTAGTAGGAGTAAAAGAAAAAGGCCAAACTTGGGAAATTTTT 1150 
SBV-UK AAACAAAATGTAGAATTGTTTTGCTATGGTGATGATTTAATAATGTCAGT 83 53
M M M M M M M  I I I I I I I I  I I I I I I I I I I I I 1 1 I I 1 1 I I I I I  I I
p1SBVl5 AAACAAAATGTAGAGTTGTTTTGTTATGGTGATGATTTAATAATGTCTGT 1200 
SBV-UK AACAGATAAATATAAGGATGTTTTTAACGCATTAACAATAAGTCAATTTT 8403
I I  M i l l  I I  M i l l  I I  M M M  I I I  I I  M M M  I M l
p1SBVl5 TACTGATAAGTACAAGGACGTATTTAACTCTTTGACTATAAGTGATTTTC 1250 
SBV-UK TGGCACAATATGGAATAGTAGCCACTGATGCAAATAAAGGAGACGAAGTT 8453
M M  I I  M l  I I I I I I I I  I I  M i l l  I I  I I  M i l l  I I  I I
plSBVl5 TGGCGCAGTATAAGATAGTAGCTACAGATGCTAACAAGGGAGAGGATGTC 13 00 
SBV-UK GAGGCTTATACGACGTTGTTAAATAGTACGTTTTTAAAACATGGGTTTCA 8503
l l l l l l l l l l l  I I  I I  I I  M i l l  M l  I I I  M i l l  M M
p1SBVl5 GAGGCTTATACAACATTACTATCGAGTACTTTTCTGAAGCATGGTTTTCG 1350 
SBV-UK TCCCCACGAAGTGTATCCGCATTTGTGGCAATCTGCGCTGGCTTGGAGTT 8553
M l  I I  l l l l l l l l l l l  l l l l l l l l l l l  I I  M l  M M M M I  I
piSBVl5 TCCGCATGAAGTGTATCCACATTTGTGGCAGTCGGCGTTGGCTTGGAACT 1400 
SBV-UK CTATCAATGATACTACACAATGGATATGGGAATGTGCTGACTTGAAGCTG 8603
M M  M i l l  I I  I I  I I I I I I I I  M M M M M M M  M i l l  I
p1SBVl5 CTATAAATGACACCACCCAATGGATTTGGGAATGTGCTGATATGAAGTTA 1450 
SBV-UK GCTACTAGGGAGAATTGTCGAGCCGCTCTGTATCAAGCGCATGGTCATGG 8653
I I  l l l l l l l l l l l  M i l l  I I  M i l l  I I  I I  I I  l l l l l l l l l l l
piSBVl 5 GCCACTAGGGAGAACTGTCGGGCAGCTCTTTACCAGGCTCATGGTCATGG 1500
Figure 3.15 (contd.)
SBV-UK AAGCGTCGTTTACAATAAGTTTAAGCAACAAGTAAACCAAGCATTAATTA 
1 1 1 1 1 1 III 1 1 1 1 1 IIIIIIII II II II 1 1 1 1 1 1 1! 1 1 1
8703
plSBVl5
1 1 1 1 1 1 III 1 1 1 1 1 IIIIIIII II II II 1 1 1 1 1 1 1 1 1 1 1 
AAGCGCAGCTTATAATAAATTTAAGCAGCAGGTTAATAAAGCATTAATCA 1550
SBV-UK AGCGGAAAATACAACCAATTGCTTTATCTTGGAAAGAAATTGATGATTTA 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 II 1 II 1 1 1 1 II
8753
piSBVl5
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 
AACGGAAAATACAACCTATAGCTTTATCTTGGAAGGAGATTGATGATTTA 1600
SBV-UK TTTTATCCTGAAATTAGTTATTAGTGTTTTTTAAGGTCTCATATAAGCTA 
Mi l l  II IIIIIII II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 Mi l l  MM
8803
piSBVl5
II 1 II II IIIIIII II II II II II II II 1 1 1 Mi l l  1 II 1 
TTTTACCCGGAAATTAACTACTAGTGTTTTTTAAAATTTTATATATGCTA 1650
SBV-UK TAAAGGTTATGGGTACTAATATAGTGGATTAATATCGATATATGGCATTT 
M M M M M M M M M M M M M M M M M 1 M M M M M M 1
8853
plSBVlS
II II II II II 1 1 II II II 1 1 II 1 1 1 1 1 1 II 1 1 II 1 1 II II 1 1 1 1 1 1 1 1
TAGAGGTTATGGGTACTAATATAGTGGATTAATATCAATATATGGCATTT 1700
SBV-UK T 8854 
1
plSBVlB
1
T 1701
Figure 3.15: Comparison of nucleotide sequences of 3’ end of SBV-UK genome 
(nucleotide 7154 -  8854) and plSBV15 clone.
Identity between the two sequences is indicated by “I”. Differences are shown by 
gap. 82.12% identity was found.
SBV-UK QLEDWEGPSLEEAKIILPETNVSYIGAVTKEQTPYLPRKTKIRPSLIQNV 23 68
M I I M I I I I M I I I I I I I I I I M M M I I M I I I I h l l l M l h i l M
plSBVlS QLEDWEGPSLEEAKIILPETNVSYIGAVTKEQTPYLPKKTKIRPSMIQNV 50
SBV-UK GDLHPVSEPCILDKTDPRYQHDDTPLVAGCKKHGRLTVDFGTTRVESAKE 2418
l l l l l l i l l l i l l l l M l l l i i l i l l l l l l l l M l l l l l l l l l l i l l l
plsbvl5 GDLHPVSEPCILDKTDSRYQHDDTPLVAGCKKHGQLTVDFGTTRVESAKE 100
SBV-UK ALWDGWLSKMKPLWKPKLLTPEEAASGFPDIQYYDPMILNTSAGFPYVA 2468
I I I I  m i l  I i i i i i i i i i i i i i  l l l l l l l l l l l  m i l l  I I I I I I I I  i .
P1SBV15 ALWDGWLSKMKPLWKPKLLTPEEAASGFPDIQYYDPMILNTSAGFPYVS 150
SBV-UK TEKKRKEDYIVFERNENEQPIGATIDPGVLEEMKRKSELRKQGVQPITPF 2518
I I I I I I I I I I I I I  I I I  i i i h i m i h i i i i i i i i i i i i i i i i  I I I  I I I
plSBVl5 TEKKRKEDYIVFERNENEQPVGAIIDPSVLEEMKRKSELRKQGVQPITPF 200
SBV-UK IDTLKDERKLPEKVRKYGGTRVFCNPPIDYIVSMRQYYMHFVAAFMEQRF 2568
M i i i i i i m i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
piSBVl5 IDTLKDERKLPEKVRKYGGTRVFCNPPIDYIVSMRQYYMHFVAAFMEQRF 250
SBV-UK KLMHAVGINVQSTEWTLLASKLLAKGNNICTIDYSNFGPGFNAQIAKAAM 2618
i i i i i i i i i i i i i i i i i i i i i i m i i i i i i i i i i i i i i i i i i m i i i i
P1SBV15 KLMHAVGINVQSTEWTLLASKLLSKGNNICTIDYSNFGPGFNAQVAICAAM 3 00 
SBV-UK ELMVRWTMEHVEGVNEIEAYTLLHECLNSVHLVSNTLYQQKCGSPSGAPI 2668
: | | | | i m i | : | : | | : | | | | | | | l l l l l l l | : | | | | | l l l l l l l l l l l l
plSBV15 DLMVRWTIEHVDGINEVEAYTLLHECLNSVHLMSNTLYQQKCGSPSGAPI 3 50 
SBV-UK TWINTLVNILYIFVAWETLVGSKERGQTWESFKQNVELFCYGDDLIMSV 2718
l l l l l l l l l l l l l h l l l l l l l  I h l l l l l  l l l l l l l l l l l l l l l l l l
pi SBVl 5 TWINTLVNILYIFIAWETLVGVKEKGQTWEIFKQNVELFCYGDDLIMSV 400 
SBV-UK TDKYKDVFNALTISQFLAQYGIVATDANKGDEVEAYTTLLNSTFLKHGFH 2768
l l l l l l l i m i l h l l l l l  l l l l i m | : : | | | | | | i m i l l l l l | :
plSBV15 TDKYKDVFNSLTISDFLAQYKIVATDANKGEDVEAYTTLLSSTFLKHGFR 450 
SBV-UK PHEVYPHLWQSALAWSSINDTTQWIWECADLKLATRENCRAALYQAHGHG 2818
M M  I I I I I I I  I I I  m m  i i i i i i i i i h i i i i i i  I I  l l l l l l l l l l l
P1SBV15 PHEVYPHLWQSALAWNSINDTTQWIWECADMKLATRENCRAALYQAHGHG 500 
SBV-UK SWYNKFKQQVNQALIKRKIQPIALSWKEIDDLFYPEISY 2858
M M I I I I I I i m i l l l M M  I I  M l  M M M M M M
plSBV15 SAAYNKFKQQVNKALIKRKIQPIALSWKEIDDLFYPEINY 540
Figure 3.16: Comparison of deduced amino acid sequences of 3’ end of SBV-UK 
genome (amino acid 2319-2858) and plSBV15 clone.
Identity between the two sequences is indicated by ‘r. Substitution with similar 
amino acid is indicated by or and difference is shown by a gap. 93.88% 
identity and 97.22% similarity were found.
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3.3 Discussion 
3. 3.1 Polypeptides of SBV-UK
There is considerable variation in the protein compositions reported for SBVs. 
Bailey (1976) first reported molecular mass of SBV capsid proteins as 25, 28, and 
31.5 kDa. However, later on SBV capsid proteins were reported to form a broad 
band of molecular mass range 29 to 34 kDa on 5% SDS-polyacrylamide gel which 
separated into 3 bands on gels of higher concentration (Bailey, et al 1982). However, 
the authors did not report about the individual sizes of the SBV capsid proteins. In the 
present experiment, the three major capsid protein bands were found to be 29.5, 30.5 
and 31.5 kDa in molecular mass, all slightly different to those reported by Bailey 
(1976) and Bailey et a l (1982). In addition to these three bands, three fainter bands of 
73, 33.5 and 28.5 kDa in molecular mass were also found. The variations in sizes of 
the capsid proteins in the present experiment compared to those reported by Bailey 
(1976) and Bailey et al. (1982) could be due to variations in the technique used to 
resolve the proteins on SDS-containing polyacrylamide gels (Rueckert & Wimmer, 
1984) or to strain differences.
The sizes of three major capsid proteins of SBV-UK are very similar to the 
average capsid protein sizes of the picomaviruses. PV, typical of enteroviruses, 
contain four polypeptides with molecular mass of 33.5, 30, 26.4 and 7.4 kDa 
(Kitamura et a l, 1981). However, not all the picornavirus family show the typical 
pattern of 4 polypeptides as clearly as polio virus. In FMDV, the virus proteins VPl, 
VP2 and VP3 are of very similar in size (23.3, 24.7 and 24.3 kDa) (Carrol et al., 
1984) and difficult to separate by SDS-polyacrylamide gel electrophoresis. In HAV, 
the VP4 protein has been found to be significantly smaller (1.7 kDa) (Cohen et ah.
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1987). In the present study, no VP4 like small protein was identified on 12% SDS- 
polyacrylamide gels. It has been reported that VP4, the smallest picornavirus protein 
is easily lost during the purification of some picomaviruses. Thus this protein may be 
easily overlooked (Rueckert, 1991). However, the fainter 33.5 kDa polypeptide 
reported here could be uncleaved VPO. In picomaviruses, cleavage of VPO to VP4 
and VP2 takes place in final steps of capsid assembly (Rueckert, 1996). It has also 
been demonstrated that 1 or 2 copies of VPO remain uncleaved in each capsid . The 
functional significance of this observation is unclear (Stanway, 1990). Consequently, 
it is possible that this 33.5 kDa protein could be cleaved to 30.5 (VP2) and a VP4 of 
approximately 3 kDa.
The significance of 2 faint capsid protein bands of 73 and 28.5 kDa is not 
clearly understood. 73 kDa could represent another uncleaved precursor, whilst the 28 
kDa protein could be result of the degradation of capsid protein by the proteases 
present in the dead larvae. It has been reported that SBV is inactivated by putrefactive 
processes in a dead larva in 7-10 days (White, 1917). Therefore, host cell proteases 
could play a role in degradation of the viral capsid protein. It is also possible that 
these proteins could derive from contaminating non-SBVs, however no evidence of 
unrelated vimses was observed on sequence analysis of any clone derived here.
3.3.2 Amplification of the 5' end sequence by RACE
The 5' end of the SBV-UK genome was cloned using the RACE system. 
Sequence heterogeneity was found in these 5' end cDNA clones. The longest clone 
(prSBVlO) was 251 nucleotides. Except for a few substitutions in some clones, all 5' 
end cDNA clones were identical in sequence except for a 2-10 nucleotide deletion at
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a specific site towards the extreme 5' end (nucleotide 23-32). This level of sequence 
heterogeneity may have arisen from errors introduced by reverse transcriptase in the 
synthesis of the cDNA first strand (Lomonossoff & Shanks, 1983; Meyer et a l, 
1986), or from amplification errors in PCR (Saiki et al, 1988), alternatively it might 
reflect actual heterogeneity in virus sequence (Tumbull-Ross et. a l, 1992). SBV-UK 
RNA was reverse transcribed using Superscript reverse transcriptase. Although 
reverse transcriptase may pause or cease to copy at secondary structure it is unlikely 
to produce deleted transcripts at this stage and template switching is unlikely since 
reverse transcriptase enzyme does not reinitiate transcription in this reaction during 
first strand cDNA synthesis. Taq DNA polymerase used in the PCR has a error rate 
reported in the range of 1.6x10"^ to 2.6xl0"4 (Saiki et al, 1988). This could cause 
some substitutions but deletion formation could result from copy choice in 
amplification although there are no obvious sequences for illegitimate base pairing of 
this part. Furthermore, this feature is not seen in PCR amplification of plaque purified 
picornavirus sequences and thus this heterogeneity may be a true reflection of 
polymorphism in the virus population. Further, since SBV-UK is an RNA virus, the 
potential for sequence variation between strains is likely to be higher than DNA 
viruses. The SBV-UK RNA used for RACE system was obtained from a natural 
outbreak of SBV in Devon, England. As there is no in vitro system for the 
propagation of honey bee viruses, it was not possible to plaque purify SBV-UK to 
minimise the heterogeneity in the virus populations, used for cDNA cloning. 
Therefore, SBV-UK extracted from infected larva (scales) of honey bees did not 
contain a single genomic species of defined sequence, but rather heterologous 
mixture of related genomes (Domingo et a l, 1985) and the cloning data supports this.
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Furthermore, the length of the 5' UTR has been found to be variable in different 
strains of the same virus. The size varies from 740 -747 nucleotides in different PV 
and coxsackie B virus strains. However, there is much greater diversity among other 
picomaviruses. Rhinovirus UTRs are 610-628 nucleotides long, where as the 5' UTRs
Iin the genomes of some cardioviruses and especially ap^hovimses are much longer, 
up to about 1200 nucleotides (Agol, 1991). Similar heterogeneity in the size of the 5' 
UTRs of different strains of potato virus Y have also been reported (Robaglia, et a i, 
1989; Kelly, 1995). All these reports support the heterogeneous mixture of different 
strains of SBV. Another possible explanation for these deletions could be the 
presence of extensive secondary structures around the area of deletion. The computer 
program MFOLD (Jacobson & Zuker, 1993) was used to see the potential secondary 
stmctures of the longest (prSBVlO) 5' end clone (Figure 3.17A) and compared with 
potential secondary structures of the two shorter 5' end clones (prSB V2) and prSBV4) 
(Figure 3. 17C and D ). From these figures, it can be seen that the area of deletion 
(nucleotide 23-32) appears to have the potential to form a stem-and-loop secondary 
stmcture of different length. The protocol used (heated to 70°C for 10 minutes 
followed by chilling on ice) during reverse transcription would not have removed 
secondary stmctures in this region. However, similar deletions are not seen in regions 
of similar secondary stmctures suggesting that these deletions represent tme 
differences in vims sequence.
3.3.3 Non-coding and coding sequence of SBV-UK genomic RNA
The nucleotide sequence of SBV-UK (8554 nucleotides) is longer than that of 
mammalian picornavimses (approximately 7,200 to 8,450 nucleotides), and contains
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Figure 3.17: Predicted RNA secondary structures of the 5' UTRs of SBV-UK and IFV.
RNA secondary stmctures were drawn using MFOLD program. A, C, and D indicate 
secondary stmctures on the basis of prSBVlO (longest), prSBV2 and prSBV4 clones 
of SBV-UK respectively. B indicates IFV. The area of deletion in 5' end clones of SBV-UK 
is shown by 'S'. Common stem loop stmcture in the prSBVlO and IFV is shown by arrow.
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a larger ORF encoding 2858 amino acids. However, the genomic organization of 
SBV-UK clearly resembles that of typical Picomaviridae with structural genes at the 
5' end and non-structural genes at the 3' end encoded in a similar order.
3.3.3.1 5' UTR
The 5' UTR of SBV-UK is only 200 nucleotides long although considerably 
shorter than the length of the 5' UTRs of mammalian picomaviruses, it is similar to 
IFV (156 nucleotides), an insect picorna-like vims. Several findings now indicated 
that cap independent translation of picornavims genome is dependent on a specific 
region of the 5' UTR, termed the 1RES (see section 1.10.1). The 1RES in 
picornavimses is about 450 nucleotides long and does not appear to include the 
exterme 5' proxomal sequences (Jackson & Kaminiski, 1995). Isawa et al. (1998) did 
not find any evidence for an 1RES in the 5' UTR of IFV. The nucleotide sequence of 
5' UTR of SBV-UK was found to have 38% identity with that of IFV. Analysis of 
potential secondary stmcture in the 5' UTR of SBV-UK [on the basis of nucleotide 
sequence of longest 5' end clone (prSBVlO)] revealed many stem-loop stmctures 
(Figure 3.17A) but these secondary stmctures appeared to differ from those in 
mammalian picornavimses. Prediction of secondary stmcture at the 5' UTR of IFV 
using MFOLD program (Jackobson & Zuker, 1993), showed that both SBV-UK and 
IFV had at least one unpaired stem loop stmcture (UUG) in common (Figure 3.17B). 
GNRA motifs (where N is any nucleotide and R is a purine) found in enterovims, 
rhinovims, cardiovims and a^hovims 1RES elements, were not identified in either of 
SBV-UK or IFV 5' UTRs. Another sequence motif has been found to be conserved in 
all picornavimses is a Y^-Xj^-AUG (where Yn is pyrimidine-rich region, X ^  is a
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Spacer element which is typically 15-25 nucleotides), partially responsible for internal 
initiation. In cardiovims, aj|hovims and hepatovimses, this AUG is the translation 
initiation site. In enterovimses and rhinovimses, however the authentic translation 
start site resides about 30-150 nucleotides downstream of this AUG (Stewart & 
Semler, 1997). Within the pyrimidine rich region, the sequence UUUCC has been 
considered to be the most critical (Brown et a l, 1994; Nicholson et a l, 1991; Jang & 
Wimmer, 1990; Kuhn et a l, 1993; lizuka et a l, 1989 & Gmyl, et a l, 1993). This 
sequence motif was absent in SBV-UK 5' UTR.
However 1RES sequences may vary; hepatitis C vims (HCV) and pestivimses 
have a relatively short 5' UTR (341-370 nucleotides) but also possess an 1RES of 
moderate efficiency (Reynolds et a l, 1995; Rijnbrand et a/.,1995; Poole et a l, 1995). 
The 5'-boundary of the HCV 1RES is around nucleotide 40 and the 3'-boundary 
extends up to 10 codons into the coding sequence. Similar findings have been 
reported for the pestiviruses (Jackson & Kaminiski, 1995). The 5' UTR of HCV 
shares limited nucleotide sequence homology, with the 5' UTRs of pesti vimses and in 
contrast to picornavims 1RES, the HCV 5' UTR does not have a oligopyrimidine tract 
preceding the authentic initiation codon. However, most strains of HCV contain an 
oligopyrimidine tract near the centre of the 5' UTR followed by an AUG at the 
appropriate distance, but this AUG is not absolutely conserved among all strains 
(Bukh et a l, 1992). This pyrimidine rich tract and the AUG triplet are dispensable for 
HCV 1RES function as shown by mutagenesis experiments (Wang et a l, 1994). An 
1RES even smaller than that of HCV has been found in cellular mRNAs. Mammalian 
BiP mRNA (immunoglobulin heavy-chain binding protein) has a 220 nucleotide 5' 
ÜTR devoid of AUG codons upstream of the initiator AUG codon and this BiP 5'
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UTR can function as an 1RES element as shown by dicistronic mRNA assay 
(Macejak & Sarnow, 1991). The 5' UTR of SBV-UK does not have any upstream 
AUG codon other than the presumed initiator AUG codon at the start of the open 
reading frame, similar to the BiP 5' UTR. Recently, it has been shown that the capsid 
protein gene of PSIV is translated by internal ribosome entry and the 1RES consists 
of approximately 250 nucleotides and its 3' boundary lies 6-11 nucleotides 
downstream of the initiation codon (CUU) of the capsid coding region (Sasaki & 
Nakashima, 1999). Therefore, although the 5' UTR of SBV-UK appears to lack both 
secondary structures and sequence motifs characteristic of picornavirus IRESes, it is 
possible that a relatively short 5’ UTR in SBV-UK may be sufficient for 1RES 
function.
Sequence heterogeneity was found in the 5' end cDNA clones, except for a 
few substitutions found in some places, most of the clones had 2-10 nucleotides 
deleted at the 5' terminal region between nucleotides 23-32 with respect to the longest 
clone. Predicted secondary structures of the longest 5' end clone (prSBVlO) was 
compared with that of shorter 5' end clones (prSBV2 and prSBV4) to find any major 
differences in the secondary structures due to deletions in these clones (Figure 17A, C 
and D). The stem loop structure present in the longest clone is shorter in prSBV2 and 
the stem loop appeared to be absent in the shortest 5' clone (prSBV4). The extreme 5' 
proximal nucleotide sequences of picornavirus and HCV 5' UTRs do not form part of 
the 1RES (Jackson & Kaminiski, 1995). If SBV-UK 5' UTR does have a functional 
1RES, it is possible that deletions/insertions at the extereme 5'-proximal sequences 
may not affect in the translation. The extreme 5'-proximal sequences are thought to be 
involved in regulation of RNA replication (Andino et al., 1993) and thus it is not
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known whether these deletions/insertions in the 5' UTRs of SBV-UK could influence 
replication.
3.3.3.2 Cleavage of the polyprotein precursor
The nucleotide sequence of the SBV-UK genome contains a single ORF 
encoding a polyprotein (2858 amino acids). Thus resembles the genome organization 
of the Picomaviridae, and encodes structural proteins at the 5' end and non-structural 
proteins at the 3' end. The mature viral proteins of picornavimses are generated by 
proteolytic cleavage and the full length precursor is not actually formed as it is 
cleaved co-translationally. These cleavages are performed by vims coded proteases 
(section 1.10.1)
Amongst the insect picornavims-like agents, SBV-UK resembles IFV in both 
genome length and gene order and shows an overall 23.2% identity and 45.4% 
similarity in amino acid sequence and 39.68% identity in nucleotide sequence to this 
vims. The N-terminal sequence of the capsid proteins of SBV is not available and 
thus cleavage sites have not been identified. Potential cleavage sites in the viral 
proteins of SBV-UK are suggested based on homology with IFV and other 
mammalian picornavimses. The putative cleavage sites for SBV-UK are suggested in 
Table 3.4 and compared with those of other vimses. This analysis suggests that 
cleavage sites in SBV-UK may be heterogeneous like those of a^hovimses although 
a majority of candidate sites possess either a glutamine or glutamate at P j and a 
glycine, asparagine, threonine, proline and serine at P%'. Isawa et a l (1998) have 
suggested that in common with cardiovimses and aj^hovimses an additional protein 
(16.745 kDa) might be present at the N terminus of IFV since the N terminus of the
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SBV IFV
Aptho-
viruses
Cardio­
viruses
Entero­
viruses
Rhino-
viruses
Hepatitis A  
viruses
L /IA E/G
(L=114)
G/G
(L=148)
K/G 0/G
lA /lB E/G
(1A=248)
G/G
(1A=242)
A/D A/D
UD
M/D
N/S
G^
N/S
G/S"
A/D
IB /IC K/D
(1B=70)
K/D
(1B=75)
0/G
V/G
E/G
G/y G/G G/G G/;i^
IC /ID Q/P
(1C=290)
Q/M
(1C=322)
G/G
(1C=302)
G/T
E/T
G/G G/A/
G/A
G/?V
E/G
G/F
1D/2A Q/V
(1D=278)
Q/M
(1D=280)
E/G
(1D=291)
? CW
UN
E/N
E/S
Y/G
T/G
H /G
F /G
Y/G
A/G
V/G
E/s
2A/2B Q/N
(2A=81)
(2A=79)
(2A=68)
G/P G/P
R/P
G/P G/G G/G G/G
2B/2C Q/A
(2B=119)
Q/G
(2B=102)
G/G
G/S"
G/S"
G/V
G/G
G/9
E/S
G/4
G/^
2C/3AB Q/S
(2C=447)
Q/G
(2C=467)
E/G
(2C=493)
G/^
G^^
G/G
G/y
G/G
G/G G/G
3AB/3C Q/R
(3A B=431)
(3A B=411)
Q/G
(3AB=489)
E/s G/}4
G/G
G/G G/G G/S"
3C/3D E/G
(3C=246)
(3D=534)
E/G
(3C=268)
(3D=639)
E/G G/G G/G G/G G/R
Table 3.4: Putative cleavage sites for SBV-UK by analogy with IFV and mammalian 
picornavimses.
Number o f amino acids for each protein for SBV -U K  and IFV has been shown in parenthesis. 
? indicate putative cleavage site has not been identified. Known cleavage sites are shown in 
italics.
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first structural protein is located some 149 residues downstream of the ORF start. 
Comparing the N terminal sequence of the SBV-UK polyprotein with that of IFV 
shows that these regions of the genome are similar (26% amino acid identity and 37%
similarity) and thus a similar protein may also be present in SBV-UK.
WIn apthoviruses, the cleavage site between the L polypeptide and the structural 
proteins (L/VPO) is different from those between VP0/VP3 or VP3/VP1 and the 
cleavage is catalysed by L itself releasing it from VP4 (Strebel & Beck, 1986). 
However, in cardiovims the cleavage site between L/VP4 is similar to that between 
VP3/VP1 indicating the possibility that the same 3C protease is responsible for all the 
cleavages. In SBV-UK the putative cleavage sequence between L/VP3 may be 
similar to that between VP3/VP0 and therefore suggests that the same proteolytic 3C 
could be used in releasing the putative L protein. Two possible cleavage sites (Q/P 
and Q/M) for IC/ID and 3 possible cleavage sites for 1D/2A were predicted for 
SBV-UK. Using the predicted cleavage sites of E/G for L/IA and lA /lB , K/D for 
IB /1C, Q/P for IC/ID and Q/V for 1D/2A, it has been possible to account for 
stmctural proteins of molecular mass 27.757 (VP3), 7.718 (VP4), 32.501 (VPl) and 
27.860 kDa (VP2). These size predictions are similar to the sizes estimated from 
polyacrylamide gel (31.5, 30.5 and 29.5 kDa). The other possible cleavage sites are 
Q/A for 2B/2C, Q/R for 3AB/3C and E/G for 3C/D. Two possible cleavage sites (Q/S 
or Q/G) for 2C/3AB were predicted. However, we could not identify a potential 
cleavage site between 3 A and 3B.
The amino acid residues flanking most of the cleavage sites in SBV-UK are 
not homologous from site to site. Earl et a l (198^) reported variations from site to 
site in the sequences flanking each Q/G site or equivalent cleavage sites in the same
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genome of the picornavimses. Thus it appears that 3C proteinase in these vimses does 
not always recognise a specific amino acid flanking sequence but perhaps a folded 
structure of the polyprotein.
3.3.3.3 Putative cleavage products
The putative L protein in SBV-UK appeared to be 114 amino acid residue 
long. Proteolytic activity of the L proteins has been established in FMDV (Strebel & 
Beck, 1986) and Equine rhinovims (ERV) 1 and 2 (Wutz et al, 1996). L proteins of 
these vimses have also been shown to mediate the cleavage of a cellular protein, 
eIF4G leading to host cell shut-off (Devaney et a l, 1988; Kirchweger, 1994; Wutz et 
a l, 1996). A conserved cysteine-tryptophan amino acid pair and a histidine residue, 
have been found to be essential for the L proteinase activity (Gorbalenya et a l,  1991; 
Piccione et a l, 1995; Roberts & Bel sham, 1995). In contrast, the L/Pl junction in 
EMCV is catalysed by 3C protease and no protease activity has been detected in its L 
protein (section 1.10.1). The conserved cysteine-tryptophan amino acid pair required 
for activity in FMDV, ERV-1 and ERV-2 L proteins is lacking from both IFV and 
SBV-UK putative L proteins. Thus in common with cardiovimses, the L proteins 
from both SBV-UK and IFV may not be a protease.
The order of the mammalian picornavims capsid proteins in the PI precursor 
has been determined as VP4, VP2, VP3 and VPl (lA, IB, 1C and ID) (Rekosh, 
1972; Butterworth & Rueckert, 1972; Butterworth & Korant, 1974). These stmctural 
proteins (VPl, VP2, VP3 and VP4) have been named in order of descending 
molecular mass on polyacrylamide gels. Analysis of the IFV stmctural proteins 
located their positions of cleavage from the precursor and derived an order of 5-VP3,
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VP4, VPl, VP2-3'. A different order of capsid proteins have also been found in some 
other insect picorna-like viruses with capsid proteins encoded at the 3' end of the 
genome e.g. DCV (5'-VP4-VP3- VP 1 -VP2-3') (Johnson & Christian, 1998) and RhPV 
(5'-VP4-VP3-VP2-VPl-3') (Moon et al., 1998). In view of the relationship between 
SBV-UK and IFV above, it is possible that the structural proteins may be encoded in 
the same order. Certainly the regions of VPl, VP2 and VP3 homology are located in 
similar distances from the polyprotein terminus in both viruses. Choi et al. (1992) 
have demonstrated VPl and VP4 of IFV are generated from a precursor protein, VPO. 
Therefore, if the order of the structural proteins in SBV-UK are same as IFV, VPO of 
SBV-UK unlike mammalian picornavimses could be located at the centre of the 
stmctural protein precursor.
Analysis of the predicted capsid protein sequences indicated some regions of 
similarity to a number of other vimses from Picomaviridae and insect picorna-like 
vimses. The level of sequence similarity varied from vims to vims but in general 
varied from 15% identity and 36% similarity to 26% identity and 53% similarity 
(Table 3.5). Although, it appears that the level of similarity is low however it is 
considered these levels are significant when considering RNA vimses due to their 
high mutation rate (Goldbach & Wellink, 1988; Contamine et. al., 1989; Candresse et 
al., 1990; Koonin & Dolja, 1993). The capsid protein is also under continuous 
immune pressure from the host and therefore a greater degree of sequence 
heterogeneity is also expected in the region encoding capsid protein in compared to 
the region encoding non-stmctural protein.
SBV-UK encoded non-stmctural proteins are analogous to mammalian 
picornavims and picorna-like plant viruses. No significant homology between the
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possible 2A like region of the SBV-UK and other picomaviruses was detected. This 
region of SBV-UK was most similar to 2A proteins of HAV with 22% identity and 
47%similarity (Table 3.5). The role of 2A proteases are variable among the different 
members of the Picomaviridae (section 1.10.1). Cardiovimses and apthovimses 
achieve efficient primary cleavage of the polyprotein through the use of a unique self 
cleavage mechanism between the glycine and proline of the sequence NPGP spanning 
the 2A-2B junction (Ryan et al., 1991). The consensus sequence motif NPGP have 
been reported for IFV, implying that the mechanism of cleavage at 2A-2B junction of 
the polyprotein may be similar to cardiovimses and a^hovimses (Isawa et ah, 1998). 
However, neither the catalytic sequence for the protease nor the NPGP motif were 
found near the outside of SBV-UK stmctural protein. The mechanism and site(s) 
used for initial cleavage in hepatitis A vims have also not been determined 
(Palmenberg, 1990). Therefore, the role of the2A protein in SBV-UK remains to be 
investigated.
The putative 2B protein of SBV-UK was closest to that of PV with 24% 
identity and 48% similarity (Table 3.5 ). The picornavims 2B gene is a host range 
determinant and also involved in RNA synthesis (section. 1.10.1.). However it is not 
known if this protein has also similar role in insect vimses.
2C is the largest protein derived from P2 region of the picornavimses. This 
region of the polyprotein is highly conserved and involved in RNA synthesis in 
picornavimses (section 1.10.1). This 2C region of SBV-UK contained the conserved 
sequence motifs for RNA helicase and was most similar to the 2C of EMCV, with 
26% identity and 47% similarity (Table 3.5). It is suggested that the putative 2C
80
Chapter 3
protein of SBV-UK could be concerned with helicase activity and may belong to 
helicases of superfamily III.
In picornavimses, 3B (VPg) sequences have been reported to be rich in basic 
and hydrophilic amino acids and have only one tyrosine residue (attachment site) at 
position 3 from the N terminus of the peptide (Palmenberg, 1990). It is not yet known 
whether SBV contains a VPg at its 5' end. Because of the insufficient sequence 
homology with IFV and other mammalian picornavimses we failed to locate the 
putative 3B protein in SBV-UK polyprotein.
The 3C regions of all picornavimses code for a protease (section 1.10.1). The 
3C protein of SBV-UK has all the 4 conserved motifs of chymotrypsin-like cysteine 
proteases, similar to the mammalian picornavimses and picorna-like insect and plant 
vimses (section 3.2.5.1.2) and therefore suggests that the 3C region of SBV-UK may 
encode a chymotrypsin-like cysteine protease to carry out the majority of the 
cleavages. It has been demonstrated that processing of PV capsid precursor is actually 
mediated by 3CD protease rather than 3C protease (Jore et ah, 1988; Ypma-Wong et 
ah, 1988). In addition to processing of viral proteins, 3C protease of PV has been 
involved in inhibiting host cell RNA transcription by all 3 classes of RNA 
polymerases (pol I, pol II, and pol III) (Clark et a l, 1991; Clark et a l, 1993; 
Rubinstein et a l, 1992). It would be interesting to investigate whether the putative 3C 
protein of SBV-UK has similar functions to that of the 3C protein of PV.
The 3D regions of all picornavimses encode for an RNA-dependent RNA 
polymerase which has regions of homology with all known DNA and RNA 
polymerases (Sankar & Porter, 1992). The putative 3D protein of SBV-UK shows 
considerable homologies with 3D proteins of mammalian picornavimses and insect
8 1
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and plant picorna-like viruses and possessed all of the conserved motifs 
characteristic of this protein (section 3.2.5.1.2).
The C terminal sequence of the SBV-UK polyprotein was compared with the 
deduced amino acid sequence of the protein derived from the 3' terminal 1600 
nucleotides of CrPV. No significant homology was found (data not shown). In 
contrast, N- terminal sequence of the SBV-UK polyprotein showed significant 
homology with the amino acid sequence encoded in the 3' terminal region of CrPV 
(30.86% identity and 43.21% similarity at the amino acid level). This finding further 
supports the suggestion that capsid gene in CrPV is encoded at the 3' part of the 
genome (Koonin & Gorbalenya, 1992).
3.3.3.4 3' UTR
The length of the 3' UTR differs among the picornavimses (section 1.9.1). 
The SBV-UK 3' UTR is 80 nucleotides long and AU rich (31.25% A; 7.5% C; 20% G 
and 41.25% U) in common with rhinovimses (Stanway, 1990). The 3' UTR of the 
SBV-UK genome was compared with mammalian picornavimses, insect and plant 
picorna-like vimses using GAP program of GCG. SBV-UK was found to be most 
similar to HRV 14 (51.2% similarity) followed by IFV (48.7% similarity). 
Secondary stmctures for 3' UTR sequences of picornavimses have been predicted and 
these stmctures appear to have some functional importance (Inoue et ah, 1989; 
Auvinen et a l ., 1989). It is believed that 3' UTR may be important at some stages of 
replication as it has been demonstrated that a 8-nucleotide insertion at this region 
leads to a temperature-sensitive phenotype (Sarnow et a l, 1986). The possible 
secondary stmctures at the 3' UTR of SBV-UK were predicted using MFOLD
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program (Jacobson & Zuker, 1993) (Figure 3.ISA). The same computer program was 
applied to the 3' terminal sequences from mammalian picomaviruses (PV, HRV 14, 
EMCV, FMDV and HAV) and insect picorna-like vims (IFV). The pattern produced 
in SBV-UK was most similar to PV (Figure 3.18B).
3.3.4 Evolutionary relationships among mammalian, insect and plant picorna- 
like viruses
Comparison of positive strand animal and plant RNA vimses revealed 
unexpected homologies among the non-stmctural proteins compared to capsid 
proteins (Goldbach, 1987). Possibly, there is a lack of immune pressure on this part 
of the genome and also the need to maintain active sites of the enzymes encoded in 
the non-stmctural protein region (Stanway, 1990). The non-stmctural proteins at the 
C terminal region of the SBV-UK polyprotein have been found to be similar to 
vimses from Picomaviridae, Sequiviridae, Comoviridae and insect picorna-like 
vimses with both picornavims-like (IFV) and calicivims-like (DCV, RhPV, PSIV 
and APV) genome organizations. SBV-UK encodes a helicase, 3C-like protease and 
RNA-dependent RNA polymerase. These genes are organized in a similar order to 
vimses of picorna-like superfamily. Members of the Sequiviridae encode a single 
polyprotein which contains the capsid proteins towards the N terminal regions and 
replicase protein in the C terminal regions of the polyprotein. The Comoviridae have 
two genomic RNAs, one encoding the capsid proteins and other encoding the non- 
stmctural proteins. Both Sequiviridae and Comoviridae are plant picornavimses. 
SBV-UK resembles PYFV, a member of the of the Sequiviridae in genome size and 
putative genome organization, though this plant vims has extra coding capacity and
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Figure 3.18: Comparison of predicted RNA secondary structure of 3' UTRs of
A. SBV-UK and B. PV.
RNA secondary structures were drawn as described in Figure 3.17.
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no poly (A) tail. In order to reveal the evolutionary relationships among SBV, 
mammalian, insect and plant picorna-like viruses a phylogenetic tree was constructed 
using the amino acid sequences of RNA-dependent RNA polymerase genes since it 
is the only region which contains universal sequence motifs conserved in all the 
known sequences of positive strand RNA viruses (Koonin & Dolja, 1993). The tree 
developed showed that SBV-UK and IFV (with picomavirus-like gene order) appear 
more closely related to each other than to other viruses (Figure 3.19) but none the less 
this relationship is still distant (bootstrap value 52.3%). Both SBV-UK and IFV again 
phylogenetically, related to sequiviruses and comoviruses. Insect picorna-like viruses 
with calicivirus-like genome organization (DCV, PSIV and RhPV) except APV 
formed a separate group and also phylogenetically related to SBV-UK, IFV, 
sequiviruses and comoviruses. APV, although an insect virus with calicivirus-like 
genome organization was grouped away from the rest and appeared to be different 
from other insect viruses as also reported previously (Moon et al., 1998). Goldbach 
(1986) suggested the possibility that animal and plant RNA viruses with insect 
vectors might share common insect host origin. EMCV, a mammalian picornavirus 
has been isolated from arthropoda (Murphy et al., 1995). The plant comoviruses and 
mammalian picornavimses have been supposed to have originated from the members 
of the insect picorna-like vimses (e.g. DCV, PSIV, CrPV etc) (Goldbach, 1986). The 
homologies observed among all these vimses may indicate a common evolutionary 
origin, though, they are now ecologically separated by a very different host ranges.
8 4
-----------JEV
APV
-HPeV
HAV
- P V
-HRV
—  EMCV
— FMDV
PSIV
DCV
-RhPV
SBV-UK
-IFV
-PYFV
-CPMV
Figure 3.19: Phylogenetic analysis of predicted amino acid sequences of 
RNA-dependent RNA polymerase from SBV-UK, mammalian, insect and 
plant picorna-like viruses.
Amino acid sequences were aligned using Clustal X and phylogenetic trees were 
drawn using NJplot programme. JEV was used as an outgroup.
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DETECTION OF SACBROOD VIRUSES BY REVERSE 
TRANSCRIPTION-POLYMERASE CHAIN REACTION
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4.1 Introduction
Inapparent virus infections are rather common in the honey bee (Dali, 1985; 
Anderson & Gibbs, 1988). Honey bee viruses can only be propagated in vivo using 
white-eyed pupae because of the lack of an in vitro system for their propagation . 
However, the inoculation procedure itself could activate any inapparent virus 
infections in these pupae, causing them to replicate to high titre and thus cause 
significant contamination. Serological methods have been used for detection of honey 
bee viruses with only limited success (Anderson, 1984) and occasionally, they have 
been found unreliable (Bailey et ah, 1979; Ball & Bailey, 1991) (see section 1.11). 
Stoltz et a l (1995) designed two primers from the mammalian picomavirus RNA 
polymerase gene and succeeded in amplifying 417 bp amplicon from KBV using RT- 
PCR. However, these primers also generated an identically sized amplicon from 
preparations of BQCV and ABPV and thus could not distinguish between these 
viruses (section 1.11). No sequence information was reported for any of these 
amplified products. Searching the available databases also failed to find the KBV 
sequence data. Therefore, it is not known whether the primer pair had actually 
amplified polymerase gene from all these viruses or from KBV contaminating all 
samples, or from other regions of virus genomes. In view of this potential for virus 
detection, the aim of this experiment was to develop a PCR specific for SB V.
4.2 Results
4.2.1 Reverse transcription-polymerase chain reaction (RT-PCR)
A pair of oligonucleotide primers (PIO and PI 1, Table 4.1.) were 
designed from the sequence of the SBV-UK genome and used to amplify part of the
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Primer Sequence Position in 
SBV-UK
PIO CGCTTCCATGACCATGCGCTTG 8637-8658
(complementary)
P l l TGTACCAACAAAAGTGTGGATCACC 8164-8188
Table 4.1: Oligonucleotide primers used in RT-PCR.
Sequences are shown 5’ to 3’. Sequences of PIO are the reverse compliment of the SBV- 
UK genome and indicated as complimentary. The base positions of the SBV-UK 
genome to which the viral homologous portion of the primer corresponds are indicated.
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RNA-dependent RNA polymerase gene from SBV-UK, German strain of SBV (SBV- 
G), TSBV, BQCV and ABPV. KBV was not available for these tests. Total RNA was 
extracted from semi-purified virus samples of SBV-UK, SBV-G, TSBV, BQCV and 
ABPV. 10 pg of total RNA from each of these samples was reverse transcribed using 
the antisense primer (PIO) (section 2.14.1). One fifth of the reverse transcription mix 
was employed directly as template in each polymerase chain reaction (section 2.18). 
After 40 cycles the amplification products obtained were analysed by electrophoresis 
through a 1.2% TBE agarose gel and stained with ethidium bromide (section 2. 5). 
The results obtained are shown in Figure 4.1. This primer pair as expected generated 
discrete products (approximately 500 bp) from each of SBV, SBV-G and TSBV. One 
additional product (approximately 560 bp) was also found in SBV-UK. and TSBV. 
This primer pair also generated one product each from BQCV (830 bp) and ABPV 
(500 bp).
All the PCR products were purified (section 2.13.2) and cloned in the 
pT7Blue(R) cloning vector and sequenced (section 2.19 and 2.15). The amplimer 
formed from SB Vs was 495 bp long including the primers and was derived from the 
expected regions of the polymerase gene of SBV-UK, SBV-G and TSBV. The 
nucleotide sequence of the PCR products obtained from BQCV and ABPV did not 
contain any SBV-UK sequence. The sequences of these two products will be 
discussed in section 4.2.2 and 4.2.3.
The nucleotide sequence of PCR amplified SBV-UK [SBV-UK(PCR)] was 
very similar (95.53% identity) to that obtained by cDNA cloning. At the amino acid 
level the two sequences were virtually identical with 98.65% identity and 99.32% 
similarity in this region. When the amplified sequences from all 3 sacbrood viruses
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kbp
21.7
5.15
4.27
1.59
1.37
0.94
0.83
0.56
Figure 4.1: Ethidum bromide-stained 1.2% agarose gel of DNA product 
resulting from RT-PCR (witb PIO and P ll primers) of total RNA extracted 
from SBV-UK, SBV-G, TSBV, BQCV and ABPV samples.
Two discrete products of apparent size 500 and 560 bp amplified from SBV-UK 
and TSBV One discrete product of apparent size 500 bp amplified from SBV-G. 
Bands of apparent size 500 bp and 830 bp were amplified from ABPV and BQCV 
respectively. 'M' indicates DNA size markers and "-control' indicates negative 
control without template.
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used were compared SBV-UK was found to be more closely related to SBV-G 
(92.85% identity at the nucleotide and 99.32% identity at the amino acid level) than 
TSBV (90.62% identity at nucleotide and 97.98% identity at amino acid level). The 
nucleotide and amino acid sequence identity/similarity among these sequences are 
given in Table.4.2. Although substitutions were found, the deduced amino acid 
sequence of all these sequences possessed conserved RNA dependent RNA 
polymerase motifs VI, VII and Vm (Koonin & Dolja, 1993). Clustal W alignment of 
these sequences (both nucleotide and deduced amino acid sequence) is given in 
Figure 4.2 and Figure 4.3.
The 560 bp amplimer from SBV-UK was sequenced as 549 bp, derived from 
the same region of the virus genome but containing a 3' extension. Sequence analysis 
indicated that the antisense primer had complementarity to a region of the SBV-UK 
genome (nucleotide 8715 to 8689) and therefore, could induce a product larger than 
that desired. The complementarity is shown as below:
P r i m e r  P IO  5 '  CGCTTCCATGACCATGCGCTTG S '
S B V -U K  5 '  AAAAGGCGAATTAATTACGAAC 3 '
base 8712 base 8689
The TSBV was 538 bp long when sequenced. This was derived from the same region 
amplified in the 495 bp product however, the 3' end sequence of this 538 bp product 
was found to have one extra reverse primer (PIO) sequences.
SBV-UK SBV-UK(PCR) SBV-G TSBV
SBV-UK 95.53
(99.32)
93.75
(99.32)
91.29
(97.98)
SBV-UK(PCR) 92.85
(99.32)
90.62
(97.98)
SBV-G 91.74
(98.65)
TSBV
Table 4.2: Percentage of identity in tbe nucleotide and amino acid 
(in parenthesis) sequences between SBV-UK (nucleotide 8189-8636; 
amino acid 2662-2812) and 3 PCR products [SBV-UK(PCR), SBV-G 
and TSBV].
These identities and similarities were calculated using GAP program 
of GCG package.
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-PCR 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
SBV-UK 
SBV-UK(PCR) 
SBV-G 
TSBV
6 0
TAGTGGCGCGCCCATTACTGTAGTGATAAATACTTTGGTTAATATTTTATATATATTCGT 
AAGTGGCGCCCCTATTACTGTAGTGATAAATACTTTGGTTAATATTTTATATATATTTGT 
TAGTGGAGCGCCCATCACTGTAGTGATAAATACTTTGGTTAATATATTATATATATTCGT 
TAGTGGAGCGCCCATTACCGTAGTGATAAATACTTTGGTTAATATTTTATATATTTTTGT 
***** ***** * * * * ************************** ******** * * * *
120
AGCTTGGGAGACGTTAGTAGGAAGTAAAGAACGAGGGCAAACTTGGGAATCCTTTAAACA 
AACTTGGGAGACGTTAGTAGGAAGTAAAGAACGAGGGCAAACCTGGGAATCCTTTAAACA 
AGCTTGGGAGACGTTGGTAGGAAGTAAAGAAAGAGGGCAAACTTGGGAATCCTTTAAACA 
AGCTTGGGAGACGCTAGTAGGAAGTAAAGAAAGAGGGCAAACTTGGGAATCTTTCAAACA 
* * * * * * * * * * * *  *  * * * * * * * * * * * * * * *  * * * * * * * * * *  * * * * * * * *  *  *  * * * * *
180
AAATGTAGAATTGTTTTGCTATGGTGATGATTTAATAATGTCAGTAACAGATAAATATAA 
AAATGTAGAATTGTTTTGCTATGGTGATGATTTGATAATGTCAGTAACAGATAAATATAA 
AAATGTAGAATTATTTTGCTACGGTGATGATTTGATAATGTCAGTAACGGATAAATATAA 
AAATGTAGAATTGTTCTGCTACGGTGATGACTTGATAATGTCAGTAACAGATAAATATAA 
* * * * * * * * * * * *  *  *  * * * * *  * * * * * * * *  *  *  * * * * * * * * * * * * * *  * * * * * * * * * * *
240
GGATGTTTTTAACGCATTAACAATAAGTCAATTTTTGGCACAATATGGAATAGTAGCCAC 
GGATGTTTTTAATGCATTAACAATAAGTCAATTTTTGGCACAATATGGAATAGTAGCCAC 
GGATGTCTTTAATGCATTGACAATAAGTCAGTTTTTGGCACAATATGGAATAGTAGCTAC 
GGATACTTTTAATGCATTGACAATAAGTCAATTTTTAGCACAATATGGAATAGTGGCAAC 
*  *  *  *  * * * * *  * * * * *  * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * * * * *  *  *  *  *
300
TGATGCAAATAAAGGAGACGAAGTTGAGGCTTATACGACGTTGTTAAATAGTACGTTTTT 
TGATGCAAACAAAGGAGATGAAGTTGAGGCTTACACGACGTTGTTAAATAGCACGTTTTT 
TGATGCAAACAAAGGAGATGAGGTTGAGGCTTATACGACGTTATTAAATAGTACGTTTTT 
TGACGCGAATAAAGGAGAGGAAGTTGAAGCCTATACGACGTTATTAAATAGTACGTTTTT 
*  *  *  *  *  *  *  * * * * * * * *  *  *  * * * * *  *  *  *  *  * * * * * * * *  * * * * * * * *  * * * * * * * *
360
AAAACATGGGTTTCATCCCCACGAAGTGTATCCGCATTTGTGGCAATCTGCGCTGGCTTG 
AAAACATGGGTTTCGTCCCCACGAAGTGTACCCGCACTTGTGGCAATCTGCGTTGGCTTG 
AAAACATGGGTTTCGTCCTCACGAAGTGTATCCGCATTTGTGGCAATCTGCGCTGGCTTG 
AAAACATGGATTTCGTCCCCACGAAGTGTATCCACATTTGTGGCAGTCTGCGCTGGCTTG 
* * * * * * * * *  *  *  *  *  *  *  *  *  * * * * * * * * * *  *  *  *  *  * * * * * * * *  * * * * * *  * * * * * * *
420
GAGTTCTATCAATGATACTACACAATGGATATGGGAATGTGCTGACTTGAAGCTGGCTAC 
GAGTTCTATCAATGATACTACGCAATGGATATGGGAATGTGCTGATTTGAAGCTGGCTAC 
GAGTTCTATTAACGATACTACGCAATGGATATGGGAATGTGCTGATTTGAAGCTGGCCAC 
GAGTTCTATTAATGATACTACGCAATGGATATGGGAATGTGCCGATTTAAAGCTGGCCAC 
* * * * * * * * *  *  *  * * * * * * * *  * * * * * * * * * * * * * * * * * * * *  *  *  *  *  * * * * * * * *  *  *
448
TAGGGAGAATTGTCGAGCCGCTCTGTAT
TAGGGAGAATTGTCGAGCTGCTCTGTAC
TAGGGAGAATTGTCGAGCTGCCCTATAT
TAGGGAAAATTGTCGAGCTGCCCTGTAC 
****** *********** * * * * * *
Figure 4.2: Multiple nucleotide sequence alignment of SBV-UK (nucleotide 8189-8636) and 3 PCR 
products [SBV-UK(PCR), SBV-G and TSBV].
A position is perfectly conserved is indicated by (*),
VI 60
SBV-UK SGAPITWINTLVNILYIFVAWETLVGSKERGQTWESFKQNVELFCYGDDLIMSVTDKYK
SBV-UK(PCR) SGAPITWINTLVNILYIFVTWETLVGSKERGQTWESFKQNVELFCYGDDLIMSVTDKYK 
SBV-G SGAPITWINTLVNILYIFVAWETLVGSKERGQTWESFKQNVELFCYGDDLIMSVTDKYK
TSBV SGAPITWINTLVNILYIFVAWETLVGSKERGQTWESFKQNVELFCYGDDLIMSVTDKYK
* * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
VII 126
SBV-UK DVFNALTISQFLAQYGIVATDANKGDEVEAYTTLLNSTFLKHGFHPHEVYPHLWQS
SBV-UK{PCR) DVFNALTISQFLAQYGIVATDANKGDEVEAYTTLLNSTFLKHGFRPHEVYPHLWQS
SBV-G DVFNALTISQFLAQYGIVATDANKGDEVEAYTTLLNSTFLKHGFRPHEVYPHLWQS
TSBV DTFNALTISQFLAQYGIVATDANKGEEVEAYTTLLNSTFLKHGFRPHEVYPHLWQS
* * * * * * * * * * * * * * * * * * * * * * * * . * * * * * * * * * * * * * * * * * * . * * * * * * * * * * *
VIII____________ 149
SBV-UK ALAWSSINDTTQWIWECADLKLATRENCRAALY
SBV-UK(PCR) ALAWSSINDTTQWIWECADLKLATRENCRAALY 
SBV-G ALAWS SINDTTQWIWECADLKLATRENCRAALY
TSBV ALAWSSINDTTQWIWECADLKLATRENCRAALY*********************************
Figure 4.3: Multiple alignment of deduced amino acid sequences of SBV-UK (amino 
acid 2662-2812) and 3 PCR products [SBV-UK(PCR), SBV-G and TSBV].
A position is perfectly conserved is indicated by *. Substitution with similar amino acid is 
indicated by or ‘.’RNA-dependent RNA polymerase motif (Koonin & Dolja, 1993) are 
labelled VI-VHI.
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4.2.2 Analysis of the sequence of the amplified product obtained from BQCV 
sample:
Two SBV-UK specific primers (PIO and P l l )  produced an amplicon of 
approximately 830 bp from BQCV. This was determined as 862 bp by sequence, 
however, sequences of reverse primer were found at both ends. The nucleotide 
sequence of the product (excluding primer sequences) is presented in Figure 4.4 and 
possesses only 1 ORF (Figure 4.5). Blast P search found amino acid 1-109 of this 
protein most similar to the non-structural protein of the PSIV (amino acid 672-792) 
with 39% identity and 52% similarity (Figure 4.6A). Homology was also found with 
the non-structural proteins of RhPV (40% identity and 58% similarity over an area of 
50 amino acids) (Figure 4.6B) and HRV14 (21% identity and 39% similarity over an 
area of 177 amino acids (Figure 4.6C). When the whole of the deduced amino acid 
sequence of the PCR product from BQCV sample was compared with the complete 
SBV-UK sequence using the GAP program of GCG, 21.8% identity and 46.2% 
similarity were found. This region of homology in the SBV-UK was also contained in 
the non-structural protein. The predicted amino acid sequence of the PCR product 
was found to have a conserved helicase domain motif 'C  (Koonin & Dolja, 1993) 
(Figure 4.4) except that second amino acid of this motif in the deduced amino acid 
sequence of the PCR product is alanine, where as the consensus indicates a glycine. 
However, the glycine at the second amino acid of the C  motif in helicase has been 
substituted by a different amino acid in many viruses e.g., asparagine in PSIV and 
RhPV and proline in tomato black ring virus. The 'C  motif in SBV-UK contains a 
lysine in place of glycine.
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1 GCGTCGATTGAAGAGAAGGCGAATACTGTTTTCCAATCGAAAGTTATATT 50
A S I E E K A N T V F Q S K V I L
Helicase ‘C’
51 GTGTTCATCCAACAATAAGACTCCACAGACCGAATCTTTGAATTATCCGA 100
C S S  N N K T P Q T E S L N Y P K  
101 AGGCATTATTGAGAAGATTCGCGAAATTTGTCGAAGTGAAGAGGGCTCCT 150
A L L R R F A K F V E V  K R A P  
151 TCTGAAAGTGGTACATTTTCTACTGATTGTTACACTTTCGTGCAATACGA 200
S E S G T F S T D C Y T F V Q Y D  
201 TCCGTTCGATCATTGTAACATTGTTAAATCAATGTCTTTCAATGAATTGA 250
P F D H C N I V K S M S F N E L I  
251 TAGATGAAGTAGTTGCGATGTACTTCCAGGAAGGAGAATTTGTCTCTTCC 3 00
D E V V A M Y F Q E G E F V S S  
3 01 GTAGACAAATTTATCATGGAGAACGTATTTGCTCAAGGTGGGAGTTTATC 350
V D K F I M E N V F A Q G G S L S  
351 ATCTGACGAGGATGATAATTTTGTTGAGGCAAGCTCTTCCAATGATAGTG 400
S D E D D N F V E A S S S N D S D  
401 ATTTGGATGAAACCTTAACACGTGAAGAGAAGAAAGAGATTGTGGAATGT 450
L D E T L T R E E K K E I V E C  
451 ATCAATGACCAACTTAAAAATGAGAATGATACTAAAACCTCTCTCCAACT 500
I N D Q L K N E N D T K T S L Q L  
501 AATTAGAGACTATTTCCATTGCGCCAAGGAATCGCTACAGGAGAAATTTT 550
I R D Y F H C A K E S L Q E K F S  
551 CAGTTTATCGTCAAAAGTATTCTTTTGATGAATGGTTTAGTTTCTCCAAA 600
V Y R Q K Y S F D E W F S F S K  
601 GCATCTAAGGTAGTTTTGGGAATTTTGTCTCTGGTGCTGGTGGGATATGG 650
A S K V V L G I L S L V L V G Y G  
651 CATTTATTCCTATGTCAAGGGAACTCCCGTTAAGGACTCGGCTGAATCTT 700
l Y S Y V K G T P V K D S A E S Y  
701 ACGAACCAAAAGTGGCGAGTAAGACTAAGGTCGAGGGTAATGACGGTGCT 750
E P K V A S K T K V E G N D G A  
751 CCTGAGGCATACGAACCTAAGGTTAGTAGAAAAGTTAAAGTTGAGGGATA 800
P E A Y E P K V S R K V K V E G Y  
801 TAATGCTAGAGAGAT 815
N A R E
Figure 4.4: Nucleotide sequence of the PCR product from BQCV sample.
The deduced amino acid sequence of the ORF is shown beneath the nucleotide 
sequence. Region of amino acid sequence similarity to helicase motif ‘C’ (Koonin & 
Dolja, 1993) has been underlined. The GenBank accession number of the sequence 
reported here is AF125252.
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Identities = 49/123 (39%), Positives = 65/123 (52%), Gaps = 14/123 (11%)
Q u e r y :  1 ASIEEKANTVFQSKVILCSSN NKTPQTESLNYPKALLRRFAKFVEVKRAPS 51
A++E+K NT F+S V IL SSN N + SLNYP ALLRRF VEV+ AP 
P S IV : 67 2  ANLEDKNNTWFRSSVILASSNLTAENLQSKVHSLNYPVALLRRFDLWEVEIAPGCTKPR 7 3 1
Q u e r y :  52 ESGTFSTDCYTF— VQY— DPFDHCNIVKS -MSFNELIDEWAMYFQEGEFVS S VDKF IM 1 0 6
FS D Y F V+Y D D +IV +S +S++E++ + Y SV I
P S IV : 7 3 2  AGQPFSKDIYKFTKVEYILDESDRVSIVRSEISYDEIVKLMCLKYKDNMTTCQSVSANIT 7 9 1
Q u e r y : 1 0 7  ENV 1 0 9  
E +
P S IV : 7 9 2  EMI 7 9 4
B.
Identities = 20/50 (40%), Positives = 29/50 (58%)
Q u e r y : 1 ASIEEKANTVFQSKVILCSSNNKTPQTESLNYPKALLRRFAKFVEVKRAP 50  
AS+ +K NT + K+I +SN + Q ESLN P+A+ RR V+ P
RhPV: 6 5 6  ASLLDKNNTFAEPKLICLTSNLQRLQIESLNCPEAVSRRIDFAFNVRIVP 7 0 5
c.
Identities = 40/184 (21%), Positives = 74/184 (39%), Gaps = 26/184 (14%)
ASIEEKANTVFQSKVILCSSNNKTPQTESLNYPKALLRRFAKFVEV KRAPSES 53
AS++ K +F S +L S+N+ T ++ P+AL+RRF +++ K +
GTFSTDCYTFVQYDPFDHCNIVKSMSFNELIDEWAMYFQEGEFVSSVDKFIMENVFAQG 11 3  
G + C Q F C + L+D + + + V+++ +
+D + + D ++D T ECIND LK+ + + IR+Y
:TDSLETLFQGPVYKDLEIDVCNTPPS ECINDLLKSVDSEE---------- IREY—  1 4 6 4
Q u e r y : 1
HRV14: 1 3 0 4
Q u e r y : 54
H RV14: 1 3 6 3
Q u e r y : 1 1 4
H RV14: 1 4 1 9
Q u e r y : 1 7 4
H RV14: 1 4 6 5
C K+
Figure 4.6: Sequence alignments result from a BLAST P database search (NCBI) of 
deduced amino acid sequence of an amplicon from BQCV sample (query sequence), 
identifying regions with homology to the PSIV (GenBank AB006531), RhPV 
(GenBankAF022937) and HRV14 (GenBank K02121).
The percentage of identities, positives and gaps are displayed.
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4.2.3 Analysis of the sequence of the amplified product obtained from ABPV 
sample:
Two SBV-UK specific primers (PIO and PI 1) also amplified a product of 500 
bp from the semi-purified ABPV sample. Sequencing of this product revealed it to be 
514 bp, however sequences of reverse primer (PIO) were found at both ends. Analysis 
of the sequence (excluding primer sequences) showed that only one reading frame 
was open (Figure 4.7). The nucleotide sequence along with deduced amino acid 
sequence of the fragment is presented in Figure 4.8. The translated product of the 
ORF was analysed by Blast P search to find any homology with other viruses and this 
indicated a possible relationship to other virus structural proteins. The deduced amino 
acid sequence of this PCR fragment was found to have 28% identity and 49% 
similarity with CrPV, 28% identity and 45% similarity with PSIV and DCV and 30% 
identity and 47% similarity with the RhPV (Figure 4.9A, B, C and D). A 
comparatively, lower degree of homology was found with HAV (23% identity and 
42% similarity) (Figure 4.9E). The region of homology in CrPV, PSFV, DCV and 
RhPV have been reported to have the amino acid sequences of the capsid proteins and 
are encoded at the 3' end of the virus genome. The region of homology in the HAV 
also contained the sequences of capsid gene but located at the 5'-end of the virus 
genome.
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1 TGAATATGTTTGCAACATGTTTTCATATTGGCGAGCCACTATGTGCTATC 50
E Y V C N M F S Y W R A T M C Y R  
51  GTATAGCTATAGTTAAAACAGCTTTTCACACTGGTAGGTTAGAAATTTTC 1 0 0
l A I V K T A F H T G R L E I F  
1 0 1  TTCGAACCTGGTAGGATTCCAATAACGACAACGAAAGATAATATTTCCCC 1 5 0
F E  P G R I  P I T T T  K D N I  S P 
1 5 1  GGACTTGACTCAGTTAGATGGAATTAAAGCACCTTCTGACAACAATTATA 2 00
D L T Q L D G I K A P S D N N Y K  
2 0 1  AATACATTTTGGATCTAACTAATGACACAGAGGTCACCATAAGGGTACCT 2 5 0
Y I L D L T N D T E V T I R V P  
2 5 1  TTTGTTTCAAACAAAATGTTCATGAAACCTACAGGAATTTATGGTGGAAA 3 0 0
F V S N K M F M K P T G I Y G G N  
3 01  TTCTGAAAATAATTGGGATTTCTCTGAATCATTTACTGGATTTTTATGCA 3 5 0
S E N N W D F S E S F T G F L C I  
3 51  TAAGACCTGTTACAAAGTTGATGTGTCCGGAAACTGTGTCTAATAGTGTA 4 0 0
R P V T K L M C P E T V S N S V  
4 0 1  TCGATAGTTGTGTGGAAGTGGGCTGAAGATGTGGTAGTAGTAGAACCTAA 4 5 0
S I V V W K W A E D V V V V E P K  
4 5 1  ACCTTTACTTTCAGGAC 4 6 7
P L L S G
Figure 4.8: Nucleotide sequence of the PCR product from ABPV sample.
The deduced amino acid sequence of the ORF is shown beneath the nucleotide 
sequence.
A.
I d e n t i t i e s  = 3 8 / 1 3 3  (2 8 % ), P o s i t i v e s  = 6 7 / 1 3 3  (4 9 % ), G ap s = 1 7 / 1 3 3  (12% )
YVCNMFSYWRATMCYRIAIVKTAFHTGRLEIFFEPGRIPITTTKDNISPDLTQLDGIKAP 61  
YV N F+YWR ++ Y VKT +H+GRL I  F P TT +PD+++
YVTNAFTYWRGSIVYTFKFVKTQYHSGRLRISFIP— YYYNTTISTGTPDVSR----------------- 55
K ++DL TEV+ V P+++++ + +Y E++W ++ G L V+
-— TQKIWDLRTSTEVSFTVPYIASRPW----------LYCIRPESSWLSKDNKDGALMYNCVS 1 0 7
Q u e r y : 2
CrPV: 5
Q u e r y : 62
C rPV: 56
Q u e r y : 122
CrPV: 108
B.
I d e n t i t i e s
Q u e r y : 2
DCV: 447
Q u e r y : 62
DCV: 498
Q u e r y  : 119
DCV: 553
c .
I d e n t i t i e s
Q u e r y : 2
P S IV : 417
Q u e r y : 62
P S IV : 464
++ E ++ V+
+V N YW ++ Y VKT FH+GRL I F P TT PD+++
K I+DL TEV+ +P+VS++ +M +P + G +N + TG + +
+ +L+ V S+
 = 3 6 / 1 2 8  (2 8 % ), P o s i t i v e s  = 5 8 / 1 2 8  (4 5 % ), G a p s = 1 9 / 1 2 8  (14% )
YVCNMFSYWRATMCYRIAIVKTAFHTGRLEIFFEPGRIPITTTKDNISPDLTQLDGIKAP 61  
Y+ N F YWR ++ + VKT +H+GRLE+ F P TQ
YLSNFFLYWRGSLKFTFRFVKTNYHSGRLELVFSPF---------------------------- SQTQSSDFVNR 4 6 3
YK ++DL TE ++ +P+V+ + + M + T G I  + N + + G  +
Q u e r y :  1 1 6  CIRPVTKL 1 2 3  
I +T L 
PSIV: 5 2 4  AINALTPL 5 3 1
D.
I d e n t i t i e s  = 2 6 / 8 5  (3 0 % ), P o s i t i v e s  = 4 1 / 8 5  (4 7 % ), G a p s = 1 3 / 8 5  (15% )
Q u e r y :  2 YVCNMFSYWRATMCYRIAIVKTAFHTGRLEIFFEPGRIPITTTKDNISPDLTQLDGIKAP 61  
+ + F WR M ++ VKT FH+GR+ I  + PG T +
RhPV: 4 0 0  FAASNFVLWRGGMNIKLKFVKTKFHSGRVRILYVPGFFGGTLPTN---------------------------- FE 4 4 6
Q u e r y :  62 SDNNYKYILDLTNDTEVTIRVPFVS 86  
+D NY ++DL +DT+V VP+V+
RhPV: 4 4 7  TDANYSTWDLRSDTDVEFNVPYVA 4 7 1
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E.
I d e n t i t i e s  = 3 1 / 1 3 4  (2 3 % ), P o s i t i v e s  = 5 7 / 1 3 4  (4 2 % ), G ap s = 1 6 / 1 3 4  (11% )
Q u e r y :  3 VCNMFSYWRATMCYRIAIVKTAFHTGRLEIFFEPGRIPITTTKDNISPDLTQLDGIKAPS 62  
+C MF +WR + + + T +H+GRL+ F PG I T  +T AP
HAV: 3 5 0  ICQMFCFWRGDLVFDFQVFPTKYHSGRLQFCFVPGNELIEVT-------------SITLKQATTAPC 4 0 3
Q u e r y :  63 DNNYKYILDLTN-DTEVTIRVPFVSNKMFMKPTGIYGGNSENNWDFSESFTGFLCIRPVT 1 2 1  
++D+T + + RVP++S+ + I + + + E  L +
HAV: 4 0 4 ------------AVMDITGVQSTLRFRVPWISDTPYRVNCYIKSSHQKGEYTAIEK LIVYCYN 4 5 4
Q u e r y :  1 2 2  KLMCPETVSNSVSI 1 3 5  
+L P V++ V +
HAV: 4 5 5  RLTSPSNVASHVRV 4 6 8
Figure 4.9: Sequence alignments result from a BLAST P database search (NCBI) of 
deduced amino acid sequence of an amplicon from ABPV sample (query sequence), 
identifying regions with homology to the CrPV (GenBank M21938), DCV (GenBank 
AF014388), PSIV (GenBank AB006531), RhPV (GenBank AF022937) and HAV 
(Genbank M59286).
The percentage of identities, positives and gaps are displayed.
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4.3 Discussion
4.3.1 RT-PCR
The results of this study demonstrate that the primers designed from the 
sequence of putative RNA-dependent RNA polymerase gene of the SBV-UK were 
able to detect all isolates of the SBV tested. An amplicon of 495 bp was amplified 
from all of these SB Vs including TSBV which has a different capsid protein profile 
(on SDS-polyacrylamide gel electrophoresis) from the type strain of SBV from Apis 
mellifera in the U. K. (Bailey g/ al., 1982) .However, the antisense primer showed 
complementarity with the SBV sequence downstream of the primer sequence (base 
8712-8689) and as a result of this an additional amplicon of 549 bp was found from 
SBV-UK.
Although the two primers (PIO and P ll)  specifically amplified part of the 
RNA-dependent RNA polymerase gene of SBV-UK, the same primers generated 862 
and 514 bp amplicons (including primer sequences), from semi-purified preparations 
of BQCV and ABPV respectively. These sequences were found to be distinct from all 
of the SBVs. When, the sequence of RT-PCR amplified product from SBV-UK was 
compared with cDNA cloned sequence of the SBV-UK genome, nucleotide 
substitutions were found at 16 positions in this region, though both methods of 
cloning used same virus samples. However, in most of the cases these substitutions 
did not affect the coding sequence. Only 2 resulted in an alteration in the amino acid 
sequence of the putative polypeptide. The nucleotide sequences of the PCR products 
were derived by examining 3 independently isolated cDNA clones. All these clones 
had identical sequences. This level of sequence heterogeneity in the same virus 
sample has been reported from CPMV (Lomonossoff & Shanks, 1983). The presence
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of sequence heterogeneity in SBV-UK could result from the PCR procedures 
introducing mutations at either reverse transcription or amplification stages (section 
3.3.2). If it is due to reverse transcriptase or Taq DNA polymerase, the substitutions 
would be at random. Therefore, it is very unlikely that reverse transcriptase or Taq 
DNA polymerase has caused all these 16 substitutions. But more probably this 
heterogeneity is a true reflection of a degree of polymorphism in the virus population. 
Comparison of the nucleotide and deduced amino acid sequences of the PCR products 
showed that SBV-G is more closely related to SBV-UK than TSBV (Table 4.2). This 
finding is in agreement with the very similar physical, chemical and serological 
characteristics of SBV-UK and SBV-G (Ball, B. V, personal communication). TSBV, 
although serologically related to SBV, it infects Apis cerena and from a different 
geographical area (India). Therefore, as expected comparatively greater sequence 
heterogeneity was observed in TSBV.
One of the primers (PIO) designed to recognise SBVs amplified a fragment of 
862 bp from a sample of BQCV. Thus the size of the amplicon is readily 
distinguishable from that of SBVs but more samples are required to validate this as a 
reliable discriminator. The predicted amino acid sequence of this fragment was found 
to specify a conserved helicase domain motif 'C  and therefore, it is possible that this 
PCR fragment might encode part of the nucleotide binding helicase protein of an 
insect RNA virus. No sequence data of the BQCV was found in the available data 
bases for comparison. As only total RNA from BQCV infected pupae was used for 
reverse transcription and amplification, it is difficult to say that the sequence of this 
PCR fragment is part of BQCV genome.
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One of the SBV specific primers (PIO) also amplified a 514 bp amplicon from 
the ABPV sample. Although the size of the amplicon in ABPV is not readily 
distinguishable from SBVs in Figure 4.1, it is possible to distinguish them if greater 
resolution is achieved in the electrophoresis. Deduced amino acid sequence of this 
fragment was also found to have highest homology with the insect picoma-like 
viruses (CrPV, PSIV, DCV and RhPV) and appear to be derived from the structural 
gene (Koonin & Gorbalenya, 1992; Sasaki, et a l, 1998; Jhonson & Christian, 1998; 
Moon et a l, 1998). These regions of homology between ABPV and CrPV, PSIV, 
DCV, and RhPV have been designated as VP3 in CrPV and PSIV and VPl in DCV 
and VP2 in RhPV. Again no sequence data for ABPV was available in the databases. 
Therefore, it is very difficult to be certain that the amplified fragment was actually 
obtained from ABPV rather than another contaminating virus.
4.3.2 Potential of RT-PCR for the detection of SBV
Many insects harbour latent viruses (Bailey & Gibbs, 1964; Brun & plus,
1980; Evans & Harrap, 1982; Podgwaite & Mazzone, 1986; Scotti e ta l,  1981).
These infections persist in their host for many generations causing little or no harm or 
recognisable symptoms. However, in certain circumstances they may be stimulated or 
activated to yield greater number of particles and initiate acute infections (Podgwaite 
& Mazzone, 1986). Similar findings have been reported in SBV infections of honey 
bees. SBV infects all life stages of the honey bee (Dali, 1985). However, it does not 
produce typical symptoms of the disease in adult honey bees (Bailey & Fernando, 
1972). Often SBV has been detected as an inapparent infection in adult bees and thus 
may assist in spreading the disease to honey bee larvae. Moreover, as there is no cell
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line available for propagation of bee viruses, healthy (but not necessarily virus free) 
pupae are generally used to propagate honey bee viruses (Bailey & Woods, 1977a; 
Bailey, 1981), mainly because of the ease with which they may be handled. However, 
now it has been demonstrated that even these pupae could harbour latent infections 
with SBV, BQCV and KBV which could be activated when larvae were injected with 
various salt concentrations (Anderson & Gibbs, 1988). Therefore, there is always the 
chance that any particular honey bee virus preparation may be contaminated with one 
or more additional viruses. Serological methods for the detection of honey bee viruses 
may prove unreliable in mixed infections when one virus may suppresses the 
replication of the other and also in cases of inapparent infections. The RT-PCR 
developed in the present study using SBV-UK specific primers proved successful.
The primer pair was able to amplify a portion of the polymerase gene from different 
types of SBVs only. Therefore, this RT-PCR could specifically be used to detect SBV 
in mixed infections or in inapparent infections.
Today the mite, Varroa jacobsoni is an obstacle for profitable bee keeping 
(Fries, 1993). The mite damages the bee colony by not only reducing the weight gain 
and mean life span of young bees, but it also transmits the bee viruses (Ball, 1985) 
and activates inapparent infections (Hung et al., 1996). Varroa jacobsoni has been 
found to transmit SBV from severely infected to healthy pupae (Ball, 1989). 
Therefore, Varroa jacobsoni could be a very damaging honey bee pathogen if it 
activates or transmits SBV in the honey bee colonies. The RT-PCR developed could 
be useful to detect SBV in infected or carrier Varroa jacobsoni.
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EXPRESSION OF THE PUTATIVE CAPSID 
GENE OF SBV-UK
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5.1 Introduction
The sequence analysis of SBV-UK genome has indicated that the putative 
capsid protein gene is located at the 5' end of the genome. Therefore, an attempt was 
made to express this protein in E. colt This would allow us to correlate our 
molecular studies (e.g. PCR detection) with existing data based on serology, 
demonstrate that we had indeed cloned SBV, and also forms an essential first step in 
the production of any ELISA based detection systems. Accordingly we amplified the 
5' end of the SBV-UK RNA by RT-PCR. We then attempted to express both this 
product and a clone obtained by conventional cloning (p7SBVl), in the vector 
pMAL-c. This vector is designed to produce C-terminal extension of maltose-binding 
protein (MBP) fusing the expressed protein in frame with MBP. Accordingly, the 
ORFs of these two fragments were inserted into the pMAL-c vector polylinker region, 
in the same translational reading frame as the malE gene to express the sequences as 
an MBP fusion protein.
5.2 Result
5.2.1 Cloning of RT-PCR product of the 5' end of the capsid gene in pMAL-c 
expression vector
SBV RNA appeared to be relatively degraded (Figure 3.5) and all attempts to 
amplify the entire PI region failed. We therefore designed primers to a smaller 
section of PI and two oligonucleotide primers (Table 5.1) were synthesised to amplify 
nucleotides 201-1289 of SBV-UK corresponding to part of the putative capsid gene. 
The primers incorporated Sac I restriction sites at both the 5' end and 3' end of the 
cDNA fragment, permitting the insertion of the DNA product at the Sac I site of the
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Primer Sequence Position in 
SBV-UK
P12 gtacgagctcgATGGACGATATTTCTCCTTATG 201-221
P13 tcacgagctcaTCCCTCTCCTGTTTGTAACGG 1269-1289
(complementary)
Table. 5.1: Oligonucleotide primers used in PCR amplification of the capsid 
gene.
Sequences are shown 5' to 3'. Lower case letters represent sequences added to aid in 
cloning. The base positions of the SBV-UK genome to which the viral homologous 
portion of each primer corresponds are indicated. Sequences of P I3 are the reverse 
compliment of the viral genome and indicated as 'complementary'. Underlined lower 
case letters indicate the added Sac I site.
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pMAL-c expression vector in the same translational reading frame as the malE gene. 
An in-frame termination codon was incorporated at the 3' end of the amplified 
sequence, before the Sac I restriction site of the antisense primer (PI3). cDNA was 
obtained from 10 |ig of semi-purified SBV-UK RNA by using the antisense primer 
(PI3) as described before (section 2.14.1). The PCR reaction was performed using 
Pwo DNA polymerase (section 2.18).
The PCR product was analysed by electrophoresis through a 1.2% agarose gel 
and a product of the expected size, approximately 1.1 kb was detected. The PCR 
product was excised from the gel and purified, digested with Sac I, concentrated and 
ligated to the similarly digested and dephosphorylated pMAL-c vector (2.13.3 and 
2.19).
Competent E. coli DH5a cells were transformed with the ligation mixtures 
and plated onto agar plates containing ampicillin. 10 colonies were obtained. 
Plasmids were extracted from overnight cultures (section 2.13.1) and digested with 
Sac I restriction enzyme for analysis by electrophoresis. Two clones were found to 
have the expected insert. The correct PCR product should have a Kpn I restriction site 
459 nucleotides from the 5’ end and thus, in the required orientation the PCR product 
would release a fragment of approximately 630 bp. When digested with Kpn I one of 
these two clones was found to be as required and this clone was further characterised 
by sequence analysis using malE vector sequencing primer. This analysis data 
confirmed that the translational frame of the inserted PCR fragment was fused 
correctly in frame to the malE gene. This clone was named pSl (Figure 5.1) and 
should form an expression protein of size approximately 82 kDa.
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capsid protein non-structural protein
VP4?
5' L?VP3?4 VPl? VP2?
I I  I I
201 1289
polylinker p PCR product I -► polylinker
m a l E .  .T C G AGC TCG ATG GAC GAT A T T  G AGO T CG GTA CGC
Sac I Sac I Kpn I
GGC CGG GGA TCG ATG GAG GGT AGG GOT GAA TTC AGT AAA CCT 
BamH I Stu I EcoR I
ACC CTC GAT GGA TCG TCT AGA GTC GAC CTG 
BamH I
CAG GGA AGC T T G ............................l a c Z a
Hind III
malE lacZa
rrnb terminatortac
6 1 4  8 b p  
pMAL-c
lad
Amp'
Figure 5.1: Schematic representation of pSl clone.
The PCR product (nucleotide 201-1289 of the SBV-UK genome) was cloned 
into the Sac I site of the polylinker region of the pMAL-c vector in the same 
translational reading frame as the malE gene. The nucleotide sequence of the 
start of the PCR product is displayed.
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5.2.2 Subdoning of inserted cDNA of pTSBVl clone into pMAL-c expression 
vector
Clone pTSBVl clone (section 3.2.3) contained part of the putative capsid gene 
of the SBV-UK (nucleotide 354 to 2658 of the SBV-UK genome) and was also 
expressed. This clone was found to lack the vector EcoR I restriction site towards the 
SP6 promoter, however, that towards the T7 promoter was intact. Therefore, inserted 
DNA was released with EcoR I and Hind III, and inserted into EcoR I/Hind m  
digested pMAL-c vector as described before. After transformation 10 colonies were 
analysed, 8 colonies contained inserted cDNA. Sequence analysis confirmed 
orientation and correct fusion of the reading frames. This clone was named as pS2 
(Figure 5.2) and should form a fusion protein of expected size 128 kDa.
5.2.3 Expression of putative capsid gene of SBV-UK in E. coli
MBP fusion proteins were expressed in E. coli DH5a cells under IPTG 
induction from both pSl and pS2 clones as described in section 2.22. MBP control 
inductions were also performed using the parent pMAL-c plasmid. Samples were 
taken before and after induction and 15 pi of each prepared sample was subjected to 
SDS-PAGE analysis (section 2.23). The protein bands were visualised by staining the 
gel with Coomassie brilliant blue. No obvious induction of new proteins was 
observed from either of these two clones (pSl and pS2) although MBP itself was 
produced in controls (Figure 5.3). Western blots were probed with anti-MBP 
antibodies (1:10,000) to confirm the presence of the MBP fusion proteins. Bands 
larger that MBP alone were observed in each case. However, the patterns were not 
clear and it is possible that some protein degradation is occurring in the cells. In clone
SBV-UK genome
capsid protein non-structural protein
VP4?
5' L? V P 3?i VPl? VP2? 3 ’
354 2658
EcoR I Hind III
p7SBVl clone (2304 bp)
polylinker
m a l E . . T C G AGC TCG GTA CCC GGC CGG GGA TCC ATC GAG 
Sac I Kpn I BamH I
I ► cDNA fragment
GGT AGG CCT GAA TTC GCG GCC GCT AGA TTA TTT ACA ATC  
Stu I EcoR I
p ► polylinker
CTT .......................... A AGC T T G ...................................  l a c Z a
Hind III
lacZa
lad
rrnb ternninator
Amp'
Figure 5.2: Schematic representation of pS2 clone.
The EcoR I and Hind III cDNA fragment (nucleotide 354-2658 of SBV-UK 
genome) from clone pTSBVl was inserted between EcoR I and Hind III 
restriction sites of the pMAL-c vector. The cDNA fragment was fused in 
the same translational reading frame as the malE gene. The nucleotide 
sequence of the start of the cDNA fragment is displayed.
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Figure 5.3: Expression of part of the capsid gene of SBV-UK in E. coli.
Bacteria containing clones pS 1 and pS2 or control plasmid ( pMAL-c) were 
induced with IPTG for 3 hours. Samples were taken from the cultures before (-) 
and after induction (+). Samples were analysed by SDS-PAGE on a 10% gel 
and the gel was stained with Coomassie brilliant blue. Only maltose binding 
protein (MBP, 42 kDa) from control plasmid is visible (arrow).
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pSl a major protein band was observed at approximately 50 kDa and multiple bands 
were also present ranging from 32 to 70 kDa (Figure 5.4). Clone pS2 yielded a major 
band of approximately 44 kDa and multiple bands between 38 to 60 kDa (Figure 5.4).
To confirm the presence of expressed SBV-UK protein sequences, Western 
blots were probed with antiserum to SBV-UK (1:2000) and then processed as before. 
Surprisingly, no proteins were detected at all. Western blots were therefore, also 
probed with a higher concentration of this serum (1:200) but again no protein bands 
were detected.
5.2.4 Specificity of SBV-UK antiserum
Sera to SBV-UK are not widely available. The sample used here was produced 
by Dr. B. V. Ball in Rothamsted, but was uncharacterised and was supplied for our 
use but with ‘no-guarantees’. Since we had failed to confirm the presence of SBV 
sequences in these probes, the possibility arose that the serum might be inadequate for 
this purpose. An attempt was therefore made to confirm the specificity and activity of 
this SBV-UK antiserum. 10 pi of purified SBV-UK (both gradient bands of densities 
1.34 g/ml and 1.32 g/ml) and semi-purified samples of SBV-G, TSBV and BQCV 
were resolved by SDS-PAGE and the proteins were transferred to nitrocellulose 
membrane by Western blotting. Western blots were probed with 1:2000 dilution of 
the SBV-UK antiserum. The serum failed to react with the capsid protein bands 
expected in SBV-UK (density 1.34 g/ml) from the PAGE analysis of purified virus 
performed earlier (Figure 5.5). However, a strong reaction was observed with a 40 
kDa protein band present in the lower density band SBV-UK (density 1.32 g/ml) and 
to a much reduced extent in the virus of higher density (1.34 g/ml). The same 40 kDa
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Figure 5.4: Western blot analysis of SBV-UK capsid protein expression constructs 
in E. coli.
Bacteria containing pSl and pS2 clones and a control plasmid (pMAL-c) were induced 
with IPTG for 3 hours. Samples were taken from the cultures before (-) and after (+) 
induction. Samples were analysed on a 10% SDS-polyacrylamide gel and transferred to 
a nitrocellulose membrane. The blot was probed with anti-MBP serum. Multiple protein 
bands smaller than expected size were observed in both pSl (expected size 82) and pS2 
(expected size 128 kDa) clone .
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Figure 5.5: Reaction of SBV-UK antiserum in Western blots.
Purified SBV-UK (density on CsCl 1.35 and 1.32 g/ml) and semi-purified 
preparations of SBV-G, TSBV and BQCV were resolved on 10% SDS- 
polyacrylamide gel and transferred to a nitrocellulose membrane. The blot 
was probed with anti-SB Vserum. No protein bands of expected size was 
observed in purified SBV-UK (density 1.34 g/ml).
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band was also present in all the semi-purified samples of SBV-G, TSBV and BQCV. 
The SBV-UK (density 1.32 g/ml) and TSBV samples also showed multiple protein 
bands of much larger molecular mass (approximately 120 to 250 kDa). Use of a 
higher concentration of SBV-UK antiserum (1:200) produced similar results. 
Interestingly, the serum also appeared to stain the 42.7 kDa molecular mass marker, 
carbonic anhydrase.
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5.3 Discussion
Part of the putative capsid gene (ORF) of the SBV was inserted downstream 
of the malE gene and expressed as an MBP fusion protein in E. coli DH5a. A 
polypeptide of approximately 82 kDa from pSl clone and 128 kDa from pS2 clone 
were expected on the Western blot. However, the sizes of the polypeptides from both 
the clones were much smaller and moreover, many smaller polypeptides were 
observed on the Western blots. Thus, it is likely that the fusion proteins are cleaved 
in this host resulting in smaller than full length MBP fusion proteins. The 
translational reading frame of inserts in both pS 1 and pS2 clone were confirmed by 
sequencing of the 5' ends of the inserts using the malE vector primer and no 
substitutions were detected in the first 300 nucleotides of either clone, although the 
frame could be closed later on. Clone pS2 was constructed without PCR and 
substitutions are not therefore likely. When the Western blots of these proteins were 
probed with SBV-UK antiserum, no SBV-UK specific protein was recognised. At 
first we attributed this non-detection to the degradation of the fusion protein resulting 
in loss of reactive SBV-UK specific epitope on the degraded MBP fusion protein. 
However, to rule out the possibility of poor reactivity of the SBV-UK antiserum. 
Western blot analysis of the SBV-UK proteins was performed. This SBV-UK 
antiserum could not detect SBV-UK protein on the Western blot either and thus the 
most likely explanation for these results is a defect in the antiserum. The SBV-UK 
antiserum was received as a gift from Dr. B. V. Ball. Unfortunately, it was not tested 
for its specificity of detection of SBV-UK after it was raised in rabbit. This antiserum 
was able to detect a protein of approximately 40 kDa from SBV-UK (density 1.32 
g/ml) and semi-purified SBV-G, TSBV and BQCV samples and also some high
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molecular mass proteins from SBV-UK (1.32 g/ml) and TSBV. The capsid protein 
profile of SBV-G on SDS-polyacrylamide gel has been found to be very similar to the 
SBV-UK (B. V. Ball, personal communication). TSBV produces 3 well defined bands 
of capsid protein (30.2, 34, 38.7 kDa ) on SDS-polyacrylamide gel (Bailey et a l, 
1982). Whereas, BQCV has been reported to have only one major capsid protein of 
30 kDa (Bailey & Woods, 1977a). Therefore, 40 kDa protein and other high 
molecular mass proteins, detected by the anti-SBV-UK serum did not belong to any of 
the SBVs. Semi-purified samples of SBV-G, TSBV and BQCV were used for the 
Western blot and these would contain host (honey bee larva/pupa) proteins. The SBV- 
UK (density 1.32 g/ml) may also be similarly contaminated with host cell proteins at a 
lower density of 1.32 g/ml. Therefore, it is possible that 40 kDa protein and other 
larger molecular mass proteins, detected by the SBV-UK antiserum could be derived 
from host cellular protein and thus, the SBV-UK antiserum used in this experiment 
may not be specific to SBV-UK. Further Western blot analysis of SBV-UK proteins is 
required and for this fresh SBV-UK specific antiserum should be used.
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Most of the poorly characterised insect RNA viruses were traditionally 
grouped with picornaviruses on the basis of biophysical properties. To date, only IFV 
has been reported to genuinely picomavirus-like (capsid gene encoded at the 5' end 
and non-structural gene at the 3' end of the genome). Other insect viruses (DCV, 
RhPV, PSIV, APV and CrPV) are members of a unique group of picoma-like viruses 
with a calicivirus-like genome organization. The sequence data for SBV-UK 
presented here suggests that this honey bee virus has a picomavirus-like genome 
organization which it shares with IFV. A comparison of the genome organization of 
SBV-UK with those of mammalian and plant picoma-like vimses is shown in 
Figure.6.1. Although the arrangement of the capsid proteins in the PI precursor of 
SBV-UK appeared to be different from mammalian picomavimses, the arrangement 
of the NTP-binding, protease and polymerase motifs in SBV-UK polyprotein is 
similar to that in several vimses in the picorna-like supergroup.
HAV and HPeV 1, each differ from other mammalian picomavimses by a 
greater extent than the other mammalian picomavimses differ amongst themselves. 
The identity of both HAV and HPeV polypeptides with corresponding proteins of 
other mammalian picomavimses varies between 14 and 35% (Cohen et ah, 1987; 
Hyypia, et al., 1992). Similar results were obtained when SBV polyproteins were 
compared with IFV and mammalian picomavimses; the identity varied from 14% to 
30% (section 3.3.3.3). Therefore, the similarity of SBV-UK to both IFV and 
mammalian picomavimses is low. However, the SBV-UK polyprotein was most 
similar to IFV showing an overall 23.2% identity and 45.4% similarity in amino acid 
sequence and the phylogenetic analysis on the basis of putative RNA-dependent RNA 
polymerase protein also showed that SBV-UK was more closely related to IFV than
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Chapter 6
to other members of the picorna-like viruses (section 3.3.4). Therefore, although 
SBV-UK may resemble IFV, in gene order the relationship between these two viruses 
is perhaps as distant as that between HAV and HPeV and other mammalian 
picornaviruses. Thus although, SBV-UK and IFV are both insect picoma-like vimses, 
they may eventually be found to belong to different genera.
The lack of an in vitro system for the propagation of SBV is a serious 
problem. Suitable honey bee cell lines are urgently needed to further the study of 
these agents in the laboratory; and to permit plaque purification of honey bee vimses.
The putative cleavage sites of SBV-UK were suggested by analogy with IFV 
and picomavimses, and appeared to be heterogeneous. N-terminal sequence of SBV- 
UK proteins is required to identify these sites.
The results of the cross hybridisation experiment showed that the SBV-UK 
cross hybridise with both SBV-G and TSBV. This finding supports the serological 
relatedness among these 3 SBVs (Ball, B. V., personal communication; Bailey et al., 
1982). At present there is no molecular means for the diagnosis of SBV in infected 
honey bees is available. Detection of SBV in naturally infected bees is still dependent 
on serological methods which have often been proved unreliable (Bailey et al., 1979; 
Ball & Bailey, 1991). In the present study clone p2SBV32 labelled with dCTP 
was able to detect all the 3 types of SBV RNAs on Northem blot hybridisation. No 
cross hybridisation was found with RNAs from semi-purified vims samples of BQCV 
and ABPV. Therefore, this technique might be developed for application to infected 
honey bee samples.
The RT-PCR technique developed in the present study using SBV-UK 
specific primers was able to amplify part of the polymerase gene from all the 3 SBVs.
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Therefore, this technique could also be used to detect SBVs in mixed or inapparent 
virus infections, to facilitate future studies of other SBV strains, and distinguish 
between SBV and BQCV. However, without further development some confusion 
with ABPV is also likely.
Part of the putative capsid gene (ORF) of SBV-UK was expressed as an MBP 
fusion proteins in E. coli DH5a.. But no SBV-UK specific protein was detected. To 
investigate the specificity of the anti-SBV-UK serum. Western blots of the SBV-UK 
particle proteins were probed with the anti-SBV-UK serum. However, this antiserum 
could not detect any of the SBV-UK capsid protein bands either and thus indicated a 
defect in the antiserum. Therefore, specific anti SBV-UK serum is required to 
investigate whether expressed MBP fusion proteins indeed contain any SBV-UK 
protein species.
The data presented in this thesis has increased knowledge about the genome 
organization and detection of SBVs of honey bee and it is hoped, may facilitate future 
studies in this area.
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APPENDIX 1
The chemicals and reagents used in these studies were obtained from the following 
suppliers:
Amersham International pic.
a32p dCTP.
Applied Biosystems
Reagents and other components for the synthesis of oligonucleotides.
Biotecx Laboratories
RNAzol B.
BDH Chemicals Ltd
Ammonium acetate (AnalaR); ortho-Boric acid (AnalaR); Bromophenol blue; Butan-
2-ol; Calcium chloride 6-hydrate; Chloroform;Propan-2-ol; Formaldehyde; Liquid 
paraffin; Magnesium chloride 6-hydrate (AnalaR); Polyethylene glycol; Sodium 
hydroxide (AnalaR); Sodium acetate anhydrous (AnalaR); Phenol (AnalaR).
Biorad
Pre-stained protein molecular weight markers (low range).
Boehringer Mannheim
Calf intestine alkaline phosphatase; Restriction enzymes and lOX buffers; 
Ribonuclease A; ribosomal RNA size markers.
Fuji photo film Co. Ltd.
X-ray RX film.
Genosys Biotechnologies
Oligonucleotide primers.
Gihco BRL
Electrophoresis grade agarose, Bacteriophage lambda DNA, E. coli DNA polymerase 
I; E. coli RNase H; SperScript reverse transcriptase I.
Invitrogen
PcDNAE.
May and Bayker
All solvents: chloroform, ethanol, glacial acetic acid, methanol.
Novagen
pT7Blue(R).
108
Appendix 1
New England Biolabs
pMAL-c; anti-MBP antisera.
Pharmacia Biotech
Oligo (dT) 12-18, T4 DNA polymerase; T4 DNA ligase; restriction enzymes and lOX 
buffers, DBPC treated water.
Pierce
Luminescent substrate.
Promega
Wizard DNA clean up system.
Quiagen
QIA quick gel extraction kit.
Schleicher and Schuell
Nitrocellulose membranes.
Sigma Chemicals Ltd
Acrylamide; Ammonium persulphate; Ampicillin;Bovine serum albumin; Coomassie 
brilliant blue G; D-L—dithiothreitol (DTT); Ethidium bromide; EDTA; Fetal calf 
serum; Formamide; Isopropyl p-D-thiogalactopyranoside (IPTG); 5-bromo-4-chloro-
3-indolyl-P-D-galactopyranoside (X-gal); 2-mercaptoethanol; N-lauroylsarcosine 
(sodium salt); N;NiN'N'-tetramethyl ethylenediamine (TEMED); Protein molecular 
weight markers; Salmon sperm DNA; Caesium chloride (CsCl); Guanidine 
thiocyanate; Anti mouse IgG peroxidase conjugate.
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APPENDIX 2 
CULTURE MEDIA 
Rich medium+glucose and ampicillin
Bactotryptone 10 g
Yeast extract 5 g
NaCl 5 g
Glucose 2 g
Water to 1000 ml. After autoclaving sterile ampicillin was added to 100 pg/ml.
SOB medium
Bactotryptone 20 g
Bacto-yeast extract 5 g
N ad 0.5 g
250mM Kcl 10 ml
water to 1000 ml. The pH was adjusted to 7.0 with NaoH. After autoclaving 5 ml of 
sterile solution of 2 M Mgcl2 was added.
YT medium
Bactotryptone 8 g
Yeast extract 5 g
Nad 5g
water to 1000 ml, autoclaved.
Antibiotics
Ampicillin was added to the final concentration of 50 pg/ml or 100 pg/ml.
IPTG
IM IPTG was prepared in water and stored in 1ml aliquots 
X-gal
20% x-gal solution was made in formamide and stored at -20^C
Bacterial agar plates
YT medium
Bactotryptone 8g
Yeast extract 5g
Nad 5g
H2O to 1 litre
Antibiotic was added to the final concentration of 10 mg/ml.
Agar-plates
For the growth of bacteria on solid media, agar plates were prepared by dissolving 
Bactoagar to a final concentration of 1.2% in 2YT medium. The molten agar medium 
was cooled to 56®C and ampicillin was added to the final concentration of 50 pg/ml. 
Approximately 15 mis of molten media was poured into each bacterial petri dish and
110
Appendix 2
allowed to set. The plates were then dried for about, 10 minutes. For blue/white lac Z  
complementation screening of the pcDNA II and pT7Blue(R) vector, the agar-plates 
were prepared as above with the incorporation of the inducer isopropylthio-B-D- 
galactoside (IPTG) to a final concentration of 0.25mM and the colour change 
substrate 5-bromo-4-chloro-3-indolyl-B-D-galactoside (X-gal) to 0.005%.
GENERAL BUFFERS AND SOLUTIONS 
Sodium acetate
3 M sodium acetate solution was prepared in water and pH was adjusted to 5.2 with 
glacial acetic acid and autoclaved.
Ammonium acetate
4 M ammonium acetate solution was prepared in water and filter sterilised.
EDTA
0.5 M EDTA was prepared in water and the pH was adjusted to 8.0 with NaOH 
pellets and autoclaved.
Tris-HCl
1 M tris-HCl was prepared in water and the pH adjusted to the desired value by 
adding concentrated HCl. The solution was sterilized by autoclave.
Sodium dodecyl sulphate (SDS)
10% SDS solution was prepared with electrophoresis-grade SDS in water. The pH 
was adjusted to 7.2 with HCl and the solution was filter sterilised.
Sodium hydroxide
4 M NaOH solution was prepared in water and stored in a plastic bottle.
Phenol
Phenol stored at -20°C was allowed to warm to room temperature and then melted at 
68®C. Melted phenol was saturated with 0.1 M Tris-HCl, pH 8.0 and stored in the 
presence of the antioxidant 8-hydroxyquinolone (0.1% w/v) at 4^C.
Phenol/Chloroform
Phenol:Chloroform was prepared as mixture consisting of equal parts of equilibrated 
phenol and chloroform. The mixture was stored under 100 mM Tris-HCl (pH 8.0).
5X first strand buffer
Tris-HCl ( pH 8.3) 250 mM
KCl 375 mM
MgCl2 15 mM
The buffer was supplied with Superscript E RNase H" reverse transcriptase.
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lOX second strand buffer
Tris-HCl (pH 8.3) 188 mM
KCl 906 mM
MgCl% 46 mM
DTT 37.5 mM
T4 DNA polymerase buffer
Tris-HCl (pH 7.9) 0.33 M
Potassium acetate 0.66 M
Magnesium acetate 0.1 M
DTT 5mM
lOX ligation buffer
Tris-Hcl (pH 7.6) 660 mM
MgCl2 100 mM
DTT 150 mM
Spermidine 10 mM
Bovine serum albumin 2 mg/ml
This buffer was supplied with T4 DNA ligase by Pharmacia Biotech.
NT buffer
NaCl 100 mM
Tris-HCl, pH 7.4 10 mM
Transformation buffer (TB)
Pipes 10 mM
MnCl2 55 mM
Cacl2 15 mM
KCl 250 mM
All the components except for MnCl2 were mixed and the pH was adjusted to 6.7 
with KOH.
SOLUTIONS FOR PLASMID MINI PREP
Resuspension buffer
Tris-HCl, pH 7.5 50 mM
EDTA lOmM
RNAse A 100 pg/ml
Lysis buffer
NaOH 0.2 M
SDS 1%
Neutralization buffer
2.55 M potassium acetate. pH adjusted to 4.8 with glacial acetic acid.
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Diatom suspension
Guanidine thiocyanate 4 M
Tris HCl, pH 7.0 20 mM
EDTA 20 mM
Diatoms 10 mg/ml
Pellet wash solution
NaCl
Tris HCl, pH 7.5
EDTA
Ethanol
0.1 M 
10 mM 
2.5 mM 
50%
SOLUTIONS FOR HYBRIDISATION
Stop/ Quench solution
Nad 20mM
Tris-HCl (pH 7.5) 20 mM
EDTA 2mM
SDS 0.25%
Prehybridisation buffer
6X SSC 15ml
EDTA (10 mM) 2.5 ml
5X Denhardt's 2.5 ml
SDS (0.5%) 1.5 ml
Salmon sperm DNA 0.5 ml
(0.1 mg/ml)
Water to 50 ml
MOPS buffer
Morpholinopropionic acid 0.2 M 
Sodium acetate 5.0 mM
EDTA (pH 7.0) 1.0 mM
20X SSC
NaCl 3.0 M
rn-sodium citrate 0.3 M
2X SSC
N ad
sodium citrate
0.3 M 
30 mM
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SOLUTIONS FOR SDS-PAGE
Resolving gel (10%)
10 ml acrylamide:bisacrylamide (40:1)
20 ml 0.75M Tris, pH 8.8 
200 pi 20% SDS
9.2 ml water
800 pi ammonium persulphate (20 mg/ml)
16 pi Temed
Resolving gel (12%)
12.6 ml acrylamide:bisacrylamide 
20 ml 0.75M Tris, pH 8.8
200 pi 20% SDS
6.6 ml water 
200 pi 20% SDS
1.2 ml ammonium persulphate 
24 pi Temed
Stacking gel (4%)
2 ml acrylamide:bisacrylamide 
10 ml 0.25 M Tris, pH 6.8 
100 pi 20% SDS 
7.5 ml water
500 pi ammonium persulphate 
20 pi Temed
SDS-PAGE sample buffer
Tris-HCl (pH 6.8), 0.25 M 5.0 ml 
20% SDS 2 ml
Glycerol 4 g
2-Mercaptoethanol 0.5 ml
1% bromophenol blue 0.1 ml
Water to 10 ml
Tris-glycine electrophoresis buffer
Tris-base 3.02 g
Glycine 14.44 g
20% SDS 5 ml
Water to 1 litre
Coomassie stain
Kenacid brilliant blue 1.25 g
Propan-2-ol 125 ml
Acetic acid 50 ml
water 325 ml
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Destain solution
Propan-2-ol 125 ml
Acetic acid 50 ml
water 325 ml
SOLUTIONS FOR WESTERN BLOT 
Transfer buffer
Tris-base 25 mM
Glycine 192 mM
Methanol 20%
Rinse buffer
PBS plus 50 pi Tween 20 per 100 ml water
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APPENDIX 3
SINGLE LETTER AMINO ACID CODE
A Alanine
C Cysteine
D Aspartic acid
E Glutamic acid
F Phenylalanine
G Glycine
H Histidine
I Isoleucine
K Lysine
L Leucine
M Methionine
N Asparagine
P Proline
Q Glutamine
R Arginine
S Serine
T Threonine
V Valine
W Tryptophan
Y Tyrosine
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